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SUMMARY 
Answers have been sought for two key questions relevant to the 
proposed mode of action of the thymus as a 11 central" lymphoid organ. 
Does the peripheral lymphocyte population contain a large number of 
thymus-derived cells and do these cells respond to antigens by producing 
a progeny of antibody-forming cells? 
The number of small lymphocytes emerging from a thoracic duct 
fistula in young adult neonatally-thymectomized CBA mice was approxi-
mately 2o/o of that in intact mice of the same age and body weight. 
Multiple injections of chromosomally-marked thymus cells increased 
the size of the lymphocyte pool and the majority of thoracic duct cells, 
stimulated into division, carried the chromosome marker of the thymus 
cell donor. Thymectomy in adult life was not followed by a significant 
decrease in the output of thoracic duct lymphocytes until many months 
after the operation. Whole body x-irradiation resulted in a dramatic 
reduction in the number of cells drained from a thoracic duct fistula 
and, in mice protected from the lethal effects of haemopoietic failure, 
the reestablishment of the lymphocyte population was dependent upon 
the presence of the thymus. The data supports an increasing bulk of 
indirect evidence which, when taken in toto, strongly suggests that a 
large proportion of recirculating lymphocytes are thymus -derived cells 
or their descendants. 
The number of sheep erythrocyte antigen-reactive cells (ARC) 
in the thoracic duct lymphocyte population of neonatally-thymectomized 
mice was markedly reduced when compared with the number in the 
population from normal mice. The bone marrow did not contain ARC 
but was a potent source of ARC precursors. Neonatally-thymectomized 
mice did not lack precursor cells in the bone marrow but apparently 
lacked the thymus influence necessary for the differentiation of these 
precursors into ARC. Further studies on the thymus-dependent 
(x) 
development of ARC hinted at the possibility that the entity known as 
"an ARC" required the presence of both thymus- and bone marrow-
derived cells to express itself in terms of haemolysin production. 
Neonatally-thymectomized CBA mice failed to respond in normal 
fashion to a primary injection of sheep erythrocytes (SRBC) and the 
peak number of haemolysin plaque-forming cells (PFC) in the spleen 
was reduced by a factor of 1 log10. The PFC response was increased 
by injections of either thymus or thoracic duct lymphocytes from CBA, 
(CBA x C57BL)F 1 hybrid, and C57BL donor mice. In thymectomized 
mice reconstituted with s emiallogeneic and allogeneic cellular inocula, 
the PFC carried the immunogenetic characteristics of the host and not 
those of the inoculated cells. Hence, thymus and thoracic duct cells 
were not reconstitutive simply by virtue of the ability to transform into 
PFC. 
Thymus and thoracic duct cell inocula contained "reactor cells" 
which responded to SRBC antigens in irradiated mice by undergoing 
a burst of mitosis. Thoracic duct lymphocytes, unlike thymus and 
bone marrow cells, were able to produce PFC when injected together 
with SRBC into irradiated mice. However, the PFC response in 
irradiated recipients of thoracic duct lymphocytes was increased substan-
tially by a simultaneous injection of bone marrow cells. Combinations 
of cells from semiallogeneic mice did not interact upon transfer to 
irradiated recipients but clear evidence of synergism in PFC production 
was apparent in adult-thymectomized irradiated mice protected with 
CBA bone marrow cells and injected two weeks later with (CBA x C57BL)F 1 
thoracic duct cells. In this case, the vast majority of PFC were derived 
from the bone marrow inoculum. 
The results suggest that the bone marrow contains only PFC 
precursors, the thymus only "reactor cells", b:ut that the thoracic duct 
lymph contains both cell types. It seems that the normal 19S haemolysin 
response to SRBC in the CBA mouse requires the collaboration of 
bone marrow-derived PFC precursors and thymus-derived "reactor 
cells". The neonatally-thymectomized mouse contains adequate 
numbers of PFC precursors but, after challenge with SRBC, few 
are recruited into 198 haemolysin production because of the severe 
deficiency in thymus-derived''reactor cells". 
(xii) 
I. INTRODUCTION 
A. The Circulating Pool of Lymphocytes and the Effects of 
Thymectomy on Peripheral Lymphocyte Populations 
The small lymphocyte has long been recognized as the major 
cellular constituent of lymph and lymphoid tissues. One of the 
notable advances in cellular immunology over the past decade or so 
has been the demonstration that these morphologically identical 
small lymphocytes are, in point of fact, representativesof a hetero-
geneous population of cells with different functions and life histories. 
The population may be divided for convenience into three "lympho-
cyte compartments", namely, thymus, circulating pool and bone 
marrow (e. g. Miller and Osoba, 1967). As will be discussed, the 
bulk of the lymphocytes in these three compartments may have 
vastly different functions, fates, and life spans but they may be 
related through differentiative cell lineages. In this section the 
effects of thymectomy on the cellular composition of the peripheral 
lymphoid organs, and the circulating lymphocyte pool in particular, 
will be examined in detail. In addition, the possible sites of 
origin of the lymphocytes in organs such as the spleen and lymph 
nodes will be considered, the emphasis being placed on the cellular 
contribution of the thymus to the circulating pool. 
( 1) The lymph -borne lymphocytes 
The technique of lymphatic cannulation has been used as a 
means of enumerating lymph-borne lymphocytes (reviewed in Yoffey 
and Courtice, 1956). Early investigations established that the 
lymph in the major lymphatic vessels ("central lymph") contained 
1. 
many more small lymphocytes than the "peripheral lymph" which 
drained into organized lymphoid aggregates such as the lymph 
nodes and Peyer1 s patches (Baker. 1933; Yoffey and Drinker.1939; 
Ehrich and Harris. 1942 ). The conclusion therefore seemed 
warranted that the majority of lymphocytes constantly entering the 
blood from the lymphatics were newly formed within the lymph 
nodes and were not. as suggested by Sjovall (1936). part of a 
recirculating population of cells migrating from blood to lymph 
within the connective tissues. As a necessary corollary. the 
lymphocytes in the blood and lymph were assumed to have a short 
life span and to be destined to die in some anatomical "graveyard" -
a site which thwarted all attempts at identification. 
The results of cell output determinations in chronically 
drained. unanaesthetized rats led to much revised thinking on the 
fate of the ubiquitous small lymphocyte. Mann and Higgins (1950) 
first described a progressive decrease with time in the number of 
cells emerging from a thoracic duct fistula in rats. With the 
assumption that lymphocytes were manufactured in the lymph nodes. 
one would not expect the number in efferent lymph to be affected by 
chronic drainage unless the lymph. cells. or cell breakdown 
products were essential for continued production of new cells within 
the nodes. By comparing the output of cells from the thoracic duct 
and the intestinal and hepatic lymphatics. Mann and Higgins also 
demonstrated that the major cellular contribution to the thoracic 
'\ 
duct· was from the intestinal region and presumably the mesenteric 
lymph nodes and Peyer' s patches. This conclusion has been challenged 
by Fichtelius (e. g. Fichtelius, 1960; Fichtelius and Bryant. 1964) 
who described a preferential localization of injected lymph node and 
thymus lymphocytes in the liver and hepatic lymph nodes. A number 
of objections can be raised to these experiments and thus to the 
2. 
conclusion that there is an asymmetric recirculation of lymphocytes 
through the hepatic lymphatics (vide infra). Mann and Higgins 
also found no correlation between the output of cells and the volume 
of lymph drained on any one day of drainage. Furthermore, rats 
cannulated after three days of restraint displayed no differences, from 
rats not stressed prior to cannulation in the pattern of thoracic duct 
cell output. 
Gowans (1957, 1959a) confirmed and greatly extended many 
of the observations of Mann and Higgins. Using rats maintained by 
reinfusion of cell-free lymph, Gowans fully documented the progressive 
decline in cell output over the first 4 to 5 days of thoracic duct 
drainage. A crucial finding was provided by Gowans (1957) when he 
showed that by slowly reinfusing viable thoracic duct cells, the fall 
in cell output could be obviated. In addition, the intravenous infusion 
of syngeneic lymphocytes into chronically-drained rats significantly 
elevated, and then maintained, the output of cells (Gowans, 1959a). 
The first direct evidence for recirculation of lymphocytes was 
provided in this paper. Thoracic duct cells were harvested from 
donors injected with P 32 and were infused into other chronically-
drained rats. The donor lymphocytes were shown to be labelled 
and the increase in radioactivity in the cells from the thoracic duct 
of the recipient paralleled the increased cell output. Shorter and 
Bollman (1960) also recorded a marked increase in the radioactivity 
of cells in the intestinal lymph of rats 24 hours after intravenous 
. . t' f c 51 32 . lllJec wns o r - and P -labelled thorac1c duct cells. By 
injecting tritiated thymidine into the recipients, the increased 
number of cells emerging from the thoracic duct was shown by 
Gowans not to be due to the appearance of newly-formed lymphocytes. 
He concluded that constant replenishment of the blood lymphocyte 
3. 
4. 
compartment was essential for maintaining the thoracic duct lymphocyte 
output in rats. An interesting observation, which has been adequately 
confirmed (Caffrey, Rieke and Everett, 1962; McGregor and Gowans, 
1963; McGregor, 1966), was that the output of large and medium 
lymphocytes (a large proportion of which incorporate tritiated thy-
midine in vitro and in vivo) did not fall dramatically with increasing 
times of drainage. These cells were therefore most likely to have 
been newly formed within the lymph nodes and must differ in this 
respect from the majority of thoracic duct small lymphocytes. 
The output of cells from the thoracic duct of unanaesthetized 
mice has been recorded over short periods of drainage by Shrewsbury 
(1959) and Boak and Woodruff (1965) and for longer periods by Gesner 
and Gowans (1962a), Houba and Houba (1966), Mandel (1967) and 
Morse and Riester (1967). As in rats, the number of lymphocytes 
decreased markedly some days after the commencement of drainage 
and the proportion of large lymphocytes increased. No correlation 
was observed between lymph and cell outputs and mice stressed prior 
to cannulation did not exhibit any alterations in the essential features 
of the daily cell output profile (Gesner and Gowans, 1962a). 
Strong supporting evidence for the existence of a recirculating 
population of lymphocytes has come from the work of Hall and Morris 
( 1964, 1965a) in sheep. Following local irradiation of the popliteal 
lymph node, the reduction in the number of lymphocytes in the 
efferent lymph was not as great as would have been expected if cells 
were being produced within the node. In another experiment, tritiated 
thymidine was infused for 100 to 150 hours into the afferent lymphatics 
of unstimulated nodes. The cells draining from efferent cannulae 
were examined autoradiographically for the presence of labelled cells. 
By estimating the proportion of the lymph node actually infused with 
tritiated thymidine, and by enumerating labelled cells in the efferent 
lymph, Hall and Morris (1965a) calculated that no more than 4o/o 
of the small lymphocytes in the lymph were produced by cell 
division within the node. The finding that the majority of large 
lymphocytes had incorporated the tritiated thymidine suggested 
that this morphological cell type may originate in lymph nodes by 
processes involving DNA synthesis. 
Olsen and Yoffey (1967) have called attention to the fact that 
the ·popliteal lymph node in the guinea pig is an 11 oligosynthetic11 
node. The proportion of labelled lymphocytes leaving in the efferent 
lymph is therefore unlikely to be as great as that from 11 polysynthetic11 
structures such as the Peyer1 s patches and the mesenteric and 
cervical lymph nodes. Even though this objection to the conclusions 
of Hall and Morris may influence any calculation on the extent of 
recirculation of lymphocytes through lymph nodes, the proportion of 
labelled lymphocytes leaving an infused lymph node probably reflects 
the degree of local antigenic stimulation (Hall and Morris, 1965a, b). 
Hence. the conclusion still seems valid, that in the resting node the 
majority of small lymphocytes in the efferent lymph have not been 
produced within the substance of the node. 
(2) The life span of lymphocytes 
That a proportion of blood and lymph-borne lymphocytes has 
a long life span is now firmly established. The best evidence for 
this comes from tritiated thymidine studies in rodents and cytogenetic 
studies in man (reviewed in Gowans, 1966; Elves, 1966; Everett and 
Tyler, 1967). Little, Brecher, Bradley and Rose (1962) and Robinson, 
Brecher, Lourie and Haley (1965) followed the appearance of labelled 
cells and, more importantly, the persistence of unlabelled cells 
(which were therefore undamaged by the uptake of tritium) in the 
5. 
blood of rats after prolonged infusions of tritiated thymidine. The 
presence of unlabelled small lymphocytes after months of tritiated 
thymidine administration, coupled with the rapid labelling of 100o/o 
of the blood neutrophils, led these workers to conclude that some 
small lymphocytes in the rat may have a life span of many months 
if not years. Cytogenetic studies in man, using peripheral blood 
cells from patients exposed some time previously to therapeutic 
x-irradiation, have shown that, under the influence of PHA, cells 
with severe radiation-induced chromosomal observations can be 
induced into mitosis. The aberrations were considered inimical 
to cell viability after mitoses and it was concluded that the cells 
must have survived in interphase from the time of irradiation to 
the time of PHA stimulation. The life span of such damaged lympho-
cytes has been measured in terms of years (Buckton, Jacobs, Court ' 
Brown and Doll, 1962; Buckton and Pike, 1964; Court Brown, Buckton 
and McLean, 1965; Norman, Sasaki, Ottoman and Fingerhut, 1965). 
Using radioisotopically-labelled carbon and phosphorus, the life span 
of some lymphocytes in patients with chronic lymphatic leukaemia 
had previously been estimated to be greater than 12 months (Hamilton, 
1954; Christensen and Ottesen, 1955). An objection to such evidence, 
based on the reutilizaUon of the label and labelled DNA or DNA pre-
cursors, has been raised by Hamilton (1956). 
Only a very small proportion of blood or thoracic duct small 
lymphocytes in a variety of species including the mouse, incorporate 
tritiated thymidine after short exposure times in vivo or in vitro 
(Cronkite, Bond, Fliedner and Rubini, 1959; Schooley, Bryant and 
Kelly, 1959; Gowans, 1959a; Everett, Rienhardt and Yoffey, 1960; 
Gowans, 1962; Whitelaw, 1965; Perry, Irvin and Whang, 1967). 
Caffrey et al. (1962) subjected growing rats to multiple injections of 
6. 
tritiated thymidine and, by means of autoradiography, examined the 
peripheral blood and thoracic duct small lymphocytes at intervals 
thereafter. The curve of the reduction in the number of labelled 
small lymphocytes with time was found to be biphasic. The work 
of this group (summarized in Everett and Tyler, 1967) strongly 
suggested that circulating small lymphocytes may be considered, 
in broad terms, as being either long-lived or short-lived cells. 
Cell smears from bone marrow and thymus contained no labelled 
small lymphocytes 16 days after ceasing a two weeks' course of 
12 tritiated thymidine injections. By contrast,the proportion of 
labelled small lymphocytes in thoracic duct lymph, blood, mesen-
teric lymph node and spleen preparations declined rapidly in the 
first two weeks and decreased more slowly thereafter. Estimations 
of the average life span of the short-lived small lymphocytes are 
worthless, mainly because of the problem of reutilization of label 
(Craddock, Nakai, Fukuta and Vanslager, 1964; Robinson et al., 
1965) and the fact that the rats were still growing. On the other 
hand, the data provides good evidence that the great majority of 
small lymphocytes in the bone marrow and thymus are short lived 
whereas organs involved in the circulation of lymphocytes (vide 
infra) contain a variable number of long-lived lymphocytes. The 
existence of more than one population of lymphocytes in the thoracic 
7. 
duct lymph of rabbits was suggested by the labelling experiments of Coassin 
and Kline (1957) and the preponderance of short-lived lymphocytes in the 
thymus and bone marrow has been demonstrated by many workers 
(Craddock~·, 1964; Osmond and Everett, 1964; Craddock, 1965; 
Matsuyama, Wiadrowski and Metcalf, 1966). 
In other experiments performed by the Everett group, tritiated 
thymidine was injected every 6 hours for 2 weeks and the rats killed 
at intervals during the injection regime. Plots of the percentage of 
small lymphocytes labelled in different organs showed that 90 to 
100o/o of bone marrow and thymus small lymphocytes were labelled 
within 4 to 5 days but that labelled small lymphocytes in spleen, 
blood, mesenteric lymph node and thoracic duct lymph accumulated 
more slowly. A sharp break was apparent in the slope of the curve 
of the cumulative percentage of labelled blood small lymphocytes and 
a far less obvious one was described in the thoracic duct small 
lymphocyte curve. Everett, Caffrey and Rieke (1964) and Everett and 
Tyler (1967} calculated from the data that 60 to 70o/o of the small 
lymphocytes in the blood and 90o/o of the small lymphocytes in the 
thoracic duct lymph were long-lived cells. These figures are in 
keeping with similar data and calculations reported by Rieke and 
Schwarz (1967) and Robinson et al. (1965). Caffrey et al. (1962) 
coined the term "mobilizable lymphocyte pool" (MLP) to describe 
the total population of lymphocytes drained from a thoracic duct 
fistula in two to three days. The proportion of emergent small 
lymphocytes, which had been labelled by multiple injections of 
tritiated thymidine prior to cannulation, remained constant during 
this period of drainage. It has been pointed out that the figure 
quoted for the number of cells in the MLP may be an overestimate 
of the number of cells actually involved in recirculation since the 
loss of cells from the pool may mobilise many others (Gowans, 1966). 
Caffrey et al. (1962 ). using a single rat, showed that a pulse of 
tritiated thymidine prior to cannulation labelled 1 o/o of small lympho-
cytes but that if injected after 4 days of drainage, 10o/o of small 
lymphocytes were labelled. The absolute number of labelled small 
ly~phocytes was unchanged and a steady state production of this cell 
type was therefore suggested. 
8. 
(3) The route of recirculation of lymphocytes through lymphoid tissues 
The experiments reported by Gowans and Knight (1964) have 
unequivocally established that some lymphocytes recirculate from 
blood to lymph and that the main site of migration from the blood 
stream is within the diffuse cortex of lymph nodes. In this paper the 
effects of stress and heparin were shown to be insignificant factors 
involved in cell output determinations from restrained rats receiving 
heparinized cell-free lymph as a reinfusion mixture. Following 
incubation of thoracic duct cells with tritiated adenosine or thymidine 
and injection into recipient rats, very few large lymphocytes were 
shown to be capable of migrating from blood to lymph. A large 
proportion of the inoculated small lymphocytes, however, appeared 
in the thoracic duct with no reduction, following autoradiographic 
processing of thoracic duct cell smears, in the mean grain count 
per cell. Several hours after injecting thoracic duct cell populations 
depleted of large lymphocytes in vitro (Gowans, 1962; Gowans and Uhr, 
1966), small lymphocytes could be detected in all the lymph nodes. 
Initial concentrations were observed in the mid and deep cortex within 
the endothelial cells of the postcapillary venules and particularly in 
the periendotheliallayers of the venules. Labelled cells were rarely 
present in the subcapsular sinus, lymphoid follicles and germinal 
centres. 
Time course studies on the appearance of labelled cells in the 
cortex of the lymph nodes strongly suggested that the direction of 
migration was from blood to lymph and that cells ultimately passed 
out of the nodes via the medullary sinuses and, presumably, the 
efferent lymphatics. A partial depletion of the injected small lympho-
cytes could be achieved by thoracic duct drainage of the recipients. 
The Peyer' s patches and spleen also contained many of the injected 
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thoracic duct small lymphocytes and the postcapillary venules in the 
Peyer' s patches seemed to possess properties in common with 
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similar structures in the lymph nodes. In the spleen, initial concen-
trations of labelled small lymphocytes were observed in the red pulp. 
At later time points, the Malpighian follicles and, more specifically~ 
the areas around the central arterioles, were crowded with labelled 
small lymphocytes. Recent work has indicated that the cells migrate 
into the white pulp from the marginal zone by passing between the 
lining cells of the marginal sinus {Goldschneider and McGregor, 1968a). 
The ultrastructural studies of Marchesi and Gowans { 19 64) 
demonstrated quite clearly that the small lymphocytes migrate from 
the blood into the substance of the lymph nodes by passing through 
the endothelial cells of the postcapillary venules. The lymphocytes 
differed in this respect from inflammatory cells, such as neutrophils 
and monocytes, which migrated out of the blood by passing between 
the endothelial cells of the venules. Hudson and Yoffey {1966) have 
also shown that small lymphocytes in the guinea pig bone marrow 
migrate between the substance of the marrow and the blood stream 
by passing between the lining cells of the sinusoids. 
The capacity of small lymphocytes to penetrate and traverse 
the cells of the postcapillary venules may be related to configurations on, 
or constituents of, the lymphocyte surface and to certain properties 
of the specialized endothelial cells themselves. Gesner and Ginsburg 
{1964) showed that after treatment of thoracic duct lymphocytes with 
glycosidases, the passage of these lymphocytes through endothelial 
_ cells was largely inhibited. Trypsin also temporarily reduced the 
number of inoculated Cr 51 -labelled thoracic duct cells appearing in 
the thoracic duct of recipient rats {Woodruff and Gesner, 1968). 
Goldschneider and McGregor {1968a) recently reported that by promo-
ting lymphocyte migration in animals depleted of circulating lymphocytes, 
the histological appearance of the postcapillary venule changed, 
the endothelial cells becoming larger and pyronin positive. Similar 
changes have been described by Burwell (1962) and Kruger (1968) 
in antigenically stimulated lymph nodes of rabbits and mice and it 
is tempting to postulate that this is a result of an increased migra-
tion of lymphocytes into the node. An alternative possibility is that 
the endothelial cells play an active role in the processing of antigen 
or the triggering of competent cells in the population of recirculating 
lymphocytes (Burwell, 1962; Ballantyne and Burwell, 1965). A 
further proposal, which also lacks any experimental proof, is that 
the endothelial cells of the postcapillary venule are plasma cell 
precursors and that they receive the stimulus for differentiation from 
migratory small lymphocytes (Sainte-Marie, 1966). 
The histological consequences of chronic thoracic duct 
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drainage have been fully documented in the rat (McGregor and Gowans. 
1963; McGregor, 1966; Goldschneider and McGregor, 1968a). Imme-
diately following prolonged periods of drainage and reinfusion of 
cell-free lymph, a decrease in the weight of all lymph nodes was re-
corded, irrespective of whether the efferent lymphatics drained into 
the thoracic duct (McGregor and Gowans, 1963). A marked lympho-
penia was apparent after drainage and lymphocyte counts remained 
depressed for 3 to 4 weeks after closing the fistula. Within the 
lymphoid tissues. certain areas in the Peyer' s patches and the cortices 
of the lymph nodes were depleted of lymphocytes. Lymphoid follicles 
and germinal centres appeared normal with respect to both number and 
cellularity (McGregor, 1966; Goldschneider and McGregor, 1968a). 
Similarly. the medullary regions of the lymph nodes displayed no 
differences in chronically-drained and restrained rats. In the 
spleen a paucity of lymphocytes was noted in the areas of the white 
pulp immediately surrounding the central arterioles.· 
It is apparent from the results of these studies, that the 
regions of the spleen~ lymph nodes~ and Peyer' s patches which 
are depleted of lymphocytes by thoracic duct drainage are those 
to which intravenously-injected labelled thoracic duct lymphocytes 
migrate in large numbers. McGregor {1966) noted that the 
depleted areas of the spleen and lymph nodes often contained an 
increased number of large pyroninophilic cells in histological pre-
parations but it is difficult to assess whether the absolute number 
of such cells was altered by chronic drainage. As mentioned 
previously, there is no evidence that chronic thoracic duct drainage 
is associated with an increase in the absolute number of newly-
formed lymphocytes present in duct lymph. Atrophic changes were 
apparent in the thymuses of both chronically-drained and restrained 
rats {McGregor and Gowans~ 1963) and were thus ascribed to stress 
effects. Thymus lymphocytes are known to be inordinately sensitive 
to the cytolytic effects of the steroid hormones of the adrenal cortex 
{Selye~ 1936; Dougherty~ 1952 ). One would expect to see changes in 
the thymus of cannulated and restrained animals long before the 
changes in the spleen and lymph nodes which have been attributed to 
a loss of circulating lymphocytes. 
Using the technique of extracorporeal irradiation of blood~ 
Cronkite and his collaborators documented a dramatic fall,following 
such a procedure)in the thoracic duct lymphocyte output in unanaesthe-
tized calves {summarized in Cronkite, Jansen,Cottier~ Rai and Sipe~ 
1964). A combination of extracorporeal irradiation of blood and 
thoracic duct drainage resulted in a severe deficiency in the number 
of lymphocytes in areas of the lymph nodes and spleen corresponding 
to the areas mentioned above in the rat. The germinal centres were 
reported to be intact {'.Cottier. Cronkite~ Jansen~ Rai, Singer and 
Sipe~ 1964). 
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Binns and Hall (1966} have challenged the conclusion that a 
large scale recirculation of lymphocytes from blood to lymph 
occurs in all species. Various lymphatics, which in the sheep were 
rich in their content of lymphocytes. contained very few cells of 
this morphological type in the pig. However. the authors have 
stressed that the peculiarities of the pig lymph node:,. with "inverted" 
cortex and medulla, multiple efferent lymphatics, and the absence 
of medullary cords, may contribute to the paucity of lymphocytes in 
efferent lymphatics. It would be of interest to know whether post-
capillary venules are prominent structures in the porcine lymph 
node •. 
(4} Similarities between the histological effects of thoracic duct 
drainage and thymectomy 
An observation which is encountered in virtually all reports 
on the effects of thymectomy is that the number of peripheral blood 
lymphocytes is reduced in thymectomized animals. The existence 
of this deficiency was established in many early studies dating back 
to 1904 (reviewed in Arnason, Jankovit! and Waksman~ 1962} and 
has been reported in a large number of different species including 
the mouse and rat (reviewed in Miller and Osoba, 1967}. The 
number of lymphocytes in the thoracic duct and circulation increases 
rapidly in the perinatal period (e. g. Heath, 1964} and, in general, 
it can be said that the effects of thymectomy on peripheral lymphocyte 
number are more pronounced, the earlier in life that the operation 
is performed. Neonatal thymectomy in the mouse was found to 
limit the increase in the blood lymphocyte: polymorph ratio which 
occurred in sham-operated mice shortly after birth. Furthermore, 
the leucopenia noted in some neonatally-thymectomized mice could be 
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attributed solely to a reduction in the number of lymphocytes 
(Miller, 1961, 1962a). In the experiments of Ernstrom and 
Larsson (1966), neonatal thymectomy in guinea pigs did not 
interfere with the postnatal increase in 11 circulating" lymphocytes, 
but a deficiency was noticed from 14 to 180 days after birth. This 
species difference may be related to the observation that peripheral 
lymphocytes are numerous at birth in species such as the guinea pig 
(Mandel, personal communication) and rabbit (Archer, Papermaster 
and Good, 1964) whereas typical lymphocytes are scarce in extra-
thymic tissues of the neonatal .mouse (Archer et al., 1964) and 
hamster (Adner, Sherman and Dameshek, 1965). Thymectomy in 
the young adult mouse has been followed by a progressive diminution 
in the number of peripheral blood lymphocytes but, when compared 
with the levels in intact mice of the same age, the reduction was not 
marked (Metcalf, 1960). 
The lymphocyte deficiency following neonatal thymectomy 
extends to the spleen and lymph nodes and several studies have 
pinpointed the lesion to those areas now known to be involved in the 
route of recirculation of small lymphocytes. Waksman, Arnason 
and Jankovi6 (1962 ), from a histological examination of the spleen 
and lymph nodes of neonatally-thymectomized rats, concluded that 
the lymphocyte deficiency was restricted to the population of small 
lymphocytes in the cuffs surrounding the arterioles in the Malpighian 
follicles of the spleen (i. e. periarteriolar lymphocyte sheaths) and 
the "primary lymphoid nodules" of the lymph nodes (i.e. paracortical 
areas or diffuse cortex). The paucity of lymphocytes in these areas 
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was striking, especially in view of the statement that any animal with 
less than 100 mgm residual thymus tissue was considered to be 
"thymectomized". A low or high proportion of the rats may therefore 
have been partially thymectomized. The photographs and the calculations 
of the relative sizes of various structural entities in the spleens 
and lymph nodes of neonatally-thymectomized, sham-operated, 
and non-operated rats. clearly showed that no significant defect 
in the number, size. and cellularity of the lymphoid follicles or 
germinal centres was apparent in the tissues of any one group. 
Plasma cells were present in their customary position around the 
penicilli arterioles of the splenic red pulp and in the medullary 
cords of the lymph nodes. Often an increase in the number of 
plasma cells was seen with an associated encroachment of those 
areas which in non-thymectomized rats contained an abundance of 
small lymphocytes (Waksman et al •• 1962; Azar. 1964; Schriever, 
Hsu and Azar, 1967). 
A comparative study of the effects of chronic thoracic duct 
drainage and neonatal thymectomy has been conducted recently by 
Goldschneider and McGregor (1968a). The lymphocyte deficiency 
in both neonatally-thymectomized rats and rats drained of lympho-
cytes for 8 days. involved the splenic periarteriolar lymphocyte 
sheaths and diffuse cortices of the lymph nodes and Peyer' s patches. 
Plasma cells were numerous in the medullary cords of the lymph 
nodes and red pulp of the spleen. The marginal zone at the boundary 
between red and white pulp in the spleen was prominent in neonatally-
thymectomized rats and contained many reticular cells. Lymphoid 
follicles in the spleen and lymph nodes, arid the rim of cells at the 
corticomedullary junction in the lymph nodes. were not obviously 
affected by chronic thoracic duct drainage and were histologically 
normal in neonatally-thymectomized rats. The photographs of 
Agnew (1967) indicate. nevertheless. that germinal centres may be 
less obvious in the lymph nodes of neonatally-thymectomized rats. 
In the initial descriptions of the histological effects of 
neonatal thymectomy in the mouse. emphasis was placed on the 
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absence of all lymphoid elements in the spleen and lymph nodes 
including germinal centres and plasma cells (Miller. 1961, 1962a; 
Good. Dalmasso. Martinez, Archer. Pierce and Papermaster. 
1962; Parrottand East. 1964}. It now seems that germinal centres 
are quite normal in neonatally-thymectomized mice until the onset 
of wasting disease and that plasma cells may be plentiful (Parrott, 
de Sousa and East. 1966}. As in the rat the periarteriolar lympho-
cyte sheaths in the spleen and the diffuse cortex of the lymph nodes 
of neonatally-thymectomized mice contained few small lymphocytes 
(Parrott, 1962; Parrottand East. 1964; Osoba. 1965a; Parrottet al.. 
1966; Dukor and Dietrich. 1967}. These areas have been termed 
"thymus-dependent areas" (Parrott.et al.. 1966}. the implication 
being that the cellularity of the areas. and notnecessarily the 
functional capacity of the remaining cells. is thymus dependent. 
The radiosensitivity of cells in thymus-dependent and non-
thymus -dependent areas. and the repopulation of these areas in 
sublethally-irradiated rats. has been the subject of experiments 
reported by Bos ( 1967 }. Total body irradiation resulted in a rapid 
loss of cells from the follicles in the spleen and lymph nodes and 
also from the marginal zone in the outer cortex of the lymph nodes 
and outer regions of the Malpighian follicles. Loss of cells from 
the diffuse cortex of the lymph nodes and periarteriolar lymphocyte 
sheaths in the spleen was less obvious with the doses of irradiation 
employed in this study. Following local irradiation of the lymph 
nodes or spleen, the repopulation of the follicles and marginal zones 
within these organs was effected within 24 hours. On the other hand, 
the regeneration pattern in the thymus. following local irradiation 
of the organ. was different and lymphocytes were not apparent until 
4 days postirradiation. Balner and Dersjant (1964} had previously 
shown that the slow regeneration of the lymphocyte compartment in 
the thymus contrasted with the thymus -independent and rapid 
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repopulation of lymphoid follicles in heavily-irradiated mice 
following an injection of labelled bone marrow cells. 
Of particular significance to the present discussion are the 
studies reported by Bos (1967) on the histological consequences of 
total body sublethal irradiation combined with subsequent local 
irradiation of the thymus at intervals of 6 days. The thymus 
remained atrophic and the splenic periarteriolar lymphocyte sheaths 
and the diffuse cortices of the lymph nodes were virtually devoid of 
lymphocytes. By contrast, regenerative processes were obvious in 
primary follicles and marginal zones. In the converse experiment, 
in which rats were irradiated with the thymus shielded, the number 
17. 
of lymphocytes in the thymus-dependent areas was increased over 
that in comparable areas in the spleen and lymph nodes of totally-
irradiated rats. The difficulty of shielding the thymus, without 
shielding associated structures such as lymph nodes and even 
vertebral bone marrow, may conceivably complicate the interpre-
tations of the latter experiment (e. g. Adams, 1967). Bos, on the 
basis of this histological data, concluded that the follicles and 
marginal zones were repopulated after irradiation by blood-borne 
cells not derived from the thymus. Manipulations which precluded 
thymus regeneration seemed to specifically affect the cellular compo-
sition of these areas known to contain a large number of long-lived 
recirculating lymphocytes. Auerbach (1963) and Globerson and 
Feldman (1964) had previously shown in irradiated mice that the 
presence of the thymus was required for the complete regeneration 
of peripheral "lymphoid centres". 
Several groups have reported that thymectomy does not lead to 
a reduction in the number of marrow lymphocytes (Bierring, 1960; 
Waksman et al., 1962; Bierring and Grunnet, 1964; Corsi and 
Giusti, 1967a) even though a change in the relative numbers of 
erythroid cell types (Corsi and Giusti, 1967a) and other myeloid 
abnormalities (Miller, Block, Rowlands and Kind, 1965) have 
been recorded. Moreover, Rieke and Schwarz (1967) found no 
evidence for altered lymphopoiesis in the bone marrow of neonatally-
thymectomized rats and Craddock, Winkelstein, Matsuyuki and 
Lawrence (1967b) showed that the recovery of rat marrow lymphocyte 
numbers after cortisol depletion was not thymus dependent. Recently, 
Stutman, Yunis and Good (1968) reported that the bone marrow of young 
adult neonatally-thymectomized mice did not lack haemopoietic colony-
forming units (Till and McCulloch, 1961) even though the number of 
small lymphocytes was reduced by a factor of 3 when compared with 
the number in intact mice of the same age. The increased size of 
the spleen in some neonatally-thymectomized mice has been ascribed 
to extensive extramedullary haemopoiesis in conventionally-reared 
(Miller and Howard, 1964) and germ-free mice (Dukor, Miller and 
Sacquet, 1968). Hyperplastic changes in the reticuloendothelial 
system are considered to be related to infection and/ or the impending 
onset of wasting disease (Miller, 1963; Miller and Howard, 1964; 
Schooley, Kelly, Dobson, Finney, Havens and Cantor, 1965). 
The question of whether the reduction in the number of peri-
pherallymphocytes is a primary consequence of thymectomy has 
received considerable attention. A depletion of lymphocytes may be 
a direct result of the absence of a thymic influence necessary for the 
establishment or maintenance of peripheral lymphocyte numbers. 
Alternatively, it may be a secondary consequence of the heightened 
susceptibility of neonatally-thymectomized animals to the spectrum 
of microorganisms encountered in the conventional colony. These 
two factors may not be mutually exclusive and one may exacerbate the 
effects of the other. A common sequela of neonatal thymectomy is 
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the development of a fatal wasting disease and the condition seems 
to be particularly severe in conventionally-reared neonatally-
thymectomized mice and hamsters in some laboratories {Miller, 
1962a, 1964a; Parrott., 1962; Sherman, Adner and Dameshek, 
1963). Clinical signs such as a reduction in growth rate, ruffled 
fur, hunched posture, inactivity and, in some animals, diarrhoea, 
led to the notion {Miller and Howard, 1964) that the pathogenesis of 
the condition was similar to the immunologically-based "runt disease" 
and "F 1-hybrid disease" {e. g. Billingha+n.1967). On the basis of these 
clinical similarities and the histological appearance of tissues from 
neonatally-thymectomized mice, de Vries, van Putten, Balner and 
van Bekkum (1964) have postulated that an autoimmune process may 
cause, or at least contribute to, the development of wasting disease. 
Early attempts to isolate pathogenic bacteria and viruses 
from severely wasted mice were unsuccessful (Parrott and East, 
1964). In later passage experiments, in which cell-free organ 
extracts were injected into newborn mice, the presence of an hepato-
trophic virus in the spleen and liver of some, but certainly not all, 
wasted mice was reported (East, Parrott, Chesterman and Pome-
ranee, 1963). Since the virus could not be isolated invariably, East 
and her colleagues considered it not to be the primary cause of 
wasting. Young adult neonatally-thymectomized mice have been 
shown to be more susceptible to certain viral infections (Mori, 
Takeya, Minamishima and Tasaki, 1965; de Somer, Denys and 
Leyten, 1963), the endotoxins of some Gram negative bacteria 
(Salvin, Peterson and Good, 1965, c. f. Porter, Spievack and Kass, 
1966), mycobacteria (Rees, 1966) and to harbour large numbers of 
Candida albicans cells for prolonged periods of time (Salvin et al. •. 
1965 ). Miller ( 1964a) reported that neither high vitamin diets nor 
antibiotics were curative in wasting mice. By contrast, Azar (1964), 
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in a study in which the incidence of abscesses in surgical wounds 
and pneumonia in sham -operated rats was very high, concluded 
that tetracyclines did reduce the number of losse~ from wasting 
disease in neonatally-thymectomized rats. Similar drug therapy 
in animals in which wasting disease had been induced by the injection 
of hydrocortisone at birth (Schlesinger and Mark, 1964), significantly 
reduced the number of mortalities (Duhig, 1965) as did rearing the 
animals in a germ-free environment (Reed and Jutila, 1965, 1967). 
The case for infectious agents as precipitating factors in 
wasting disease has been reviewed and supported recently by 
Miller and Osoba (1967). Perhaps the evidence which is most 
convincing in this regard is the demonstration that germ-free and 
pathogen-free mice do not display any of the signs of wasting disease 
(Mcintire, Sell and Miller, 1964; Wilson, Sjodin and Bealmear, 1964; 
Hess and Stoner, 1966; Dukor et al., 1968). Such mice are, never-
theless1 susceptible to induced graft-versus-host reactions (Mcintire 
et al., 1964; Salomon and Lecourt, 1966) and, as is the case in the 
vast majority of conventionally-reared neonatally-thymectomized 
mice, rarely show histological evidence of autoimmune involvement 
of any organ (Dukor et al., 1968). The absence of wasting disease 
in germ-free neonatally-thymectomized mice, coupled with a 
reduction in the cellularity of the periarteriolar lymphocyte sheaths 
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in the spleen and the diffuse cortex of the lymph nodes, has been used by 
Dukor et al. (1968) as evidence that a defect in the peripheral lympho-
cyte number is a primary consequence of neonatal thymectomy and is 
not related to the presence of infectious agents. The question is 
still open, as viruses have often been observed in tissues from germ-
free mice (de Harven, 1964; Pollard, 1967) and the presence of 
considerable "background antigenic noise" was evident in the mice 
studied by Dukor et al. (1968). It is obvious, nevertheless, that 
extrathymic lymphopoiesis in seemingly normal structures, such as 
lymphoid follicles, germinal centres and bone marrow, does not 
make up the defect in small lymphocytes in lymphoid organs of 
neonatally-thymectomized rats and mice. 
(5.} Defects in the thoracic duct lymphocyte population following 
thymectomy 
Since the bulk of the evidence points to a selective reduction 
of recirculating small lymphocytes in neonatally-thymectomized 
animals, the technique of thoracic duct cannulation should provide 
a means of confirming and quantitating this deficiency. Thoracic 
duct cell output determinations following thymectomy have been 
reported in the rat, mouse and guinea pig. Anaesthetized animals 
were used in these studies and since collection times were invariably 
restricted to less than two hours, the results have been expressed 
as the output of cells per aliquot of lymph collected or per hour of 
drainage. Several weeks after thymectomy in young guinea pigs, 
the lymphocyte output from the thoracic duct had fallen to 50o/o of 
control values (Reinhardt and Yoffey, 1956; Reinhardt, 1964; Clark, 
Williams and Yoffey, 1966). Bierring (1960) thymectomized young 
adult rats and collected thoracic duct lymphocytes two months later. 
The number of such cells was found to be reduced by 40% over that 
in controls. Similar acute drainage experiments performed by 
Schooley and Shrewsbury (1967) showed that thymectomy in 4 weeks 
old rats and mice was followed by a 50 to 60% reduction in the number 
of thoracic duct cells several days later. Schooley and Kelly (1964) 
thymectomized and sham -thymectomized 6 day old rats and demons-
trated a 7 3% reduction in cell output in the thymectomized group 
2 months later. In an abstract, Rieke (1964) reported that the thoracic 
duct of neonatally-thymectomized 60 - 200 gm rats contained approx-
.. imately 20% of the number of lymphocytes present in the thoracic 
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duct of intact rats of the same body weight. The deficiency involved 
only the small lymphocytes~ there being no difference between the two 
groups in the absolute number of large and medium lymphocytes~ 
These various studies could be criticised on the grounds that 
the anaesthetic agent, or other factors operating in the anaesthetised 
state~ may have differential effects on the distribution of lymphocytes or 
output of lymph in thymectomized and nonthymectomized rodents~ 
Acute output determinations in immobilized, anaesthetised animals may 
thus give a false picture of the effects of thymectomy on the number of 
cells in the circulating pool of lymphocytes~ 
Rieke has examined the proliferative and metabolic properties of 
thoracic duct cells from neonatally-thymectomized rats (Rieke, 1964, 1966). 
Ten to 14o/o of thoracic duct lymphocytes in neonatally ... thymectomized rats 
incorporated tritiated thymidine when only 2- 3o/o of lymphocytes in control 
rats were labelled: This difference was ascribed to the presence of 
increased numbers of large and medium lymphocytes in the lymph of the 
thymectomized group~ By injecting tritiated thymidine daily for two 
weeks, Rieke and Schwarz {1967} found tln t 60o/o of the small lymphocytes 
in the thoracic duct lymph of neonatally-thymectomized rats were labelled 
compared with 30o/o of small lymphocytes in the thoracic duct of control 
rats. The decay in the percentage of labelled small lymphocytes was found 
to be biphasic in both groups and, by extrapolating the two horizontal 
portions of the curves, they calculated that the number of short .. lived small 
lymphocytes was the same in both groups:· The deficiency in the thoracic 
duct lymphocyte population in neonatally-thymectomized rats therefore 
seemed to be confined to the population of long ... lived cells~ 
In another experiment~ Rieke and Schwarz (1967) found that all 
the large lymphocytes of the blood and lymph of both thymectomized 
and control rats were labelled at 17 hours after the initiation of 6 .. hourly 
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injections of tritiated thymidine~ These labelled large lymphocytes 
were reported to disappear more slowly in thymectomized animals, lOo/o 
being labelled 7 days after discontinuing a 5 day course of thymidine 
injections~· This could quite conceivably represent an increased rate of 
antigen ... induced blast transformation in previously labelled small 
lymphocytes within the environment of the neonatally ... thymectomized 
hosts~ Such immunological "cripples" (Section IC) could be expected to 
encounter a greater array of persisting antigenic material than rats with 
an intact immunological system: 
Rieke (1966} incubated thoracic duct cells with tritiated uridine 
for 1 hour in vitro and performed grain counts in standard autoradio-
graphic preparations of cell smears~ He concluded that the thoracic duct 
small lymphocytes from neonatally-thymectomized rats displayed a 
defect in RNA metabolism since a decreased number of grains was 
apparent over this cell type. Twenty million lymphocytes from neonatally-
thymectomized rats did not cause runt disease in newborn allogeneic 
recipients whereas 2 million from intact donors were invariably effective. 
Interestingly~ the differences in the percentage of blast cells in short 
term PHA culture or in the percentage of mitotic figures in the presence 
of allogeneic or xenogeneic cells in vitro~ were not as great as would 
have been expected from the results of the in vivo assays. 
Rieke proposed that the difference in the in vitro and in vivo 
activity of lymphocytes from neonatally-thymectomized rats could be 
accounted for on the basis of a qualitative defect in these cells. From 
the work of Gowans (1962}, small lymphocytes most probably initiate 
graft-versus-host reactions. The reduction in the relative number of 
small lymphocytes in the lymph of neonatally-thymectomized rats 
may necessitate the use of large cellular inocula to induce runt disease. 
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In addition, and more importantly, the small lymphocytes responsive 
to histocompatibility antigens may be diluted out by small lymphocytes 
committed to other antigens. There may thus be a simple 
quantitative defect in the thoracic duct lymphocyte population 
from neonatally-thymectomized rats with respect to cells competent 
to engage in graft-versus-host reactions. This proposition, however, 
begs fundamental questions about the clonal individuation and restricted 
reactivity of competent lymphocytes. 
The finding that the difference in the activity of the two populations 
in vitro was not particularly striking may not be irreconcilable with 
the conclusions reached above. Perhaps the elaboration of factors after 
the initiation of blast transformation in responsive cells in vitro (e. g. 
Lawrence, 1967) nonspecifically recruits many others into blastoid or 
mitotic activity (Section IC). A further hypothesis, relevant to the 
status of thoracic duct lymphocytes from neonatally-thymectomized rats 
with respect to RNA metabolism, is most attractive in the light of the 
discussion to follow. Perhaps lymphocytes derived from the thymus 
have a higher RNA metabolic rate than lymphocytes derived from other 
sources. In the thoracic duct of neonatally-thymectomized rats 
the decreased ability of the cells to incorporate RNA precursors might 
then reflect a relative and absolute decrease in the number of thymus-
derived lymphocytes. Thymus lymphocytes themselves incorporate 
less tritiated uridine than thoracic duct lymphocytes in vitro 
(Goldschneider and McGregor, 1968a), but the relative capacities of 
migrant thymus cells and non thymus-derived cells are not known. 
(6) Thymus cell migration 
The finding that thymectomy affects lymphocyte numbers in the 
circulating pool, coupled with the well-documented and obvious 
lymphopoietic activity of the thymus~ has led to the notion that the 
lymphocytes in these two compartments may be members of the same 
cell lineage. If this is the case~ then extirpation of the thymus simply 
removes the primary source of the circulating lymphocytes. By 
inference from the histological effects of thymectomy at different ages~ the 
postulated peripheralization of thymic lymphocytes must be in progress 
very early in life and the extent of migration must decrease with increasing 
age. 
Considerable controversy has centred around the fate of the small 
lymphocytes produced in the thymus and it seems that the question 
will be resolved only when a stable marker unique for thymus and thymus-
derived lymphocytes is available. The studies of Metcalf and his 
co-workers~ employing thymus grafting~ tritiated thymidine labelling, 
and autoradiographic techniques~ have suggested that the majority 
of thymus lymphocytes die within the thymus. The autonomous 
lymphopoietic behaviour of the thymus and thymus grafts~ and the 
inductive influence of the epithelial cytoreticulum, were firmly established 
by Metcalf~ Sparrow~ Nakamura and Ish~date (1961} and Metcalf (1963}. 
In mice grafted with as many as 48 thymus grafts (the weight of which 
amounted to ll60 mgms of autopsy}, no increase in peripheral 
lymphocyte numbers was detected. Lymphopoiesis was~ however~ 
as intense in the grafts as in the host thymus (Matsuyama et al. ~ 1966}. 
By performing grain counts in autoradiographic preparations~ Matsuyama 
et al. (1966} showed that the total amount of tritium incorporated 
into the thymus or thymus grafts, after a "pulse11 intraperitoneal 
injection of tritiated thymidine~ was not reduced until 3 to 4 days after 
the injection. A similar phenomenon was reported by Craddock et al. 
(1964}. The total radioactivity in the thymus of rats after systemic 
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tritiated thymidine administration remained constant for 3 days. 
When considered together with the demonstration that approximately 
90% of thymus lymphocytes are lightly labelled at 3 days after 
a single injection of H3 thymidine, these findings suggest that total 
lymphocyte renewal in the thymus is rapid and that cells must be lost 
from the thymus environment, not on a random basis,. but after 3 to 4 days~ 
The plateau in radioactivity may be due to a migration of labelled 
cells from the spleen and lymph nodes into the thymus. This possibility 
is rendered unlikely by the work of Gowans and Knight {19 64), Galton and 
Reed {1966) and Goldschneider and McGregor {1968a) who showed that very 
few lymphocytes migrate to the intact adult thymus. In addition, very 
few heavily-labelled lymphocytes, of the type found in spleen and lymph 
nodes after pulse injections of tritiated thymidine, were found in the 
thymus {Craddock et al. , 19 64; Matsuyama et al. , 19 6 6). The 
possibility that bone marrow-derived lymphocytes had migrated in 
large numbers to the thymus does not seem to have been discounted. 
Such cells could be expected to be lightly labelled under the conditions 
of the experiments {Osmond and Everett, 1964; Craddock, 1965), and 
the data of Matsuyama et al. {1966) actually shows an increase in 
total grain counts in thymus cell smears over the 3 day "plateau" phase. 
Very few bone marrow cells, however, migrate to the thymus at least 
immediately after irradiation (Bainer and Dersjant, 1964) and the results 
of parabiosis experiments almost exclude any possibility of massive 
migration of lymphocytes through the thymus {Harris, Ford, Barnes 
and Evans, 1964; Brumby and Metcalf, 1967)~ 
Estimates of thymus cell migration, based on lymphocyte numbers 
in afferent and efferent thymic blood and lymph, have been made by 
Kotoni, Seiki, Yamashita and Horii {1966) in the rat and in the guinea pig 
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by Sainte-Marie and Kostuck (cited in Sainte-Marie and Leblond, 1964) 
and Ernstrom, Gyllensten and Larsson (1965). In the guinea pig, higher 
lymphocyte counts were obtained from certain thymic veins than thymic 
and carotid arteries and the femoral veins. Histological evidence 
for diapedesis of cells across the perivascular channels and the walls of 
medullary venules was presented by Sainte-Marie and Leblond (1964) but 
the direction of migration was impossible to determine. Kotani et al. 
(1966) described accumulations of thymocytes in septal areas traversed 
by lymphatic channels. They believed these channels drained to the cervical 
lymph nodes. By measuring the number of lymphocytes in the efferent 
lymph of the right cervical lymph node, Kotani et al. demonstrated 
that removal of the appropriate thymus lobe resulted in a 50o/o reduction 
in lymphocyte output from the node. It is difficult to assess whether 
the cells in septal areas of the thymus were derived from the thymic 
parenchyma and what effect the introduction of antigenic material during 
surgery might have had on the output of cells from the regional lymph 
node. Hall and Morris (1965b) have documented a dramatic and rapid 
reduction of lymphocytes in the efferent lymphatics of popliteal lymph 
nodes in sheep after the local application of a variety of antigens. 
Intrathymic labelling studies using the labelled nucleosides, 
' tritiated thymidine and tritiated adenosine, have been performed by Nossal 
(1964), Murray and Woods (1964}, Weissman (1967) and Linna (1968) in 
an attempt to detect, and quantitate the extent of, thymus cell migration. 
The major criticisms of this approach relate to problems of leakage 
of the labelled nucleosides, reutilization of label, and damage to thymus 
cells. In the study of Murray and Woods (1964} tritiated thymidine 
was injected into one lobe of the adult guinea pig thymus. Leakage from 
the injection site must have occurred since lightly-labelled granulocytes 
and plasma cells accumulated rapidly in various organs. The 
lymphocytes in the noninjected lobe were also lightly labelled even 
though no labelled cells were detected in the portion of the duodenal 
epithelial mucosa used as an indication of leakage. Nossal {1964) 
performed similar experiments in newborn and young adult 
guinea pigs. Migrant cells were distinguished from cells resident in the 
peripheral lymphoid tissues by a difference in the intensity of label. Small 
and medium lymphocytes, with 28 x the label present in labelled dividing 
cells of the mesenteric lymph node, were detected in small numbers 
within this and other nodes, particularly in those of newborn guinea 
pigs. The results of both these studies, and of Linna (1968) in hamsters 
of various ages, indicated that very few thymus cells migrated to 
peripheral lymphoid organs. 
The recent report of Weissman (1967) has indicated that 
the extent of thymus cell migration in the rat may be more pronounced 
than had hitherto been supposed. Weissman used newborn and adult rats 
and, by employing a variety of controls, he seems to have performed the 
most satisfactory intrathymic labelling study to date. Control preparations 
in adult rats consisted of a certain number of adrenalectomized animals, 
continuous intravenous infusions of "cold" nucleoside, and the injection of 
labelled thoracic duct lymphocytes and bone marrow cells in an attempt 
to detect the infiltration of lymphocytes and inflammatory mononuclear 
cells into, and subsequent migration out of, the injection site. At the end 
of the 1. 5 to 2 hours intrathymic infusion period, labelled cells were 
confined to the thymus and, more specifically, to the lymphocytes around 
the point of insertion of the needle. As might be expected, tritiated 
adenosine labelled all lymphocytes in the thymus, whereas tritiated 
thymidine was incorporated initially into large and medium lymphocytes. 
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The appearance of labelled small lymphocytes following tritiated 
thymidine injection into the thymus coincided with a migration pulse 
of labelled cells in peripheral lymphoid organs~ In adult rats~ 
the migrant cells were confined to the diffuse cortex of the lymph 
nodes and the periarteriolar lymphocyte sheaths of the spleen. 
Small - and medium -sized migrant lymphocytes were observed 
in adults and all three morphological cell types~ large~ medium and 
small lymphocytes~ appeared to migrate from the thymus in newborn 
animals. Control preparations were not~ however~ applied as 
rigorously in newborns as in adults. By calculating the proportion 
of thymus lymphocytes labelled and by enumerating migrant cells 
in the diffuse cortices and periarteriolar sheaths~ Weissman 
concluded that cell migration from the adult thymus could renew 
the entire circulating lymphocyte pool in 1 to 2 months. In 
the newborn a case could be made ,out for the hypothesis that virtually 
all of the lymphocytes in the spleen and lymph nodes were derived from 
the thymus. Weissman assumed that the majority of thymus cell migrants 
persisted in peripheral lymphoid tissues. 
If~ as Weissman suggests~ the circulating pool is being replaced 
every 1 to 2 months in the adult, one is faced with the problem of 
accounting for the slight effects of adult thymectomy on the number of 
circulating lymphocytes. Decreased~ rather than increased, extrathymic 
lymphopoiesis has been recorded in the lymphoid organs of adult-thy-
mectomized mice {Metcalf~ 1960; Metcalf and Brumby, 1966; Metcalf~ 1967). 
Such a mechanism is thus unlikely to be in operation to compensate for the 
deficit caused by the elimination of the major source of the circulating 
lymphocytes. A possible explanation is that thymus lymphocytes do 
migrate in large numbers but have a short life span within peripheral 
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lymphoid organs unless required in the participation of immunological 
responses. Perhaps these few persisting migrants are selected for, or 
altered1 by, antigen and they or their progeny then enter the circulating 
pool of lymphocytes. In the adult rat the majority of cells in the 
circulating pool may carry immunological memory (Section IB} and 
are certainly long lived. Hence, the requirement for extra 
cells from the adult thymus is presumably minimal. 
A non-immunological, trephocytic function of lymphocytes would 
resolve this dilemna (Loutit, 1962; Rieke, 1962; Bryant, 1963; Fichtelius 
and Bryant, 1964; Fichtelius and Linna, 1967). Thymus lymphocytes 
would simply die and furnish nuclear building blocks for other cell 
types be they lymphocytes, parenchymal cells of various organs, 
or cells involved in wound repair. This function of lymphocytes 
is difficult to prove; trophic effects cannot be attributed to lymphocytes 
only (Robinson and Brecher, 1963} and the presence of the thymus 
or thymus grafts does not appear to influence kidney regeneration 
or erythropoiesis (Metcalf, 1964}~ Linna (1967) was unable to 
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demonstrate any transfer of H -labelled material from intrathymically-
labelled thymus cells to regenerating liver cells in the guinea pig. 
At variance with this finding, Fichtelius and Bryant {1964} and 
Craddock, RytOmaa and Nakai (1964) have presented evidence 
that the regenerating liver may reutilise labelled DNA or DNA precursors 
liberated from labelled leucocytes and thymocytes. It has yet to be resolved 
whether lymphocytes, and in particular, thymus-derived lymphocytes, have 
no role to play in the body's economy other than the provision of nucleo-
protein, amino acids, histones, and nucleic acids for reutilization by 
other cells. The innumerable demonstrations of immunological activity 
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of purified populations of small lymphocytes in adoptive transfer 
systems militates against the concept of a simple trophic function 
for this morphological cell .type (Section IB and IC). 
Evidence for migration of lymphocytes from chromosomally-
marked thymus grafts in neonatally-thymectomized and in adult-
thymectomized. irradiated and marrow protected mice has come from 
the work of Miller {1962b). Harris and Ford (1964). Miller. Osoba 
and Dukor (1965), Leuchars. Cross. Davies and Wallis (1964}. Leu-
chars, Cross and Dukor (1965}, Dukor. Miller. House and Allman 
(1965}. Davies. Leuchars. Wallis and Koller (1966}. Ford (1966a). 
Leuchars, Morgan. Davies and Wallis (1967) and Davies. Festenstein, 
Leuchars, Wallis and Doenhoff (1968a). Dividing graft-derived cells 
were detected in the spleen and lymph nodes and an increase in the 
number of such cells occurred after antigenic stimulation (Leuchars 
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et al •• 1964; Davies et al •• 1966; Miller. de Burgh, Dukor, Grant, 
Allman and House. 1966). Davies ~ (1968a) used phytohaemagglu-
tinin to stimulate peripheral blood lymphocytes from adult-thymectomized 
mice which had been irradiated, bone marrow inoculated. and thymus 
grafted up to 50 days previously. They demonstrated that approxima-
tely 80% of the mitotic figures carried the chromosome marker of the 
thymus graft. If thymus -derived cells are more resistant to in vitro 
culture conditions. or are preferentially stimulated by PHA (Section 
IC). then this figure may be a gross overestimate of the proportion of 
total peripheral blood lymphocytes which are in fact derived from the 
thymus graft. 
The value of this data to the question of thymus cell migration 
from the intact thymus in situ is debatable. As has often been em-
phasit=>ed (e. g. Matsuyama et al., 1966; Miller and Osoba. 1967). the 
process of grafting leads to disruption of the thymus capsule and the 
release of thymocytes. When the architecture of the graft is restored. 
the lymphocytes, which after two or three weeks may all be host in 
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type (Dubert and Kaplan, 1961; Green, 1964; Metcalf and Wakonig-
Vaartaja, 1964; Dukor et al., 1965; Ford, 1966a; Schlesinger and 
Hurvitz, 1968). may nat migrate in large numbers. This receives 
some support from the data of Davies et al. (1966, 1968a) which 
shows a surprisingly large proportion of thymus graft-derived cells 
in the peripheral lymphoid organs some weeks after grafting. If 
thymus cells migrate extensively then this number would be expected 
to be diluted out by host type mitotic figures rather rapidly. Perhaps 
the lymphopenia following irradiation is much reduced at the time of 
complete thymus graft repopulation and the call for lymphocytes in 
peripheral tissues is less. This is unlikely to be so, however, as 
the recovery of circulating and peripheral blood lymphocyte numbers 
following whole body irradiation is slow and is noticeable only after 
two weeks (Ross, Furth and Bigelow, 1952; Hulse, 1963). In adult 
thymectomized mice, which are not lymphopenic, thymus graft-derived 
cells were detected in small numbers in the lymph nodes and spleen 
and no increase in their number occurred after sheep erythrocyte 
challenge {Leuchars et al., 1967). This may reflect either a lack 
of thymus cell migration or a massive dilution of migrants by long-
lived lymphocytes present in the host at the time of thymus grafting. 
The fate of intravenously-injected thymus cells has been studied 
usingP 32 -, H3-. and acridine-labelled cells (reviewed in Fichtelius, 
1960; Fichtelius and Bryant. 1964; Elves, 1966). This whole 
experimental approach as an indication of thymus cell migration and 
thymus cell function has been criticised on many grounds (Lajtha, 
1960; Gowans. 1959b; Elves, 1966). The apparent organ localization 
of the cells may depend on the viability of the inoculated cells, the 
infusion rate and. unless a high proportion of the cells are labelled 
and the label is relatively stable, the results obtained may be quite 
.fallacious. Furthermore, the injection of cells from a disrupted 
thymus into the blood stream of recipient animals can hardly be 
considered remotely physiological (Gowans, 1959b; Fichtelius, 
1960). In homotransfusion experiments, Fichtelius and co-
workers (e. g. Fichtelius. 1960; Fichtelius and Bryant, 1964) traced 
cells to many organs but to the spleen and liver in particular. 
Murray and Murray {1961) found a preferential localization of 
thymus cells in the spleen of irradiated rats and Mims (1962) and 
Everett et al. (1964) also singled out the spleen of mice and rats 
as being the organ to which infused H 3 -labelled thymus cells homed 
in large numbers. Everett~· (1964) detected a small number of 
labelled cells in the thoracic duct lymph within 4 hours of thymus 
cell injection. Both Everett (1964) and Gowans (1964) have stated, 
however, that thymus cell inocula do not boost the thoracic duct 
lymphocyte output in draining rats. Moreover, Goldschneider and 
McGregor (1968b) recently demonstrated that injected thymocytes 
failed to elevate the thoracic duct lymphocyte output whereas equal 
numbers of thoracic duct lymphocytes were highly effective. 
It can be said that the results of experiments on the fate of 
inoculated thymus lymphocytes can not be used as evidence that the 
thymus normally contributes cells to the population of thoracic duct 
lymphocytes. The experiments simply indicate that a small number 
of lymphocytes resident in the thymus at any one time can be shown 
to be capable of passing from blood into the thoracic duct lymph. 
Transfusion experiments did, however. lead Fichtelius to postulate 
as early as 1953 that the thymus exports: lymphocytes to the spleen 
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in which location they are able to participate in immunological reactions. 
possibly by transforming to plasma cells (Fichtelius, 1960) 
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(7) Non-thymic origin of circulating pool lymphocytes 
If it is assumed that peripheral circulating pool lymphocytes 
are the end products of lymphopoiesis in" central" lymphoid organs 
then, an organ having a function akin to the avian bursa of Fabricius 
(Section IC) should be a source of peripheral lymphocytes in the 
mammal. Conceivably, production of lymphocytes could be initiated 
in such an organ which later in life may not bear any resemblance to 
an intensively lymphopoietic organ such as the thymus. The popu-
lation of lymphocytes originally derived from this site might then be 
maintained by replication of the lymphocytes themselves. Evidence 
for the expansion of peripheral lymphocyte populations comes from 
the work of the Gowans group and will be discussed in Section IB. 
Replication of lymphocytes in this manner appears to be antigen 
dependent and a paucity of lymphocytes in the blood, lymph nodes, 
and spleen of germ-free mice, rats and chickens strongly suggests 
that, in the absence of numerous antigenic insults, the circulating 
pool of lymphocytes may be strikingly reduced in size (Thorbecke, 
Gordon, Wostman, Wagner and Reyniers, 1957; Gordon, 1959; 
Wilson, Bealmear and Sobonya, 1965; Olson and Wostmann, 1966; 
Dukor et al., 1968). 
Structures which qualify on lymphopoietic criteria as candidates 
for the site of origin of peripheral lymphocytes are the germinal 
centres and the bone marrow. From the autoradiographic data of 
Fliedner, Kesse,; Cronkite and Robertson (1964), lymphopoiesis in 
the germinal centres does not result in the export of large numbers 
of lymphocytes. In support of this, histologically normal follicles 
and germinal centres have been reported in the presence of a severe 
deficiency of lymphocytes in the spleen, lymph nodes and peripheral 
blood (vide supra). 
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Goldschneider and McGregor (1966} have produced evidence 
that both the thymus and bone marrow can contribute cells to the 
thoracic duct lymphocyte population. A certain~ albeit unknown~ 
proportion of the thoracic duct lymphocytes from F 1 rats~ injected 
at birth with either parental type bone marrow or thymus cells~ 
possessed the immunological characteristics of the parental cells. 
Thoracic duct lymphocytes from adult (Lewis x DA}F 1 rats~ inoculated 
at birth with 50 million Lewis bone marrow or 100 million Lewis 
thymus cells~ were transferred to irradiated (Lewis x BN}F 1 rats 
presensitized against DA histocompatibility antigens. An inoculum 
of 100 million thoracic duct cells (calculated to contain 1 million 
parental type cells} killed a large number of the secondary hosts in 
contrast to the negligible graft-versus-host activity of an equal number 
of thoracic duct lymphocytes from uninjected (Lewis x DA}F 1 rats. 
Inocula of 50 million Lewis bone marrow cells and 100 million Lewis 
thymus cells were themselves unable to kill many of the secondary 
hosts. Such an experimental system cannot be expected to yield any 
-information on the proportion of thoracic duct lymphocytes which are 
bone marrow derived or thymus derived or whether the bone marrow 
precursors have been influenced by the thymus prior to~ or during~: 
their maturation into immunocompetent cells. 
In summary~ two conclusions arising from the results of experi-
ments discussed in this section seem to be well founded. Firstly, the 
majority of thoracic duct small lymphocytes, in the rat at least~ are 
long-lived cells which continuously migrate from blood to lymph within 
the lymph nodes by passing through the postcapillary venules of the 
diffuse cortex. The results of thoracic duct output determinations in 
several other species, coupled with the evidence for a long life span 
of many peripheral blood and lymph-borne lymphocytes, indicate that 
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large-scale recirculation of lymphocytes may be common to many 
species. Such a phenomenon would readily account for the fate of 
the large number of lymphocytes discharged into the blood from the 
major lymphatics each day. 
The second general conclusion is that a paucity of lymphocytes 
in peripheral lymphoid organs is almost an invariable histological con-
sequence of thymectomy. Recent evidence suggests that the lymphocyte 
deficiency, which may be exacerbated by intercurrent infections and 
which does not extend to entities such as lymphoid follicles, germinal 
centres and plasma cells, may be confined to the population of recircu-
lating, long-lived small lymphocytes. Intrathymic labelling studies 
indicate that a proportion of thymus lymphocytes are destined to leave 
the organ but the extent of cell migration to peripheral lymphoid organs 
is unknown. It remains to be determined whether emigrant thymus 
cells are potentially long-lived small lymphocytes invested with the 
capacity to enter the recirculating pool directly. Thymus cell migrants 
could quite conceivably be short-lived cells. The hypothesis that the 
thymus is the principal source of recirculating lymphocytes remains 
attractive but no quantitative data is available to indicate whether a 
majority or a minority of thoracic duct lymphocytes are thymus derived. 
B. The Concept of the Antigen-Reactive Cell 
The nature of the cellular events of various immunological 
responses has occupied the attention of many immunologists for some 
time. As a sequel to the interest in the identity of the cell type actively 
engaged in antibody production~ the focus of attention has now centred 
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on the precursor cell which initiates the immune response. The immu-
nologically competent cell has been defined by Medawar (1963) as a 
cell which, whilst not yet engaged in an immune response, has the capa-
city of doing so when stimulated by antigen. The cell is therefore 
endowed with the property of antigenic reactivity and can only be en-
visaged in retrospect since it is required to demonstrate its activity 
before qualifying for the title of immunologically competent or immuno-
competent cell. The term has~ in general~ been restricted to cells 
responsive to foreign histocompatibility antigens and thus to cells 
involved in the initiation of transplantation immune reactions (Wilson 
and Billingham~ 1967 }. 
In those reactions in which the measurable consequence of antigen 
injection is the production of specific antibody molecules~ the equivalent 
cell type has recently been termed the antigen-sensitive, antigen-target~ 
antigen-responsive~ or antigen-reactive cell. This postulated cell 
corresponds to the X cell in the scheme of immunogenesis proposed by 
Sercarz and Coons (1962} and Nossal (1965} and to the PC2 and also 
the PC 1 cell of the Makinodan group (e. g. Makinodan and Albright, 1963 ). 
The antigen-reactive cell can be considered as a cell type which responds 
to antigen either by producing antibody or by producing a progeny of 
antibody-forming cells. The morphological identity of this precursor 
cell could be any one or several of the multitude of cell types resident 
in~ or migrating through, lymphoid tissues. Possible candidates 
include macrophages, fixed primitive reticular cells, large~ medium 
or small lymphocytes~ large pyroninophilic cells or even plasma cells 
and their differentiating precursors. 
(1) Generation of plasma cells from their precursors 
The antibody producing capacity of the plasma cell is now 
well established and qruite undisputed (Fagraeus, 1948; Leduc, Coons 
and Connolly, 1955; Nossal and MakeUt, 1962; Baney, Vazquez and 
Dixon, 1962 ). Experiments employing radioactively-labelled DNA 
precursors have unequivocally demonstrated that the vast majority 
of mature plasma cells, in situations in which maximal production of 
such cells is evident, are end cells and the result of recent mitotic 
divisions (Schooley, 1961; Nossal and Ml:lkeHl:., 1962; Baney et al., 
1962; Urso and Makinodan, 1963). As mentioned earlier, the identity 
of the precursor of this expanding population of plasma cells has been 
the subject of much debate. According to the concepts of Burnet 
38. 
(1959), this ancestral cell would be expected to be genetically restricted 
in its reactivity and to respond to antigen by proliferation. The end 
result of this proliferation would be a clone of antibody-producing 
cells, each elaborating antibody molecules specific for the antigenic 
determinant which elicited the clonal expansion. Depending on the 
morphological identity and the antibody-producing status of the pre-
cursor cell, this proliferative response may or may not be associated 
with differentiation. 
On the basis of the results of pulse labelling experiments, 
Nossal and Makela (1962) concluded that, in the secondary response 
to Salmonella adelaide flagella antigens in the rat, the precursor of 
the antibody-producing plasmablasts and mature plasma cells was a 
cell type which incorporated tritiated thymidine prior to antigenic 
challenge. The same conclusion seemed to apply to the cellular 
events of the primary immune response to flagella antigens (Nossal, 
Mitchell and McDonald, 1963). The antigen-reactive cell in this 
system may therefore be a DNA-synthesizing member of a 11 proliferating" 
population of cells. The possibility that reutilization of the label 
i: 
(Mitchell, McDonald and Nossal, 1963; Robinson et al. 1 1965) 
accounted for the high number of labelled plasma cells in the sti-
mulated nodes could not be dismissed, even though it was stated 
that the pattern of labelling in the early nonantibody-producing blast 
cells did not lend support to this contention (Nossal ~ 1 1963). 
On this latter point it can not be known with certainty whether the 
heavily-labelled blast cells were in fact the precursors of antibody-
producing cells. They may have been short-lived cells which were 
destined to die soon after antigen injection. Any labelled material 
liberated into the milieu of the node would presumably be available 
for incorporation into the cells of the proliferating and differentiating 
plasma cell line. 
Cohen and Talmage (1965) used a transfer system in which 
spleen cells from mice stimulated with bovine serum albumin were 
incubated in vitro with tritiated thymidine and were subsequently 
injected into syngeneic irradiated recipients. They found that a 
proportion of anti-BSA antibody-forming cells (identified by the 
indirect fluorescent antibody technique) were labelled only when spleen 
cells were incubated 6 to 24 hours after the donor mice were challenged 
with antigen. Since no antibody-producing cells were labelled when 
spleen cells were removed immediately after challenge, these workers 
concluded that the precursor cell was a non-cycling cell type which 
entered S phase, by commencing DNA synthesis, some time after 
antigenic stimulation. They therefore suggested that reutilization of 
label accounted for the large number of labelled plasma cells in the 
experiments of the Nossal group. It is possible of course that certain 
antigens may temporarily suppress the incorporation of DNA precur-
sors into antigen-reactive cells which are indeed members of a proli-
ferating, or at least a cycling, cell population. This arrest may 
last for 6 hours in which case the results of Cohen and Talmage might 
be anticipated. 
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( 2) Generation of haemolysin-forming cells from their precursors 
Two techniques, capable of enumerating single antibody-
producing cells in the presence of a large excess of non-antibody 
producers, have provided much quantitative information on the immune 
response to heterologous erythrocyte antigens and have added a new 
dimension to studies of the cellular dynamics of antibody production. 
The plaqu'e-forming cell (PFC) assay, described independently by 
Jerne (Jerne, Nordin and Henry, 1963; Jerne and Nordin, 1963) and 
Ingraham and Bussard (1964), detects haemolysin-releasing cells by 
virtue of the appearance of pinpoint areas of haemolysis in nutrient 
gels containing the appropriate erythrocytes mixed with cells obtained 
from immunized animals. Erythrocytes immediately surrounding 
a single antibody-producing cell within the semisolid gel are sensitized 
and lysed after incubation at 37°C and the addition of complement. 
Following the injection of sheep erythrocytes into mice, the number of 
PFC in the spleen increases from a "background" number of about 
100 at the time of immunization to levels approaching 100,000 4 to 5 
days later (Jerne et al., 1963; Friedman, 1964; Miller, de Burgh, and 
Grant, 1965; Wortis, Taylor and Dresser, 1966; Zaalberg, van der 
Meul, van Twisk, 1966; Wigzell, M~ller and Andersson, 1966; 
Berenbaum, 1966; Hege and Cole, 1966; Eidinger and Pross, 1967). 
The increasing number of such cells in the exponential phase of the 
response could be (1) the result of non-mitotic differentiation of as 
many non-antibody-producing precursor cells, these cells commencing 
antibody synthesis at various times after antigenic challenge, (2) the 
consequence of a series of cell divisions, subsequent to antigenic 
stimulation, on the part of a limited number of antibody-producing 
precursor cells, (3) a combination of the 2 previous schemes, or 
(4) the result of proliferation of a small number of nonantibody-
producing precursor cells with differentiation to antibody-secreting 
cells subsequent to, or during the course of, the proliferative response. 
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These four models may be illustrated, in their simplest form, in the 
following manner where 0 is a cell not producing antibody· and e 
is an antibody-secreting cell (extension of the illustrations in Beren-
baum, 1966): 
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Syeklocha, Siminovitch, Till and McCulloch (1966), using the 
drug vinblastine (VLB), have demonstrated that the precursors of PFC 
are not dividing as rapidly in the absence of antigen as in its presence. 
VLB at. certain dose levels is known to cause an irreversible loss of 
the capacity for cell proliferation. In the experiments of Syeklocha 
et al., doses of VLB in excess of 0. 1 mgm per mouse resulted in a 
dose dependent reduction of up to 1, 000 fold in the number of PFC in 
the spleen 3 to 4 days after an injection of sheep erythrocytes. If 
antigen initiates a change in the growth kinetics of precursor cells, 
then injecting VLB before antigen should have a less dramatic effect 
on the re[3ponsiveness of mice to sheep erythrocytes. By injecting 
0. 3 mgm VLB 3 days prior to antigen (a protocol which supposedly 
ensured that very little VLB remained at the time of immunization), 
a depression in the number of PFC of less than a factor of 2 was 
obtained. Even with highly lethal doses of VLB and the use of an 
adoptive transfer system in irradiated mice, the deficiency in the 
response to sheep erythrocytes was by no means as great as when 
smaller doses of the drug were injected after antigen. The data 
supports the proposition that precursor cells generate PFC by 
processes involving cell division and that these cells are dividing far 
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more rapidly after immunization than immediately prior to antigen 
administration. 
Work in the same laboratory by Kennedy, Till, Siminovitch 
and McCulloch (1965b) further established that the radiation sensitivity 
of the primary immune response of mice to sheep erythrocytes was of 
the same order of magnitude as that for mammalian cell proliferation 
in general. Groups of mice were given graded doses of total body 
irradiation of up to 700 rads followed by sheep erythrocytes within 
2 hours of irradiation. Doses of antigen and the time of PFC assay 
following irradiation were varied, and, on this basis, the study was 
more satisfactory than that of Uyeki (1967) addressed to the same 
question. By constructing seini<;.log survival curves of PFC numbers 
relative to those in unirradiated control mice, the n 37 was found to 
be 80 rads and was thus very similar to values obtained in other 
related immunological systems in which antibody titres were measured 
(Makinodan, Kastenbaum and Peterson, 1962; Celada and Carter, 1962 ). 
The only mammalian cell function with such a high radiation sensitivity 
is believed to be the capacity for continued proliferation (e. g. Kaplan, 
1966). In marked contradistinction to the radiation sensitivity of 
the cellular system responsible for the generation of PFC, the ability 
of cells to release haemolysing antibodies was not affected by< 2, 000 
rads in vitro or in vivo and many cells retained the capacity to release 
antibody after as much as 9 kilorads (Kennedy et al.. 1965b). 
Berenbaum (1966) and Rowley, Fitch, Mosier, Salliday, 
Coppleson and Brown (1968) used various drugs to inhibit the in vivo 
PFC response of rats and mice, and the in vitro PFC response of 
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mouse spleen cells, to sheep erythrocytes. The drugs used, namely 
thioguanine, colchicine and VLB, are believed to be immunosuppressive 
by virtue of their effects on the mitotic activity of cells (Schwartz, 1965). 
Dutton and Mishell (1967a, b) used the "hot pulse" technique to 
assess the role of cell proliferation in the PFC response of normal 
mouse spleen cells to heterologous erythrocytes. In their in vitro 
system. the incorporation of "hot" tritiated thymidine inhibited the 
response. and was presumably lethal to cells. only when added to 
the culture after 24 hours. They suggested from this evidence that 
DNA synthesis was minimal in the first 24 hours of culture and that 
all PFC arose by cell division. With two different heterologous ery-
throcytes and the judicious use of "hot" tritiated thymidine. Dutton 
and Mishell showed that inhibition of the response to one antigen did 
not affect the PFC response to the other. Hence, the proliferative 
response was associated with a high degree of specificity with respect 
to antibody formation. As first reported by Bussard (Bussard, 1966; 
Bussard and Lurie, 1967). the peculiarities of the behaviour of peri-
toneal exudate cells in vitro were also noticed in the system of 
Dutton and Mishell (1967b). Mitotic inhibitors and "hot" tritiated 
thymidine did not seem to affect the generation of PFC from sheep 
erythrocyte-stimulated peritoneal exudate cells in vitro. 
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These various studies emphasise the importance of proliferation 
in the generation of PFC in the spleen of the mouse and rat. Cell 
proliferation has long been considered a concomitant cellular event in 
antibody production and, within stimulated lymphoid orgall?.iS apparent 
in both antibody-producing and nonantibody-producing cells (Wissler, 
Fitch, La Via, Gunderson, 1957; Schooley. 1961; Nossal and MakeHi, 
1962; Baney et al., 1962; Balfour, Cooper and Meek, 1965). Wortis 
et al. (1966} measured the increase in spleen cell number after a 
challenge injection of sheep red cells in mice. They calculated that 
only 1% of the increase could be accounted for by both 198 and 78 
haemolysin-forming cells. The increase in spleen cell numbers could 
reflect recruitment of cells into the spleen and/ or a burst of cell 
proliferation. The demonstration that measures which are inimical 
to cellular proliferation decrease the number of PFC arising in the 
spleen after sheep erythrocyte injection~ does not prove that PFC 
have arisen by proliferation from precursor cells. There is little 
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doubt that PFC in mitosis are commonly encountered (Claflin and 
Smithies, 1967; Jerne, 1967a; Nossal, Cunningham, Mitchell and 
Miller, 1968) but it is still possible that proliferation may be an 
essential property of another cell population, this proliferative response 
ensuring that precursors differentiate into PFC. 
Direct differentiation of precursor cells to PFC has been invoked 
to explain, in part, the explosive increases in PFC in the spleen between 
"' , days 2 and 4 after sheep erythrocyte challenge (Sterzl, Vas ely, Jilek 
/ 
and Mandel, 1964; Sterzl and Jilek, 1967; ~alaviya and Tannenberg, 
1967; Eidinger and Pross, 1967). The doubling time of PFC in the 
exponential phase, bearing in mind the proposed 12 - 18 hour generation 
time for mammalian cells (Defendi and Manson, 1963), does seem to 
be too rapid to be accounted for by division of PFC alone. This as a 
conceptual difficulty has been challenged recently by Rowley et al.(1968) 
who cite the data of Metcalf (1966), Wagner, Cunningham, Cottier, 
Jansen, Rai and Cronkite (1967) and Saffier, Cottier, Cronkite, Jansen, 
Rai and Wagner (1967) to point out that lymphoid cells may have very 
short cell cycle times. 
The observation that few PFC were labelled after tritiated thy-
midine or C 14 thymidine injections and infusions appears to support 
the existence of mechanisms of cellular reactivation and transformation, 
rather than proliferation, in the evolution of PFC (Sterzl et al., 1964; 
Tannenberg, 1967). In addition, Sterzl (1961) reported that the 198 
phase of the immune response was not affected by inhibition of DNA 
synthesis. The positive findings of a large number of labelled PFC in 
rats and mice responding to sheep erythrocytes is of much greater 
significance than the negative results mentioned above (Ellis~ Gowans 
and Howard, 1967; sz·enberg and Cunningham, 1968). The PFC in 
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these two latter systems could have acquired label from a DNA-synthesizing 
nonantibody-producing precursor cell or they may have incorporated the 
label after entering a DNA synthetic phase of the cell cycle subsequent 
to producing antibody. A recent report has indicated that a large number 
3 
of PFC do incorporate H thymidine in short term in vitro cultures 
(Koros, Mazur and Mowery, 1968). 
Relatively large numbers of unlabelled PFC were observed by 
Ellis et al. (1967) and Szenberg and Cunningham (1968) in the early 
phases of the response to sheep erythrocytes. Ellis et al. suggested 
that this would be expected if" early" PFC were derived from a non-
dividing precursor cell. It must be borne in mind, however, that 
interpretations are complicated by the presence of "background" PFC 
f II ' II c . 3 in uninjected animals. Very ew background PF mcorporate H 
thymidine (Szenberg and Cunningham, 1968) and if the relative contri-
bution of these cells to the total number of PFC during, or soon after~ 
the latent period is great, one might expect not to see many labelled 
PFC at early sampling times. The role ofthe "background" PFC in 
the response of animals to sheep erythrocytes will be discussed later. 
(3) The number of antigen-reactive cells in the mouse spleen 
The work of two groups in particular has suggested that the 
normal mouse spleen contains a limited number of cells which respond 
to sheep erythrocytes by proliferation and differentiation into PFC. 
Kennedy, Siminovitch, Till and McCulloch (1965a), Kennedy~ Till, 
Siminovitch and McCulloch (1966), Playfair, Papermaster and Cole 
(1965) and Papermaster (1967) described the appearance of discrete 
foci of haemolysis in the spleens of lethally-irradiated mice injected 
with lymphoid cells and sheep erythrocytes. At various times after 
irradiation, cell injection,and sheep erythrocytes challenge, spleens 
were cut into slices which were in turn laid in sequential order on 
regular Jerne agar plates containing sheep erythrocytes. After incu-
bation of the plates and addition of complement, zones of haemolysis 
47. 
or "active areas" appeared in the agar-erythrocyte layer in association 
with some of the slices or portions thereof. These foci. which were 
noticed to be larger than the plaques resulting from the activity of a 
single PFC in agar, were presumed to indicate the sites of clusters 
of PFC in the spleens of the irradiated mice. A restricted distribution 
of PFC in spleens of mice was evident also in the work of Celada and 
Wigzell (1966) and ,Nakano and Braun (1966). Kind and Campbell (1968) 
showed that positive slices in the assay system of Playfair et al. (1965) 
contained more PFC than negative slices. 
A linear relationship was found to exist between the number of 
nucleated cells injected and the number of foci appearing in excess of 
the "background" number, the line of best fit extrapolating to zero 
(Kennedy et al., 1965a). The number of foci in the spleens of irr~diated 
mice injected with erythrocytes only, nucleated cells only, or in spleens 
of mice which were left uninjected. was considered to be the "background" 
number and was subtracted from all the experimental results. When 
the spleens from some mice were assayed for PFC and others for , 
haemolytic foci. the number of foci was found to be constant between 
days 7 and 10 after irradiation whereas the number of PFC increased 
exponentially and then decreased in this time span of 4 days (Kennedy 
et al. • 1965a. 1966). The mean number of PFC per focus at the peak 
of the response was calculated to be 46 following the injection of sheep 
erythrocytes and a fixed number of spleen cells. Lymph node cell 
inocula. mixed with foetal liver cells. gave rise to foci calculated to 
contain a mean number of 23 PFC at the peak of the response. The 
hypothesis was advanced that each focus resulted from the clonal proli-
feration and differentiation, through several generations, of an antigen-
sensitive "founder" cell which had localized in the spleen. Additional 
evidence that the foci resulted from a limited number of single entities 
was provided by Kennedy et al. (1966) using a limiting dilution assay. 
This particular assay was also used to substantiate the calculations 
now to be described, on the number of antigen-reactive cells in the 
normal mouse spleen. 
The focus assay has been used by Kennedy et al. (1966) and 
Playfair et al. (1965) in experiments designed to estimate the total 
number of antigen-reactive cells in any one population of lymphoid 
cells. Meaningful numbers of mice were used by the Kennedy group 
in a double transplantation technique in which irradiated mice injected 
with spleen cells were themselves used as donors of cells for passage 
into further irradiated mice. The method is similar to that described 
by Siminovitch, McCulloch and Till (1963) for determining the fraction 
' 
of colony forming units which localise in the spleen of irradiated mice, 
there to produce macroscopic haemopoietic colonies. One group of 
irradiated mice was injected with a certain number of spleen cells 
(= x ) and sheep erythrocytes and the spleens assayed for their content 
of haemolytic foci 8 days later (=y). Other mice were injected with 
10x spleen cells and single cell suspensions were prepared from the 
spleens of these mice 2 hours after cell injection. Further irradiated 
mice were injected with 10x spleen cells from these hosts together 
with sheep erythrocytes. The number of foci was determined 8 days 
later (= z ). The fraction (f) of focus-producing, or antigen-reactive 
cells, localizing in the spleen is thus y / 10z. This fraction was found 
to have a mean value of 15o/o and Kennedy et al. (1966) used this figure 
to calculate that the normal mouse spleen contained approximately 
1000 antigen -reactive cells. 
Using a s~ilar transplantation technique, but very few assay 
mice, Playfair et al. (1965) calculated the number of antigen-reactive 
cells to be 5000 per spleen. Papermaster (1967). using a radioisotope 
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technique, subsequently reduced this figure to 2 000. In these latter 
experiments, irradiated mice were injected with I 125 - or Cr51 -labelled 
spleen cells and the percentage of injected radioactivity in the spleen 
determined 24 hours later. The percentage of recoverable counts in 
recipient spleens varied from circa 5 to 15. Gregory and Lajtha (1968) 
also estimated f to be approximately 10o/o. 
As pointed out by Jerne (1967b), the figure of 10o/o for the locali-
zation of antigen-reactive cells into the irradiated spleen, may give 
estimates of the total number of antigen-reactive cells in lymphoid 
inocula which are higher than the actual number. The transfer methods 
do not take into account further recruitment of antigen -reactive cells 
into the irradiated spleen after 2 - 24 hours. The f value cited may 
therefore be incorrect by an order of magnitude butit is of interest to 
note that the figure of 1000 antigen-reactive cells per spleen correlates 
well with that obtained using a radiobiological as say (vide infra). It is 
higher than the figure mentioned by Makinodan and Albright (1967) and 
Jerne et al. (1963) by a factor of 1 log10 .• Jerne et al. assumed 
symmetrical divisions of PFC over a number of generations and, from 
the rate of increase in PFC number in the spleens of normal mice, 
-6 
estimated the frequency of target cells to be ofthe order of 10 for 
sheep erythrocytes antigens. The conclusion that the increase in PFC 
numbers is too rapid to be accounted for simply by proliferation of PFC 
has been discussed previously and has been supported recently by 
Jerne (1967a). 
Makinodan and Albright (1967) used a limiting dilution assay 
with rat erythrocytes and spleen cells in in vivo diffusion chambers and 
arrived at a similar figure. These determinations, based on antibody 
titres, are open to objections such as the unknown sensitivity of the 
antibody titrations and the extent of cell death in diffusion chambers. 
--- - -- -~-------- -
Even if the figure for the number of antigen-reactive cells per spleen 
was known with certainty, it would be unwise to use it in calculations 
of the minimum number of generations involved in the production of 
PFC from their precursors. The percent recruitment of available 
antigen-reactive cells would still be an unknown quantity. Moreover, 
the work of Ford {Ford, Gowans and McCullagh, 1966; Ford and 
Gowans, 1967) has clearly shown that the magnitude of the haemolysin 
response of the isolated and perfused rat spleen is determined more by 
the number of cells {in this case lymphocytes) migrating through the 
organ rather than the resident number. 
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The experiments of Kennedy et al. {1965b) on the radiosensitivity 
of the haemolysin response to sheep erythrocytes also give some indication 
of the total number of antigen-reactive cells present in the spleens of 
normal mice. Following 700 rads y-irradiation the plaque-forming cell 
response to sheep erythrocytes was reduced by a factor of 1000. Never-
theless, the response in the spleen {about 100 PFC) was greater than the 
1/ 
"background number of plaque-forming cells in the spleens of heavily-
irradiated mice not injected with sheep erythrocytes. Implicit in the 
argument formulated by these workers is that the effects of y-irradiation 
are "all or none" and that some cells will escape with their proliferative 
capacities unaffected. The 100 or so PFC appearing in response to 
sheep erythrocytes in the spleens of mice receiving 700 rads may there-
fore be the outcome of at least 6 - 7 generations of cells in a clone 
which originated from one antigen-reactive cell. In this case the 
number of antigen-reactive cells required to produce 100,000 splenic 
PFC in the normal immune response to sheep erythrocytes would be in 
the vicinity of 1000. This figure, taken together with those obtained 
with the limiting dilution and double transplantation techniques {Kennedy 
et al., 1966), immediately casts doubt on the notion that the "background" 
PFC {which often amount to no more than 10 per spleen) are the cells 
which are the precursors of the bulk of PFC appearing in the spleen 
in response to sheep erythrocytes (Jerne et al., 1963; Hege and Cole, 
1966; Aisenberg and Wilkes, 1967). 
Additional evidence that "background" PFC are not the sheep 
erythrocyte antigen-reactive cells, or at least do not make up the 
sum total of antigen-reactive cells in the spleen, has come from 
various sources. Miller et al. (1965) and Hege and Cole (1967) 
showed that neonatal thymectomy did not decrease the "background" 
PFC nuniber yet the primary immune response of neonatally-
thymectomized mice to sheep erythrocytes was severely depressed. 
Injections of PHA and typhoid-paratyphoid vaccine increased the 
number of PFC in the spleen yet decreased the immune response to 
a subsequent injection of sheep erythrocytes (Hege and Cole, 1967 ). 
Cheng and Trentin (1967a) injected heat killed enteric bacteria from 
conventionally-reared mice into specific pathogen-free mice and 
recorded an increase in the number of splenic anti-sheep erythrocyte 
PFC several days later. Piglets reared in an environment and fed 
diets largely devoid of known antigenic material did not have any 
"background" PFC yet they responded to sheep erythrocytes by 
producing PFC in the spleen (Sterzl et al., 1965). Germ-free and 
specific pathogen-free mice raised in some laboratories contained 
few or no PFC in the spleen (Cheng and Trentin, 1967a) although near 
normal levels have been reported {Miller, Dukor, Grant, Sinclair 
and Sacquet, 1967; Nordin, 1968). The environment and the food 
of mice reared in germ-free isolators could be expected to be free 
of viable microorganisms but considerable antigenic stimulation 
may be provided by killed organisms and bacterial products. 
The incidence of "background" PFC therefore seems to be 
related to the immunological history of the animals. It has been 
suggested that their presence represents the outcome of a degree 
of cross-reactivity between sheep erythrocytes and various antigenic 
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determinants encountered in every day life. Anti-sheep erythrocyte 
"background" PFC differ from "background" anti-horse erythrocyte 
haemolysin -producing cells and doses ci whole body x-irradiation 
exceeding 2 00. rads are required to significantly decrease their 
number either 2 or 7 days later (Hege and Cole, 1967 }. Interestingly, 
they are not sensitive to mouse anti-sheep erythrocyte sera of high 
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19S or 7S antibody titre (Wigzell, 1967; Hege and Cole, 1967} yet the 
depressive effect of hyperimmune sera on the primary antibody response 
to sheep erythrocytes has been well documented (Henry and Jerne, 1968; 
Uhr and Moller, 1968}. Szenberg and Cunningham (1968} and Cunningham 
(1968a} examined "background" PFC in mice and reported that very few 
were in DNA synthesis, that few were classical plasma cells, and the 
finding which is particularly pertinent to the discussion in the next 
subsection, was that the large majority were lymphocytes. 
(4} Small lymphocytes as antigen-reactive cells 
The property of antibody production is now known not to be invested 
solely in the plasma cells and their immediate developmental precursors. 
Mononuclear cells, some of whiCh are indistinguishable from classical 
small lymphocytes on light microscopic examination, contain (Baney 
~·, 1962; van Furth, Schmit and Hijmans, 1966b} and secrete 
antibodies (Attardi, Cohn, Hori9ata and Lennox, 1964; Harris, Hummeler 
and Harris, 1966; Hummeler, Harris, Tomassini, Bechtel and Farber, 
1966; Cunningham, 1968a}. Tubules of endoplasmic reticulum and/or 
an abundance of ribosomes have, however, been demonstrated in many 
of these lymphoid antibody producers (Harris et al., 1966; Hummeler 
et al., 1966}. As emphasised by Cunningham (1968}, the differences 
of opinion concerning the relative roles of lymphoid and plasma cells 
as antibody producers may be more apparent then real. From the 
proposed genealogy of plasma cells (e. g. Nossal, 1965} there seems 
to be no reason why an almost continuous histological picture of 
antibody-forming cell types. from lymphoid to plasmacytoid cell, 
should not be encountered. The lack of intracellular organelles 
characteristic of protein synthesis does suggest, however. that any 
postulate on the role of the small lymphocyte in antibody production 
should invoke functions other than secretion of antibody molecules. 
The immunological activity of small lymphocytes has been 
suspected ever since the demonstration that regional lymph nodes 
were intimately involved with antibody production (McMaster and 
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Hudack, 1935; Ehrich and Harris, 1942). Small lymphocytes predominate 
in unstimulated nodes and their absolute number is increased in sti-
mulated nodes (Nossal and M~keHi. 1962; Miller. J. J., 1964). Many 
early experiments demonstrated that the adoptive transfer of immune 
reactions could be achieved successfully with lymphocyte-rich inocula 
(Landsteiner and Chase. 1942; Billingham. Brent. and Medawar, 1956; 
Harris and Harris (reviewed in Harris and Harris, 1960). Mitchison. 
1957; Dixon, Weigle and Roberts, 1957; Stavitsky, 1958; Sterzl, 1959; 
Makinodan, Gengozian and Shekarchi, 1958). In those systems 
involving antibody production, most investigators used cells harvested 
from sensitized donors and the findings were of value in identifying the 
organ, rather than the cell type, responsible for antibody production. 
In addition, the relative roles of the host and donor cells were not 
ascertained and a further limitation was that, in many cases. the host 
could have mounted an effective host-versus-graft reaction (discussed 
at length by Mitchison, 1957; Gengozian, Makinodan and Shekarchi, 
1961). Largely from the work of Gowans and McGregor and their 
colleagues. the small lymphocyte has been elevated recently to the 
status of antigen-reactive and immunologically competent cell. Physio-
logically. it is admirably suited for candidacy as the precursor of both 
antibody-producing plasma cells and the sensitized cells believed to 
be involved in cell-mediated immune responses. The capacity for 
extensive migration through lymphoid organs (Section IA) would 
enable this cell type to be deployed most effectively in sites of 
antigen accumulation (e. g. Fitzgerald, 1964; Gowans and McGregor, 
1965). 
Rats, drained of thoracic duct lymphocytes over a period of 
many days, failed to respond by producing normal amounts of antibody 
to tetanus toxoid and sheep erythrocytes. This finding provided 
circumstantial evidence that lymphocytes were involved in primary 
antibody responses. Cellular inocula, containing more than 99% 
viable thoracic duct small lymphocytes, restored the response of 
chronically-drained rats to normalJevels (Gowans, McGregor, Cowen 
and Ford, 1962; McGregor and Gowans, 1963). The immunological 
deficiency in chronically-drained rats was shown not to be due to th~ 
effects of an adrenal-mediated stress reaction or chronic restraint 
afl:d was also shown not to be absolute. Lymphocyte ... depleted rats 
responded quite well to large doses of sheep erythrocytes and the 
capacity to reject skin homografts was dependent upon the genetic 
disparity of the skin graft donor and the chronically-drained host. 
The rejection time was prolonged only when donor and host differed 
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at weak histocompatibility loci (McGregor and Gowans, 1964; McGregor 
1966). 
Lymphoid cell preparations had been shown to abrogate an existing 
state of immunological tolerance (Billingham, Brent and Medawar, 1956) 
and Gowans et al. (1962) and Gowans, McGregor and Cowen {1963) 
demonstrated that inocula rich in small lymphocytes were able to effect 
rejection of tolerated grafts. Host rats were rendered tolerant at birth 
by injections of appropriate F 1 spleen cells {Gowans et al., 1962) or 
F 1 bone marrow cells (Gowans et al., 1963). Variations in skin graft 
survival times were striking and probably reflected the degree of cellular 
chimaerism in the tolerant hosts (Billingham, 1963; Gowans and McGregor, 
1965). 
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The Gowans group went on to show that small lymphocytes were 
able to restore the haemolysin response in rats rendered unresponsive 
to sheep erythrocytes by sublethal (Gowans et al. ~ 1962; McGregor~ 
McCullagh and Gowans~ 1967) and lethal (Ellis et al •• 1967) doses of 
whole body irradiation. The response in sublethally-irradiated rats 
could be increased significantly by yeast extracts which were, in point 
of fact, as effective as large numbers of spleen cells (McGregor et al.. 
1967 ). Host responsiveness may therefore. have contributed to the 
measured haemolysin response in irradiated recipients of small 
lymphocytes. Crucial to the argument that donor small lymphocytes 
were providing cells with the potential for initiating antibody production, 
was the demonstration that small lymphocytes from rats rendered un-
responsive to sheep erythrocytes were vastly inferior to cells from 
normal rats in this system. Even though it is unknown whether tole-
rance in the donors was specific for sheep erythrocyte antigens only. 
the use of small lymphocytes from such donors strongly emphasises 
that the response of the irradiated recipients cannot be elevated simply 
by injecting large numbers of lymphocytes from any source. 
The fate of small lymphocytes has been investigated in recipients 
in which the inoculated lymphocytes induce a graft-versus-host reaction. 
Taking advantage of the differential uptake of tritium -labelled RNA and 
DNA precursors by small and large lymphocytes, Gowans (1962) showed 
that, in the presence of foreign histocompatibility antigens, small 
lymphocytes differentiated into large cells which were pyronin positive 
in histological preparations. Large pyroninophilic cells incorporated 
tritiated thymidine and the appearance of increasing numbers of lightly-
labelled small lymphocytes in subsequent days, suggested that the DNA-
" 
synthesizing large pyroninophilic cells divided to produce small 
lymphocytes (Gowans et al. • 1962. Gowans. 1962). some of which 
may possess the property of migrating from blood to lymph (Ford~ 
Gowans and McCullagh, 1966). A point often stressed (e. g. Gowans 
and McGregor~ 1965), and which is suggestive of a functional hetero-
geneity in the thoracic duct small lymphocyte population~ is that 
only a small number of inoculated lymphocytes differentiate to large 
pyroninophilic cells under the impact of foreign histocompatibility 
antigens. 
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The simplest hypothesis relating these histological events to 
the proposed function of the small lymphocytes as an immunologically 
competent or antigen-reactive cell~ is that small lymphocytes respond 
to antigen by differentiating and proliferating to produce a progeny of 
immunocytes (whether they be sensitized lymphocytes or antibody-
forming cells} through the intermediary of the large pyroninophilic 
cell. The clonal· expansion of lymphocytes in this manner also 
provides a mechanism for the development of specific immunological 
memory. The anamnestic response~ as measured by an increased 
level of circulating antibody or a decreased rejection time of homo-
grafts~ could be a function of an increased number of reactive or 
competent cells. The emergence of different classes of antibody or 
the production of more avid antibody molecules could be a function 
of either a selective increase in the number of certain types of reactive 
cell OIJ alternatively. a qualitative change in the original antigen-
reactive cell type. Gowans and Uhr (1968} have transferred secondary 
responsiveness to <bX 174 bacteriophage to sublethally-irradiated 
recipient rats with purified populations of thoracic duct small lympho-
cytes collected from donor rats primed 1. 5 to 15 months previously. 
The incubation procedure used to eliminate the majority of large and 
medium lymphocytes was shown not to involve the differentiation of 
these cells to small lymphocytes since the proportion of lymphocytes~ 
which had originally incorporated tritiated thymidine~ decreased during 
the course of incubation. "Incubated inocula" were in fact more potent 
than freshly- collected thoracic duct cells when equal numbers of cells 
were injected into irradiated recipients together with (/> X 17 4. 
The results of the Gowans and Uhr (1966) experiments were 
clear cut and demonstrated unequivocally that thoracic duct cell 
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inocula, rich in small lymphocytes, are very effective in transferring 
secondary responsiveness adoptively to syngeneic irradiated recipients. 
Interpretations. however. are complicated by the fact that sublethally-
irradiated recipients were used and th~ contribution of host cells to 
the heightened antibody response cannot be discounted. The finding 
that appropriately·sensitized,chronically-drained rats were still able 
to respond normally. or in a secondary fashion, to antigens such as 
sheep erythrocytes, tetanus toxoid, and C/J X174 bacteriophage, suggests 
that a sessile population of sensitized and reactive cells persist within 
the tissues of drained rats (McGregor and Gowans, 1963; Gowans and 
Uhr, 1966). This population may or may not be related to the reactive 
cells which are removed by chronic thoracic duct drainage. Finally. 
Ellis et al. (1967) recently . demonstrated that thoracic duct lympho-
cytes from primed donor rats were highly effective in transferring 
tetanus toxoid responsiveness to lethally-irradiated rats. By using 
a combination of immunofluorescent and autoradiographic techniques, 
they showed that the DNA-synthesizing .. antibody-forming cells in the 
spleens of the heavily-irradiated recipients soon after transfer were 
not derived from medium and large lymphocytes. The antibody formers 
were therefore most likely to have evolved from nonDNA-synthesizing 
small lymphocytes in the inoculum. Thus " ••• the candidature of the 
small lymphocytes for the precursor cell (of the antibody-producing 
cell) is very strong but the crucial test has yet to be performed" (Ellis 
et al. • 1967 ). 
(5) Evidence for synergism in haemolysin production 
A new lead in the investigations into the underlying cellular 
mechanism of haemolysin production was provided in 1966 by Claman 
and his collaborators. Claman, Chaperon and Triplett (1966a) demon-
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strated that a mixture of thymus and bone marrow cells~ when injected 
into syngeneic irradiated mice~ produced a greater haemolysin response 
to sheep erythrocytes than could be accounted for by summating the 
response of mice injected with either thymus or marrow cells alone. 
Using the assay system of Playfair et al. (1965)~ they firstly confirmed 
the finding of Kennedy et al. (1965a) and Playfair et al. {1965) that a 
linear relationship existed between the number of spleen cells injected 
and the number of "active areas" of haemolysis appearing in the spleens 
of the irradiated recipients. In addition to the number of active areas~ 
they also determined the "specific activity" of the spleens~ the latter 
being a measure of the proportion of spleen segments with haemolytic 
activity. Mice injected with sheep erythrocytes and either 50 million 
syngeneic thymus cells or 10 million syngeneic bone marrow cells 
contained no more haemolytic activity in their spleens than control 
mice injected with the antigen only. Spleens of mice receiving both 
thymus and bone marrow cells contained many more~ and apparently 
larger, zones of haemolysis. In further experiments~ in which either 
the thymus or bone marrow inoculum was kept constant at 2 0 million 
and 10 million cells~ respectively, a linear response curve was obtained 
over a certain range with increasing doses of the other cell type. On 
the basis of their observations, Claman et al. (1966a) proposed that 
"auxillary" cells and" effector" cells were involved in the haemolysin 
response to sheep erythrocytes. The basic findings of the Claman 
group have been confirmed (Cheng and Trentin, 1967b}. 
Claman et al. (1966b} extended these experiments and measured 
serum haemolysins in the irradiated mice as well as "active areas" 
and "specific activity" in the recipient spleens. In experiments 
involving groups of only 4 to 6 irradiated mice~ no synergism with 
adult bone marrow was obtained when thymus cells from one day old 
donors were used in contrast to the situation in which thymus cell 
donors were 6 days old or adult. Synergism was demonstrated in 
recipients of 50 million thymus and 1 million adult spleen cells but 
not in recipients of 10 million bone marrow and 1 million adult 
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spleen cells. One million spleen cells were as effective as 10 million 
bone marrow cells when combined with 50 million thymus cells. 
Thymus cells from irradiated donors were inactive and attempts to 
substitute subcutaneously placed thymus grafts for thymus cells were 
also unsuccessful. By delaying the injection of one or other of the 
cell types. Claman et al. {1966b)hoped to show in which population the 
"auxillary" cell resided. No difference was apparent. however, in 
any of the groups in which either bone marrow or thymus cells were 
initially stimulated with sheep erythrocytes and the other cell type 
injected two days later. 
In a recent report, Claman. Chaperon and Selner {1968) used 
the Jerne plaque-forming cell assay as well as serum haemolysin 
determinations in an analysis of the interaction between thymus and 
bone marrow cells. This study, combined with another· from the same 
group (Chaperon, Selner and Claman, 1968), clearly demonstrated 
that the number of splenic plaque-forming cells may give a false picture 
of the haemolysin-producing status of the irradiated animal. The 
effect of varying the route of injection of one or other of the cell types 
was determined in experiments again involving only very few mice per 
group. The serum titre was not affected by injecting either bone 
marrow or thymus cells intravenously or intraperitoneally. By 
contrast. significant numbers of PFC were present in the spleen only 
when bone marrow was injected intravenously. This finding can be 
interpreted to indicate that the site of residence of haemolysin-forming 
cells depends on the site of residence of the majority of inoculated 
bone marrow cells. Bone marrow cells could be expected to home in 
greater numbers to the spleen when injected intravenously rather than 
intraperitoneally {e. g. Bainbridge. Brent and Gowland. 1966). 
Massive doses of sonicated thymus cells or rat thymus cells injected 
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daily. did not mirror the effects of untreated syngeneic thymus 
cells when injected together with bone marrow cells and sheep 
erythrocytes on the day of irradiation. Thymus segments placed 
intraperitoneally were effective in increasing the haemolysin response 
in mice injected intravenously with bone marrow cells but irradiated 
thymus segments were inactive. In addition, the presence of the 
thymus in the irradiated recipient was shown not to be important in 
the interaction between inoculated thymus and marrow cells in the 
production of haemolysins. As many splenic plaque-forming cells 
were present in adult-thymectomized, irradiated mice as in sham-
thymectomized, irradiated mice injected with 50 million thymus cells 
and 10 million bone marrow cells and the serum haemolysin titre was 
identical in both groups. 
Claman et al. (1968) were unable to determine which 
population containedthe "auxillary" cells and which contained the 
11 effector!' cells'·. In their system, allogeneic combinations of cells 
failed to interact in the production of haemolysins (Chaperon and 
Claman, 1967) and measures to identify the immunogenetic character 
of the antibody-forming cell could not be instituted. Claman et al. 
( 1966a) suggested that the bone marrow provides the "effector" cells 
and the thymus the "auxillary" cells. Radovich, Hemingsen and 
Talmage (1968) have presented data which they believe favours the 
alternative hypothesis. Nonprimed and primed spleen cells, when 
injected with bone marrow cells into irradiated mice, were effective 
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in promoting the appearance of haemolysin plaque-forming cells in 
numbers exceeding the summated activities of spleen cells or bone marrow 
cells alone. Even though standard errors of the mean responses were 
very large and group sizes small, the finding does contrast with that 
of Claman et al. (1966) in which evidence for synergism was obtained 
in mixtures of thymus and spleen and not mixtures of bone marrow and 
spleen. Radovich et al. considered that the enhancement in the response 
was roughly proportional to the extent of haemopoietic regeneration 
following bone marrow inoculation. This led to the hypothesis that 
the regenerating spleen provided a more suitable milieu for the 
trapping and/ or differentiation and/ or proliferation of antibody-
forming cells or their precursors, resident in the spleen cell inoculum 
or, in: the case of the Claman et al. experiments, in the thymus cell 
inoculum. It is obvious that the controversy will persist until such 
time as chromosomal, immunogenetic, or immunoglobulin allotype 
markers are introduced into the system. 
Davies, Leuchars, Wallis, Marchant and Elliott (1967) and 
Davies, Leuchars, Wallis, Sinclair and Elliott (1968b) have presented 
evidence in favour of the concept of a thymus -marrow interaction in 
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the immune response to sheep erythrocytes. Their system employs 
thymectomized, irradiated CBA/Cbi mice injected with CBA/Cbi bone 
marrow cells and grafted with a chromosomally-marked allogeneic 
thymus graft from CBA/H-T6T6 mice. It is based on a system devised 
by Doria, Goodman, Gengozian and Congdon ( 1962) for the analysis of 
the immunological activity of cells in allogeneic radiation chimaeras. 
Thirty days after irradiation, bone marrow protection.and thymus 
grafting the chimaeras were immunized with two injections of sheep 
erythrocytes and mice with high antibody titres selected as donors of 
spleen cells. These cells were injected together with sheep erythro-
cytes into irradiated CBA/Cbi and CBA/H-T6T6 mice, some of which 
had been presensitized against CBA/H-T6T6 and CBA/Cbi histocompa-
tibility antigens, respectively. High anti-sheep erythrocyte antibody 
titres were obtained in nonsensitized mice and in isoimmune CBA/Cbi 
mice which were capable of eliminating thymus graft-derived cells. 
In secondary recipients sensitized against CBA/Cbi cells (i.e. bone 
marrow-derived cells}, no antibody response was obtained (Davies 
et al., 1967}. Previous work had shown that, in thymectomized 
irradiated mice protected with bone marrow cells and grafted with 
thymus tissue, the majority of cells in mitosis in the spleen and lymph 
nodes were of bone marrow type. A striking increase in the number 
of mitotic figures of thymus graft cell type was observed 2 to 3 days 
after sheep erythrocyte challenge (Leuchars et al. , 1964; Davies et al. , 
1966). This burst of mitosis coincided with a sharp increase in the 
number of large pyroninophilic cells in the spleen. 
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The observations in this selective transfer system were extended 
to include the primary immune response to sheep erythrocytes (Davies 
et al., 1968b). The haemolysin titrations and Jerne :plaque-forming 
cell assays clearly showed that the presence of cells of bone marrow 
genotype was absolutely essential to effect a response to sheep erythro-
cytes in the secondary hosts. No conclusions could be reached on the 
requirement of thymus graft-derived cells in the primary immune response 
to sheep erythrocytes in the secondary hosts since the haemolysin 
titrations and PFC assays gave quite different results. In discussion, 
Davies et al. (1968b) favoured the notion that thymus-derived cells 
influence the immunological activity of bone marrow-derived cells by 
means of a humoral factor especially in the secondary response to sheep 
erythrocytes. 
The only point which may be a seriom criticism of the experi-
mental design and which would negate the validity of the conclusions, 
is that cells were transferred from the primary hosts up to 51 days 
after thymus grafting. The rapid replacement of graft lymphocytes with 
exogenous cells has been well documented in several systems (Section I.A). 
It is 'quite conceivable that at the time of antigen challenge, and certainly 
by the time of spleen cell transfer, the graft had been completely 
replaced by bone marrow-derived cells which may have migrated in 
large numbers from the graft. Such thymus graft migrants would be 
of CBA/Cbi type and would be rejected in the appropriate secondary 
hos~ogether with the bone marrow-derived cells which had not migrated 
through the thymus. The possibility cannot be excluded that the bone 
marrow-derived, antibody-forming cell precursors had been resident 
at some stage in the thymus graft. The continued production of 
thymus donor type cells within the thymus graft, and subsequent emi-
gration from the graft, appears to extend beyond the time of thymus 
grafting and hence the time associated with much tissue disruption and 
escape of thymus cells. This evidence has been furnished by experi-
ments in which chromosomally-marked thymus grafts were removed 
after one week. Fewer cells of graft origin were found dividing in 
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the spleen and lymph nodes of the, chimaeric mice (Davies et al., 1968a). 
Nevertheless, the number of bone marrow cells which had migrated 
through the thymus graft cannot be determined and the objections raised 
in the discussion above remain valid. 
In conclusion, the present day concept of the antigen-reactive 
cell can be said to have evolved largely from the speculations of Burnet 
and the experimentation of Gowans and his colleagues. It has been 
proposed that antigen-reactive cells, which in many systems are probably 
small lymphocytes, respond to antigenic determinants by producing a 
progeny of specific antibody-forming cells through processes involving 
proliferation and differentiation. Only a small proportion of cells present 
in lymphoid organs, such as the spleen and lymph nodes, responds to 
antigen and Kennedy and his colleagues have estimated this number to 
be 1, 000 per normal mouse spleen in the sheep erythrocyte system. 
The figure of 1, 000 may, however, be grossly inaccurate and the actual 
number of cells responsive to a single antigenic determinant remains 
unknown. If antigen recognition is a cell surface-mediated phenomenon 
then the specificity of the interaction between antigen and reactive cell 
could be achieved by the presence of antibody-combining-site-configurations 
on the surface of antigen-reactive cells. The question remains open as to 
whether individual cells are genetically restricted in their reactivity or 
whether they are invested with the property of multipotentiality prior 
to contact w.ith antigen. The concensus of opinion seems to favour 
the former hypothesis and much speculation now centres around the 
processes whereby the presumptive mechanisms of somatic mutation 
and genetic recombination generate the diverse patterns of immunolo-
gical specificity in antigen-reactive cells or their precursors (Jerne, 
1967c). 
The end cell in the proliferative and differentiative cellular 
·events of antibody production is probably the plasma cell. The abun-
dance of intracytoplasmic structures, indicative of a protein secretory 
function, set this cell apart as a fully differentiated antibody producer 
par excellence. It is obvious from the literature that cells of lympho-
cyte-like morphology may contain and secrete antibodies and it is 
unlikely that all these cells are destined to mature into plasma cells. 
Selective processes may occur at this stage to restrict the maturation 
of antibody-producing cells and these processes may act at the level 
of individual clones of cells or at the level of the cells within the 
"expanding" clones. The antigenic reactivity of some small lympho-
cytes in the circulating pool has been clearly demonstrated but no 
direct evidence is available to indicate whether some or all of the 
responding cells eventually elaborate antibody molecules or produce 
a progeny of antibody-forming cells. Furthermore, the property of 
specific antigenic responsiveness is unlikely to be restricted to the 
population of recirculating small lymphocytes. 
The 198 haemolysin-forming cell response to sheep erythrocytes 
has been investigated at the cellular level in species such as the rat 
and mouse. Studies on the growth kinetics of splenic plaque-forming 
cells in the exponential phase of the response have indicated that the 
rapid increase in plaque-forming cell number can be accounted for 
most satisfactorily by mechanisms of differentiation from non antibody-
producing precursor cells and proliferation of plaque-forming cells 
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themselves. Many plaque-forming cells at this time are in DNA 
, synthesis and cell proliferation is an invariable accompaniment 
of haemolysin-forming cell production in the spleen. It has yet 
to be resolved whether some cells commence antibody production 
early in the response without undergoing DNA synthesis and cell 
division. The complicity of at least two cell types in haemolysin 
production has been inferred from the recent studies of thymus-
marrow synergism in irradiated animals. The cell type respon-
sible for antibody production in these systems has not been iden-
tified unequivocally. 
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C. The Immunological Activity of Thymus Cells 
( 1) The immunological effects of thymectomy 
Experiments dating from 1961 have clearly demonstrated 
that the development and maintenance of an intact immune system~ 
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in a variety of higher vertebrate species~ is dependent on the presence 
of the thymus. The immunological effects of thymec1omy have been 
reviewed recently by Miller and Osoba (1967) and it is now quite 
obvious that thymectomized animals may display defects in immune 
capacity depending on the age at thymectomy. the species under 
investigation, the antigen chosen. the age at challenge. the various 
parameters of the elicitation and detection of the particular immune response. 
and the presence or absence of intercurrent infections. In general. the 
experiments thus far conducted indicate that the effects of thymectomy 
are more dramatic the earlier in life that thymectomy is performed. 
Moreover. cell-mediated immune reactions appear to be affected to 
a greater extent than humoral immune responses. Serum immuno-
globulin levels. and the antigenic and functional characteristics of 
immunoglobulins in neonatally-thymectomized rats and mice. do not 
deviate significantly from those of the immunoglobulins in non-
thymectomized animals (Humphrey~ Parrott and East~ 1964; Fahey. 
Barth and Law. 1965) although IgA levels maybe reduced (Arnason~ 
de Vaux St. Cyr and Relyveld, 1964; Arnason~ de Vaux St. Cyr and 
Shaffner. 1964). 
The features of certain immunological deficiency syndromes in 
children. and the studies on the bursa of Fabricius in chickens, suggest 
that the compromised immunological system following thymectomy in 
mammals, may be due to the presence of other central lymphoid organs~ 
primarily involved with the development of immunoglobulin- and 
antibody-producing cellular systems (reviewed in Good~ 19 66; Warner. 
1967; Miller and Osoba, 1967; Goldstein and Mackay, 1969). The 
search for an organ, with bursa-like functions, in the gut-associated 
lymphoid tissues has been the subject of intensive investigations 
conducted by Good and his colleagues. Attention has been focussed 
on the lymphoid tissues of the gut since epithelial ... mesenchymal 
associations seem to be a feature of the ontogenetic development of 
primary lymphoid organs. The thymus and bursa arise as epithelial 
outpouchings from ectoendodermal junctions {reviewed in Miller and 
Davies, 1964; Osoba, 1968a) and studies in the embryo indicate that, 
in the chicken and mouse at least, the lymphoid cells are of mesen-
chymal origin and are sequestered from the circulation {Moore and 
Owen, 1967). 
Convincing evidence has been presented that the Peyer1 s patches 
are required for the expression of full antibody producing capacity in 
the rabbit {Perey, Cooper and Good, 1968). It remains to be deter-
mined whether the response to the antigen used (Brucella abortus 
organisms) is mediated by the Peyer1s patches themselves or whether 
these lymphoid aggregates, by influencing the responsiveness of peri-
pheral lymphoid organs such as the spleen and lymph nodes, behave in 
an analogous fashion to the thymus and bursa. Recently, Fichtelius 
( 1968) has proposed that the entire epithelial lining of the intestinal 
tract is the bursal equivalent in mammals. 
Notwithstanding the above considerations, simple extirpation 
of the thymus in the newborn period has been shown to depress the 
antibody response to certain antigens in several mammalian species. 
In some antigenic systems the primary response was unaffected whilst 
67. 
the secondary response was markedly depressed (Hess, Cottier and Stoner, 
1963; Hess and Stoner, 1966; Basch, 1966). The antigens used, 
namely MS-2 coliphage and tetanus toxoid, were quite capable of eliciting 
a response at the time the thymus was removed. By contrast, 
neonatal mice do not respond to sheep erythrocytes {Hechtel, Dishon and 
Braun, 1965) and injections of these erythrocytes resulted in a normal 
secondary response in neonatally-thymectomized mice which had 
responded poorly to the primary injection (Sinclair, 1967; Sinclair 
and Elliott, 1968a). Moreover, defective haemolytic antibody 
responses may be less apparent the later in life that neonatally-
thymectomized mice are challenged with antigen (Rogister, 1965; 
Dukor, Dietrich and Rosenthal, 1966; Sinclair and Millican, 1967; 
Zinzar and Svet-Moldavsky, 1967; Takeya and Nomoto, 1967b). 
Takeya and Nomoto {1967a) have shown that multiple injections of 
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sheep red cells elevate the antibody response in neonatally-thymectomized 
mice to levels which ultimately approach those attained in nonthymecto-
mized litter mates injected with antigen for the first time. This 
finding has been used as evidence that the few competent cells in 
neonatally-thymectomized mice (vide infra) may be increased in 
number by exposure to introduced antigens and hence to cross -reacting 
antigens in the environment. 
In a variety of experimental situations, cells from the spleen, 
lymph nodes, and thoracic duct of neonatally-thymectomized rats and 
mice have not performed as. well, when assayed on a cell for cell 
basis, as lymphoid cells from intact animals. Thus, Cross,Leuchars 
and Miller {1964) and Miller, Leuchars, Cross and Dukor (1964) failed 
to restore the haemagglutinin response to sheep erythrocyt~s. and the 
potential for allogeneic skin graft rejection, in adult-thymectomized, 
irradiated mice with spleen cells from neonatally-thymectomized mice. 
Spleen cells from normal mice improved the immunological status of 
such animals (Cross et al., 1964; Miller et al~, 1964; Duplan, 1965). 
-- ' 
Dalmasso, Martinez, Sjodin and Good (1963) showed that 5 million 
spleen cells from normal two months old mice were fully able to 
produce runt disease in newborn allogeneic recipients. The spleen 
cell inoculum, when taken from neonatally-thymectomized mice of the 
same age, had to be increased to 20 million cells to produce a similar 
effect. Spleen cells from neonatally-thymectomized mice were required 
in larger numbers than normal spleen cells in order to prevent 
wasting disease and to improve the capacity for tumour graft 
rejection in neonatally-thymeCtomized mice (East and Parrott, 1964}. 
Agnew (1967} reported a reduced incidence, and an increased mean 
latent period, of tumour growth in neonatally-thymectomized rats 
injected with 10 to 20 million thoracic duct cells from normal 
syngeneic donors. By contrast~40 million thoracic duct cells 
from neonatally-thymectomized rats were unable to modify the 
susceptibility of other neonatally-thymectomized rats to tumour 
development. As mentioned in Section IA, thoracic duct cells from 
neonatallyethymectomiz ed rats were at least 10 times less effective 
in inducing runt disease in newborn allogeneic recipients than thoracic 
duct cells from intact rats (Rieke, 1966}. 
(2} The reconstitutive capacity of thymus cells 
Reconstitution experiments in thymectomized animals have 
provided a means of assessing the immunocompetence-of various 
cellular inocula. Many groups of workers have demonstrated the 
effectiveness of normal spleen and lymph node cells in preventing 
wasting disease and improving the immunological status of thymec-
tomized mice and rats (Dalmasso ~·, 1963; Miller, 1964a, b; 
East and Parrott, 1964; Trainin, Law and Levey, 1965; Isakovi6, 
Waksman and Wennersten, 1965; Goedbloed and Vos, 1965). The 
lymphoid inocula, in the case of neonatally-thymectomized recipients, 
were usually given within two weeks of birth and the immunological 
performance of the animals assessed some weeks later. In the 
study of Isakovic et al. (1965), however, the reconstitutive capacity 
9 
of 1 x 10 lymph node cells was demonstrated when inoculated at the 
time of sensitization with antigen; in this case bovine serum albumin 
in neonatally-thymectomized rats. In the other systems, the para-
69. 
meters used to determine the degree of reconstitution were the haema-
gglutinin response to sheep red cells. the prevention of wasting 
disease. the rejection of skin or tumour homografts. and the capacity 
of recipient lymphoid cells to elicit graft -versus -host (GVH) 
reactions. 
Parallel studies using injections of dissociated thymus cells 
have usually shown that cells from this source are deficient in their 
capacity to correct the defects in neonatally-thymectomized mice 
and rats. 200 million syngeneic adult spleen cells reversed wasting 
disease in 90o/o of neonatally-thymectomized mice whereas the same 
number of thymus cells resulted in recovery of only 30o/o of the 
recipients (Hilgard. Yunis. Sjodin. Martinez and Good. 1964). 
Earlier work by the same group indicated that syngeneic thymus cells 
increased survival rates in neonatally-thymectomized mice without 
increasing the immunocompetence of spleen cells. as determined by 
the splenic GVH assay in appropriate F 1 hybrid recipients (Dalmasso 
et al.. 1963). Large numbers of intraperit~neally-injected 
syngeneic thymus cells from newborn or adult mice were later shown 
to improve substantially the immunological performance of spleen 
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cells from neonatally-thymectomized mice. Three hundred to 400 
million C3H thymus cells did not result in a GVH reaction in neonatally-
thymectomized A strain mice yet spleen cells from these hosts at 
2 months of age caused splenomegaly in 8 day old (C3H x DBA)F 1 and 
(C3H x C57BL)F 1 hybrids; hosts which are presumed to be capable 
of rejecting A strain cells (Yunis. Hilgard. Sjodin. Martinez and 
Good. 1964; Yunis. Hilgard. Martinez and Good. 1965). When 
(Ax C3H)F 1 hybrid thymus cells were used in the reconstitution of 
A strain neonatally-thymectomized mice. spleen cells from some of the 
animals possessed host type reactivity but donor type reactivity could 
be demonstrated more readily (Yunis. Martinez. Smith and Good. 1964). 
The discriminating assay of cell chimaerism described by Simonsen 
(1962) was used in all the allogeneic and semi-allogeneic reconstitu-
tion experiments. The inability of huge numbers of C3H thymus cells~ 
or even 100 million spleen cells (Yunis et al. ~ 1965L to induce a GVH 
reaction in the thymectomized A strain recipients remains unexplained. 
The data from the GVH assays~ coupled with the skin graft data 
(Yunis et al. ~ 1965 ), does indicate~ however~ that the reconstitution of 
neonatally-thymectomized mice with thymus cells is dependent upon the 
immunological activity of the inoculated cells. 
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East and Parrott (1964) and Law (1966a) were able to prevent 
wasting and improve the immunological status of neonatally-thymectomized 
mice with multiple injections of thymus cells. Miller (1964a~ b) and 
Trainin et al. (1965) reported that relatively small numbers of syngeneic 
spleen and lymph node cells~ but not thymus cells~ reconstituted 
neonatally-thymectomized mice. Trainin et al. (1965) and Law {1966a) 
observed that many thymectomized recipients~ injected with single 
cell suspensions of lymph node or spleen on the second day of life~ 
died between 3 and 6. 5 months of age. The protection afforded by 
these inocula was therefore temporary and may reflect a limited life 
span of the component cells or their progeny within the tissues of the 
recipients. Goedbloed and Vos (1965) reported that lymph node cells 
were 10 to 20 x as effective as thymus cells in restoring the capacity 
for skin graft rejection in adult-thymectomized~ irradiated mice 
protected with small numbers of bone marrow cells. 
Thymus cells injected soon after~ or some weeks prior to 
a footpad injection of BSA in Freund's adjuvant~ did not improve the 
defective response of neonatally-thymectomized rats with respect to 
delayed or Arthus type skin reactivity or anti-BSA antibody production 
(Isakovic et al. ~ 1965) . Best reconstitution could be achieved with lymph 
node cells given at the time of sensitization and a delay of 2 to 4 days 
reduced the efficacy of such inocula. Unfortunately~ these latter conditions 
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were employed in testing for the reconstitutive capacity of thymus 
cells in this system. The response to the footpad deposit of antigen 
was presumably mediated by cells in that site and the regional lymph 
node. No increase in organ size, comparable to that following lymph 
node cell injection, occurred in the lymph nodes of thymus cell-
inoculated rats. It is possible that the thymus cells did not home in 
large numbers to the lymph node (Section IA) where contact with antigen 
was presumably occurring. Interestingly. the weight and cellularity 
of the spleen increased with injections of either lymph node or thymus 
cells. Perhaps different results would have been obtained with the 
use of another systemically administered antigen, the response to which 
is mediated in the spleen by resident or migratory cells. 
As mentioned previously. the degree of reconstitution of neonatally 
thymectomized mice using spleen, lymph node, or thymus cells was 
determined several weeks after injecting the cells in the neonatal period. 
One exception to this general pattern exists in the literature and the 
results seem to be at variance with the conclusion that thymus cells are 
not as effective as lymph node cells in reconstitution experiments. 
Taylor (1963) injected 50 million adult syngeneic lymph node or thymus 
cells into groups of 7 weeks old neonatally-thymectomized CBA mice 
and challenged them with BSA in Freund's adjuvant 7 weeks later. The 
antibody titres ~ as measured by the antigen -binding capacity of the 
serum~ were increased over those in uninjected controls by a factor of 
10 and to an equal extent in both groups. Furthermore~ by using 
chromosomally-marked thymus and lymph node cells~ both cell types 
were later detected in the spleens and lymph nodes of the hosts. It 
seems~ therefore~ that the later in life that thymus cells are injected~ 
the greater is the probability of successfully reconstituting neonatally-
thymectomized mice. Perhaps the demand for cells intensifies with 
increasing age and it is tempting to postulate that antigenic stimulation 
increases the colonization potential of thymus cells by means of clonal 
expansion. In the relatively protected environment of the neonatal 
mouse in which maternal antibodies are present, thymus cells, unlike 
lymph node and spleen cells, may have a limited life span. The adult 
thymus may also be protected from most antigenic insults and, as 
discus sed in Section IA, several pieces of evidence suggest that many 
thymus lymphocytes die within the organ. 
(3) Activity of the thymus in adoptive transfer and in vitro systems 
The use of heavily-irradiated mice as recipients of thymus 
cells has established unequivocally that the thymus does not contain 
haemopoietic stem cells. Thymus and thoracic duct lymphocytes, 
when injected into lethally-irradiated isologous recipients, are unable 
to effect lymphoid regeneration of the thymus or erythromyeloid rege-
neration of the spleen and bone marrow (Gesner and Gowans, 1962b; 
Ford and Micklem, 1963; Micklem, Ford, Evans and Gray, 1966; 
Ford, 1966a). By contrast, the bone marrow contains cells capable 
of permanently repopulating the entire lympho-myeloid complex in 
irradiated mice (e. g. Micklem et al., 1966) and haemopoietic stem 
cells are present in peripheral blood (Popp, 1960; Goodman and 
Hodgson, 1962; Barnes and Loutit, 1967). 
73. 
Fragments of thymus have been shown to potentiate antibody 
production in cultures of spleen from immunized mice (Saunders and 
King, 1966) or lymph node fragments from immunized rabbits (Wolf, 
1968). Metcalf (1968) observed a slight potentiation of in vitro bone 
marrow colony growth with thymus cells in the presence of stimulating 
serum. These various in vitro systems raise the question as to 
whether the thymus lymphocytes, the thymus cytoreticulum,or products 
from either or both of these components~ are responsible for the 
synergistic effect of thymus in cultures of spleen, lymph node or bone 
marrow. Consideration must also be given to the proposals that 
lymphocytes may have non -immunological duties in the regulation of 
tissue growth and size (e. g. Humble, Jayne and Pulvertaft, 1956; 
Trowell, 1958; Pulvertaft, 1959; Loutit, 1962; Burch and Burwell, 
1965}. 
In many experiments, the antibody producing activity of thymus 
cells has been unimpressive._ but these cells have certainly not been 
without effect. Early reports indicated that thymus fragments and 
single cell suspensions of thymus prepared from immunized donors 
were able to give rise to antibodies in irradiated recipients or in vitro. 
The quantity of antibody produced was invariably less than that following 
implantation, injection, or in vitro culture of lymph node, spleen or 
peritoneal exudate cells (Fagraeus, 1948; Thorbecke and Keuning, 1953; 
Stoner and Hale, 1955; Askonas and White, 1956; Dixon et al., 1957; 
Stoner and Bond, 1963; Thorbecke and Cohen, 1964}. Antibody titres 
in extracts of thymus from immunized animals were found to be very 
low and the quantity of antibody could be accounted for by the volume 
of serum calculated to be contained within the thymus (Bj¢>rnboe, 
Gormsen and Lindquist, 1947; Harris, Rhoads and Stokes, 1948}. 
In the in vitro systems of Askonas and White (1956} and Thorbecke 
and Cohen (1964}, bone marrow cells were surprisingly potent in elabo-
rating both antibodies and gammaglobulins. . Gengozian, Makinodan and 
Shekarchi (1961} clearly demonstrated that ~.bone marrow cells from 
sensitized mice. were quite capable of transferring rat erythrocyte 
reactivity to syngeneic irradiated recipients. This was especially so 
in the case of donors immunized several weeks previously. Van Furth, 
Schuit and Hijman (1966a} ascribed the high immunoglobulin producing 
activity of human bone marrow preparations in vitro to a few resident 
plasma cells. Since no immunoglobulin-positive cells, of the type 
presumed to be the developmental precursors of plasma cells, were 
present in the bone marrow, these workers concluded that the mature 
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plasma cells had migrated from other sites. Friedman (1964) 
injected several strains of mice with 2 x 109 sheep erythrocytes and 
found fewer plaque-forming cells {Section IB) per million inoculated cells 
in the thymus and marrow than in non-lymphoid organs such as the lung 
and liver. 
Chaperon et al. (1968) have recently extended the observations 
of Gengozian et al •. (1961) and Friedman (1964). Both 19S and 7S 
plaque-forming cells (PFC) were enumerated in the spleen~ thymus 
and bone marrow after an injection of sheep erythrocytes. The number 
of 7S PFC in the bone marrow and thymus increased progressively over 
the 42 day observation period. At later time points the number of 7S 
PFC per 10 7 cells in the bone marrow actually exceeded that in the 
spleen. The activity of cells from the three organs~ in transferring 
sheep erythrocyte reactivity adoptively to irradiated recipients~ closely 
paralleled the appearance of 7S PFC in the organs. In the transfer 
experiments the bone marrow was approximately 1 Ox as effective as 
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thymus cells and at all times contained more 19S and 7S PFC per 10 
nucleated cells. These authors considered that both 7S PFC and antigen-
reactive cells (Section IB) differ from t9S PFC in that they migrate 
extensively between organs after primary immunization. However, the 
presence of 19S PFC in the blood has been well documented (Kearney 
and Halliday, 1965; Friedman~ 1964; van Furth et al., 1966b; 
Hiramoto~ Hamlin and Harris~ 1968) but their life span in the blood 
and tissues~ at least as 19S haemolysin-forming cells~ seems to be 
limited. 
Thymus cells from normal mice were essentially unable to 
adoptively transfer sheep or rat erythrocyte haemolysin and haemagglu-
tinin responsiveness to irradiated or cyclophosphamide-treated mice 
(Thorbecke and Cohen~ 1964; Kennedy et al., 1965a; Santos and Owen~ 
1966; Claman et al., 1966a~ b; Papermaster~ 1967). Furthermore~ 
normal rabbit thymus cells differed from lymph node cells in that 
they were ineffective in adoptively transferring, to homologous 
irradiated recipients, antibody responsiveness to Shigella para-
dysenteriae (Harris and Harris. 1955). Anti-BSA antibodies were 
detected in diffusion chambers containing suspensions of homologous 
thymus cells and BSA. Significant amounts to antibody were present 
7 to 10 days after intraperitoneal implantation of the chambers into 
newborn rabbits (Holub, Rfha and Kamacytova. · 1965). Several 
criticisms of these experiments may be raised. The responsiveness 
of newborn rabbits with diffusion chambers containing killed or irra-
diated thymus cells, and injected intraperitoneally with BSA, does 
not seem to have been assessed. The thymus cells may have produced 
antibody or they may have absorbed antibody which had been elaborated 
elsewhere. Thymus cell suspensions from hyperimmunized rabbits 
absorb 1131 BSA in vitro and this may in turn reflect the presence 
of passively absorbed anti-BSA antibody (Honf~th, 1963). Moreover~ 
in the data presented by Holub et al. (1965), no clear cut dose response 
with various cell numbers was apparent and substantial amounts of 
antibody were present in chambers containing alveolar macrophages. 
Background rosette-forming cells, of the type described by 
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the Biozzi group (e. g. Biozzi, Stiffel and Mouton, 1966) and Zaalberg 
(1964), are readily detected in various tissues of unimmunized mice. 
The lowest number of such cells, using· sheep and chicken erythrocytes, 
wa~ found in thymus cell suspensions (Zaalberg, 1964; Laskov, 1968). 
Furthermore, Dent and Good (1965) were unable to detect many 
rosette-forming cells or plaque-forming cells in ~he thymus and bursa 
of chickens immunized with sheep red cells. Landy, Sanderson, 
Bernstein and Lerner (1965) found that antibody-forming cells were 
present in the thymus of rabbits 5 days after injection of Salmonella 
enteritides somatic antigens. The appearance of these cells in the 
thymus coincided with a striking disruption of the normal thymus 
architecture. · Germinal centres, lymphoid follicles and plasma cells 
are rarely found in the intact thymus subsequent to parenteral injections 
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of antigenic material (e. g. Thorbecke and Keuning, 1953; Askonas 
and White, 1956). Injections of antigens directly into the thymus, 
infliction of mechanical damage to the thymus, or subjecting the 
animals to chronic stressing procedures, does result in the appea-
rance of intrathymic plasma cells and/ or germinal centres; entities 
which are considered to be characteristic of antibody ... producing tissues 
(Marshall and White, 1961; Sherman, Adner and Dameshek, 1964; 
Blau and Waksman, 1964; Sainte-Marie 1965; Hirata-Hibi, 1967). 
Architectural disruption may have contributed to the observation 
that plasma cells and germinal centres appear in subcutaneous auto-
grafts of rat thymus after parenteral injections of diphtheria toxoid 
(Stutman and Zingale, 1964). It is not knownwhether plasma cells 
and follicular cells are derived from resident thymocytes or whether 
they are extrathymic in origin. They may have infiltrated via the 
route of injection or during the course of the inflammatory response 
subsequent to disruption of the thymus parenchyma. 
The results of immunofluorescence studies on the location of 
immunoglobulin-producing cells in the human thymus strongly suggest 
that.these cells may not be derived from thymocytes but from circu-
lating cells. IgG-and IgA-containing cells were concentrated in peri-
vascular sites mainly in the interstitial connective tissue (van Furth 
et al., 1966a). Siegler (1965}., in a histological study of follicle 
and germinal centre formation in the thymus of NZB (Burnet and 
Holmes, 1962, 1964) and aged Swiss mice, concluded that these 
structures arose in the perivascular connective tissue as they did in 
many other non-lymphoid organs. 
As in the studies of Siegler (1967) and van Furth et al. (1966a), 
the distribution of plasma cells in the rat thymus led Sainte-Marie (1965) 
to the conclusion that intrathymic plasma cells were not derived from 
precursors .within the thymus. Mature plasma cells, but virtually no 
plasmablasts, were found scattered, rather than clustered, in peri-
vascular sites within the trabeculae and less commonly in the paren-
chyma. These sites coincided with the thymic distribution of intra-
mediastinally injected antigenic material (Sainte-Marie, 1963). All 
such histological evidence certainly cannot be considered definitive 
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and the conversion of lymphocytes, produced within the thymus, to 
plasma cells, other antibody-producing cell types, or follicular and 
germinal centre cells, must remain an open question. Similar con-
siderations apply to the transformation of bone marrow cells into 
antibody-producing cells but there is clear evidence from the literature 
that the bone marrow is more active in the production of immuno-
globulins than the thymus. It is not possible to decide whether bone 
marrow cells per se are more intimately concerned with this specialized 
function or whether the bone marrow differs from thymus in containing 
a higher proportion of "contaminant" immunoglobulin-producing cells. 
(4) The activity of thymus cells in GVH reactions 
By definition (Medawar, 1963), the GVH reactivity of single 
cell suspensions may be considered a measure of the immunocompetence 
of the entire cell population. Differences observed with various inocula 
may be a function of qualitative and/ or quantitative differences in the 
cellular components of the inocula. The pathogenesis of GVH reactions 
is undoubtedly complex (Simonsen, 1962; McBride, 1966; Billingham, 
1967) and many findings seem to cast doubt on whether immunological 
phenomena, as currently visualised, are solely responsible for the 
observed reaction (reviewed in Miller, 1968). The activity of thymus 
cells in initiating GVH reactions has been the subject of numerous 
investigations and the findings will be examined in detail in succeeding 
paragraphs. As a general conclusion it can be said that mouse and, 
more particularly, rat thymus cells perform erratically and are inferior 
to spleen and lymph node cells. 
In localized GVH reactions~ such as the normal lymphocyte 
transfer reaction~ rat and guinea pig thymocytes were far less effective 
in producing local lesions than lymph node~ spleen or thoracic duct 
cells (Brent and Medawar~ 1966; Ford~ 1967; Wilson and Billingham, 
1967). Using allogeneic strain combinations~ Billingham and co-
workers found that thymus cells from rats and mice were inferior to 
spleen~ lymph node~ peripheral blood and thoracic duct cells in 
inducing runt disease and conferring homograft tolerance in newborn 
animals (Billingham and Brent, 1959; Billingham and Silvers, 1961~ 
1964; Billingham~ Defendi~ Silvers and Steinmuller~ 1962). The 
reduced efficacy of thymus cells was particularly striking in the 
induction of runt disease in Lewis-EN strain rat combinations 
(Billingham et al.~ 1962). Goldschneider and McGregor (1966) 
injected newborn rats with large numbers of allogeneic bone marrow 
and thymus cells and found evidence of a GVH reaction in very few 
of the recipients. The minimal activity of bone marrow cells could 
be further reduced, and in fact abolished with the cell doses used, 
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by taking bone marrow cells from rats chronically drained of circulating 
lymphocytes. The weak but discernible activity of normal bone marrow 
cells was thus ascribed to itinerant circulating immunocompetent 
small lymphocytes (McGregor, 1968). The deleterious effects of 
restraint on the cellularity and size of the thymus presumably 
precluded any attempts to use thymus cells from chronically-drained 
rats in similar experiments. 
Newborn thymus cells have been shown to be as effective as 
adult thymus cells in inducing GVH reactions in allogeneic (Cohen 
Thorbecke, Hochwald and Jacobson, 1963) and parent to F 1 hybrid 
(Sosin~ Hilgard and Martinez~ 1966) mouse combinations. Adult 
spleen cells (unlike newborn spleen cells) were 10 times as effective 
as thymus cells in producing splenomegaly (Sosin et al., 1966). The 
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presence or absence of the F 1 host thymus did not influence the GVH 
activity of the inoculated thymus cells (Sosin et al. ~ 1966) and~ in 
some instances, thymectomy increased the severity of the reaction 
(Yunis~ Martinez and Good~ 1967). Even with parental thymus grafts 
in neonatally-thymectomized F 1 hybrid mice, some evidence for a 
GVH reaction in the grafted host has been recorded (Stutman, Yunis, 
Teague and Good~ 1968). Tyan, Cole and Nowell (1966) obtained 
similar evidence for a GVH reaction in appropriate secondary F 1hosts 
injected with spleen and lymph node cells from sublethally-irradiated 
F 1 mice grafted with parental thymus grafts. The conclusion seems 
warranted that the GVH reaction in these systems is mediated by 
thymus graft-derived cells. Parental thymus cells from 10 day old 
mice killed many sublethally-irradiated F 1 hybrid recipients (Kaplan 
and Rosston, 1959) but preimmunization was necessary before GVH 
activity could be demonstrated with thymus cells in the parent-F 1 
hybrid mouse system of Fiore-Donati, Chieco-Bianchi, de Benedictis 
and Tridente (1964). Sensitization pr,esumably occurs in peripheral 
lymphoid organs and the findings of Fiore-Donati et al. (1964) might 
suggest that sensitized cells infiltrate the thymus. Tyan and Cole 
(1964) injected 2. 5 million adult parental thymus, lymph node, or 
spleen cells into sublethally-irradiated F 1 mice. All recipients of 
spleen and lymph node cells died, whereas deaths were recorded in 
only 1/3rd of the thymus cell recipients. 
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Experiments designed to test the competence of chicken thymus 
cells have been conducted by Warner (1964, 1965) and Cain, Cooper and 
Good (1968). Warner (1964) used the chorioallantoic membrane (CAM) 
of the chicken embryo as a means of determining the pock-producing 
(or pock-initiating) capacity of chicken thymus cells. He demonstrated 
that the number of immunocompetent cells per inoculum was inversely 
related to the size of the thymus cortex. A reduction in the number of 
cortical lymphocytes was achieved by systemic administrations of 
corticoster oids or by taking thymuses from older birds. Warner 
concluded that the thymus medulla contained the CAM pock-producing 
cells. In this system. the bursa of Fabricius was found to contain 
very few competent cells and both thymus and bursa contained far 
fewer competent cells per million nucleated cells than the spleen 
(Warner. 1965}. Cain et al. (1968} reported that thymus cells from 
10 weeks old chickens were as effective as spleen cells in inducing 
splenomegaly in allogeneic 14 day old embryos. Bursal cells. on 
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the other hand. were totally inactive. The conclusion that thymus 
cells are as effective as spleen cells in this system cannot be justified 
until data is presented on the minimum number of cells required to 
induce splenomegaly. 
Phillips and Thorbecke (1966} injected mice with rat foetal 
liver cells or spleen. thymus. and bone marrow cells from adult 
rats. Four times as many thymus cells as spleen cells were 
required to give the same index of GVH activity. Large numbers of 
foetal liver or bone marrow cells were without effect. 
It is well known that heavily-irradiated mice may be protected 
from death by injectionsof allogeneic or xenogeneic bone marrow 
cells. Isologous and homologous lymphoid cells have been tested 
for their capacity to inhibit successful bone marrow homo-
or hetero-grafting. Lymph node cells were found to be 2 to 30 times 
more effective than thymus cells in preventing the therapeutic action 
of foreign bone marrow cells (Vos. de Vries. Collenteur. and van 
Bekkum. 1959; Congdon and Duda. 1961}. 
A feature of the initial stages of localized and systemic 
GVH reactions in vivo is the transformation of a certain number of 
inoculated small lymphocytes into large pyroninophilic cells which 
subsequently divide (Gowans. 1962}. The transformation of thymus 
cells in vitro, under the impact of a variety of stimulants. will 
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therefore be considered before conclusions are made on the GVH 
reactivity of thymus cells. 
(5) The blastogenic response of thymus cells in vitro 
The mitogenic and blastogenic properties of phyto-
haemagglutinin (PHA), first described by Hungerford, Donnelly, 
Nowell and Beck(1959} and Nowell (1960), are now clearly recog-
nized even though the mechanism of PHA stimulation in vitro remains 
an enigma (reviewed in Wilson and Billingham, 1967, and Naspitz 
and Richter, 1968). Lymphoid cells from the tissues and blood of a 
variety of mammalian species and chickens may show metabolic 
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and morphological changes when cultured in vitro with PHA. The 
metabolic changes include increased protein, RNA and DNA synthesis. 
In addition, it has been well documented that small lymphocytes in 
PHA cultures transform into large pyroninophilic cells which subs e-
quently divide. Whether the end result of this mitotic activity is a 
progeny of small lymphocytes has yet to be established. The effects 
of PHA and other non-specific and specific mitogens on small lympho-
cytes in vitro has added weight to the contention, derived from studies 
on the immunological activity of small lymphocytes, that these cells 
are not inert end cells which are incapable of differentiating into any 
other morphological cell type. 
It is apparent from the literature that experiments 
addressed the question of PHA responsiveness of thymus cells have 
·yielded conflicting results. Thymus cells from young rats (Schwarz 
and Rieke, 1966; Metcalf and Osmond, 1966) and pigs (Weber, 1966a) 
undergo blastic changes in response to PHA in vitro. By contrast, 
in other systems, including the mixed "leucocyte" reaction, blastoid 
transformation in cultures of thymus cells from rabbits and guinea pigs 
was minimal (Chapman and Dutton, 1965; Schrek and Batra, 1966; 
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Oppenheim, Wolstencroft and Gell, 1967}. Nevertheless, a vigorous 
blastogenic response was obtained with a mixture of thymus cells 
from genetically dissimilar rats {Schwarz, 1966). Successful PHA 
cultures of foetal and infant human thymus cells have been reported 
{extensive literature cited by Naspitz and Richter, 1968), but Claman 
{1966), Claman and Brunstetter {1968}, Winkelstein and Craddock 
{1967) and Knight, Bradley, Oppenheim and Ling (1968} have called 
attention to the fact that tritiated thymidine incorporation into thymus 
cells in vitro is initially high and that a second peak of incorporated 
radioactivity is evident in late cultures. Only the second peak of 
activity is dependent upon the presence of PHA. From the results 
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of comparative studies with human spleen, lymph node, peripheral 
blood and thymus cells, the PHA responsive cells in the adult human 
thymus are considered to be members of a relatively minor population 
of cells (Winkelstein and Craddock, 1967; Knight et al., 1968). The 
work of Weber (1966b) suggests that this particular population of cells 
may be resident in the thymus medulla. Schwarz (1968} has recently 
calculated that too few peripheral blood lymphocytes were contained 
in the vasculature of the thymus to account for the observed lymphocyte 
transformation in rat thymus cell cultures. Nevertheless, the contri-
bution of immigrant circulating cells in perivascular sites or in the 
thymus medulla cannot be discounted. 
Unlike bursal cells, chicken thymus cells underwent morpholo-
gical alterations in the presence of PHA (Weber, 1967}. Moreover, 
peripheral blood lymphocytes from bursectomized chickens responded 
normally to PHA whereas blood cells from thymectomized chickens 
were essentially unresponsive (Greaves, Roitt and Rose, 1968). There 
is one technical feature of the Greaves et al. experiments which may 
alter any conclusion arising from the findings. Simple differential 
sedimentation techniques were used to harvest peripheral blood 
11 lymphocytes11 and it is quite conceivable that culture of cells from 
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lymphopenic thymectomized chickens (Warner and Szenberg, 1962; 
Cooper, Peterson, South and Good,· 1966) contained more nucleated 
thrombocytes than cultures containing equal numbers of "lymphoid" 
cells from bursectomized chickens. 
The lymph nodes of neonatally-thymectomized mice and adult-
thymectomized, irradiated mice contain fewer cells responsive to PHA 
in vivo. After footpad inoculation of PHA into normal mice, large 
numbers of pyroninophilic cells appeared in the diffuse cortex of the 
regional lymph node. This change preceded a considerable germinal 
centre and plasma cell reaction in the popliteal node. The number of 
cells in the diffuse cortex following thymectomy is reduced (Section IA) 
and very few cells in this site responded to PHA by undergoing blastoid 
transformation (Dukor and Dietrich, 1967). Rieke (1966) and Meu-
wissen, Bach, VanAlten and Good (1967) reported that transformation 
rates in PHA cultures of thoracic duct cells and peripheral blood leu-
cocytes from neonatally-thymectomized rats were lower than in control 
cultures. Davies et al. (1968a) have recently shown that thymus 
graft-derived cells make up the bulk of mitotic figures in PHA cultures 
of peripheral blood lymphocytes obtained from adult-thymectomized, 
irradiated, bone marrow-protected mice grafted with a chromosomally-
marked thymus. 
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In an abstract, Meuwissen et al. (1967) reported that lymphocytes 
from patients with thymic alymphoplasia failed to transform in PHA 
cultures. Variable results have been obtained using lymphocytes from 
agammaglobulinaemic patients (e. g. Elves, Roath and Israels, 1964, 
c. f. Fudenberg and Hirschhorn, 1964) and it is not know whether these 
variations can be ascribed to varying degrees of thymic alymphoplasia 
or malfunction which may or may not be associated with agammaglobu-
linaemia. Functional derangements in either or both of the thymus-
dependent and immunoglobulin-producing systems have been described 
in children with rare immunological deficiency diseases such as Brut on's 
agammaglobulinaemia, Di George's syndrome and thymic alymphoplasia 
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associated with agammaglobulinaemia (discussed by Good, 1966; Miller 
and Osoba, 1967; Goldstein and Mackay, 1969). The patient of 
Lischner, Punnett and Di George (1967), with thymic agenesis and 
normal immunoglobulin levels, is of interest in this regard. Lympho-
cytes, none of which were likely to have been derived from the 
patient 1s thymus and which were not maternally derived, were numerous 
in the peripheral blood and lymph nodes. In short term cultures using 
known mitogens such as PHA, antilymphocyte serum, homologous 
lymphoid cells and also several antigens, the percent blast transfor-
mation of the lymphocytes obtained from this patient was negligible. 
As a general conclusion, it can be said that the results of PHA 
stimulation of thymus cells in vitro parallel those obtained with thymus 
cell suspensions in GVH reactions. Thymus cells behave somewhat 
fitfully and the question immediately arises as to whether their dis-
cernible activity can be ascribed to itinerant circulating lymphocytes in 
the interlobular and perivascular connective tissues or in the medulla. 
Alternatively, is the activity due to a low level of immunocompetence 
on the part of the large number of cortical lymphocytes produced within 
the thymus ? Contributing factors may include cellular immaturity, 
qualitative cellular defects, or a relative decrease in the number of 
competent cells. The inadvertent inclusion of parathymic lymph 
node lymphocytes into thymus cell suspensions must also be considered. 
Lymph nodes of considerable size have been described within, or closely 
adherent to, the thymus capsule in mice and rats (Blau and Gaugas, 
1968). Aside from these considerations of thymus cell activity, an 
impressive and increasing bulk of evidence now exists to suggest 
that the presence of the thymus is required for maximal PHA stimulation 
of peripheral blood, spleen, lymph node and thoracic duct lymphocytes. 
The possibility must be seriously entertained that many peripheral PHA-
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responsive cells are emigrant thymus lymphocytes or their descendants. 
In view of the discussion to follow in the next subsection, the operation 
of thymic humoral factors may also contribute to the responsiveness 
of peripheral lymphocytes to mitogenic agents in vivo and in vitro. 
Lymph node and spleen cells participate in both antibody produc-
tion and the various cell-mediated immune responses. Thymus and 
bone marrow cells engage in both these immunological processes to a 
limited extent. Viewed in their entirety, the results of the experiments 
using thymus and bone marrow cells indicate that these two cell types 
have differential potencies when assayed on the basis of equal numbers 
of nucleated cells. Bone marrow cells are far more active in immuno-
globulin production and thymus cells are far more active in responses 
involving foreign histocompatibility antigens. As mentioned previously, 
this observation may not necessarily reflect differences in the potentia-
lity of the lymphoid cells from these two sources. The bone marrow 
may contain a greater number of plasma cells and their precursors, 
the thymus may contain more immunologically competent cells. Both 
functional cell types may be sequestered from the circulation. 
(6) Thymus humoral factors 
The influence of the thymus on lymphopoiesis and the induction of 
immunocompetence has been investigated in organ cultures by Glober-
son (1966) and Globerson and Auerbach (1967). Thymus explants 
from normal mice induced GVH reactivity in spleen fragments from 
sublethally-irradiated mice when cultured together in vitro. The 
efficacy of thymus across a millipore filter strongly suggested that a 
thymic subcellular humoral factor was responsible for the observed 
reactivation of the residual cells in the irradiated spleen. Using 
various parent- F 1 hybrid combinations of spleen from lethally-
irradiated mice and normal bone marrow and thymus, Globerson and 
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Auerbach (1967) further showed that the bone marrow contributed the 
reactive cells. The GVH activity of thymus cells themselves cannot 
be discounted from the data but the results with parental irradiated spleen 
- F 1 hybrid thymus - parental marrow combinations can be interpreted 
readily in terms of a competence-inducing humoral factor elaborated by 
the thymus explant. 
Several early reports hinted at the possibility that the thymus 
may influence peripheral lymphopoiesis via a humoral mechanism 
(e. g. Metcalf, 1956; Gr~goire and Duchftteau, 1956). The first convincing 
evidence that the thymus may elaborate a factor(s) with competence-
inducing properties, came from investigations into the reconstitutive 
capacity of thymus tissue enclosed in cell-impermeable millipore 
diffusion chambers and implanted into neonatally-thymectomized mice. 
A number of mice implanted at 1 to 2 weeks of age with neonatal or 
embryonic thymus tissue in diffusion chambers (0. 1J.1. pore size), were 
able to reject homografts of skin and produce haemagglutinins in 
response to sheep erythrocytes. Control groups included thymecto-
mized litter mates implanted with empty diffusion chambers. No 
evidence of lymphoid regeneration was apparent in the tissues of the 
immunologically-reconstituted mice (Osoba and Miller, 1963; Osoba 
and Miller, 1964; Osoba, 1965a). Similar experiments performed 
by another group indicated that, in neonatally-thymectomized mice 
bearing neonatal thymus tissue in diffusion chambers with membranes 
of 0. 45J.J. pore size, the incidence of wasting diseases was decreased 
(Levey, Trainin and, Law, 1963), the susceptibility to lymphocytic 
choriomeningitis virus increased (Levey, Trainin, Law, Black and 
Rowe, 1963), and sheep red cell haemolysin production increased, 
albeit slightly in less than 2/3rds of the mice (Law, Trainin, Levey, 
and Barth, 1964). In this case, no depletion of lymphocytes in lymphoid 
tissues or peripheral blood was reported. Nevertheless, by calcula-
ting from the data, the absolute number of mononuclear cells in the 
blood, it is evident that a severe deficiency persisted in many of 
the mice (Levey et al., 1963). 
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Schaller and Stevenson (1967) were able to reverse the signs 
of the post-thymectomy wasting syndrome in 30o/o of mice with 5 
syngeneic or. allogeneic neonatal thymuses in diffusion chambers 
constructed with membranesof 0. 3~-t pore size. Lymphoid hypo-
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plasia persisted in surviving mice and foreign skin grafts were 
rejected in norn1al fashion. In keeping with the findings of Osoba 
(1965a). those mice reconstituted with allogeneic thymuses in diffusion 
chambers were able to reject thymus donor type skin. Host type 
GVH activity of spleen cells was demonstrated on transfer to approp-
riate F 1 hybrid newborns. 
Thymus tissue enclosed in millipore diffusion chambers has 
also improved. to some extent. the immunological performance of 
Barclay, 1964; 
adult-thymectomized, irradiated mice (Miller et al •• 1964l Osoba. 
1968b) and neonatally-thymectomized hamsters (Wong. Taub. Sherman 
and Dameshek. 1966; Sherman, 1967), rats (Aisenberg and Wilkes. 
1965; Biggart. 1966a, b) and rabbits (Trench, Watson. Walker, 
Gardner and Green, 1966). In addition. bursal tissue enclosed in 
diffusion chambers has improved the antibody -producing capacity 
of bursectomized chickens (St. Pierre and Ackerman. 1965, 1966; 
Jankovic and Leskowitz. 1965). Other workers have failed to 
demonstrate ~ny reconstitutive or protective effect of enclosed 
thymus or bursa or have failed to demonstrate any activity specific 
for these tissues (Huvos. Cali and Azar. 1966; Dent and Peterson, 
1967). In most of the experiments. other than those of Osoba and 
Miller (1964) and Sherman (1967). the extent of immunological 
reconstitution has been slight and often unconvincing. Antibody titres 
and skin graft mean survival times rarely approach those in intact 
animals and many animals do not show any evidence of heightened 
immunological responsiveness. It is not known whether these failures 
simply reflect conditions within some chambers which are inimical 
to cell survival. Further criticisms include the possible migration 
of cells through membranes with a large average pore diameter 
(Hays~ 1964; Barclay~ 1964) and the fact that it is technically not 
feasible to adequately test each diffusion chamber~ for construction 
faults~ prior to implantation. 
Thymus tissue within chambers rapidly loses its lymphoid 
appearance but epithelial reticular cells appear to remain viable for 
many weeks or months (Gregoire, 1958; Osoba and Miller~ 1963; 
Levey et al., 1963; Weiss and Miller, 1966; Wong~· 11 1966; 
Biggart, 1966a; Trench et al., 1966; Schaller and Stevenson, 1967; 
Hays, 1967). The epithelial cytoreticulum in the normal mouse and 
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rat thymus, and in cultured mouse thymus explants, displays histolo-
gical, histochemical~~ and ultrastructural features which are in keeping 
with a secretory function (Arnesen~ 1963; Clark, 1966, 1968; Shelton, 
1966; Cherry, Eisenstein and Gluckmann, 1967 ). Supporting evidence 
for the existence of a thymic humoral factor(s), and the complicity of 
the epithelial component of the thymus~ has come from two other 
sources. Allogeneic thymus grafts in adult-thymectomized, irradiated, 
and marrow-protected mice, and xenogeneic grafts in neonatally-
thymectomized mice 11 failed to become lymphoidal (Dukor et al., 1965; 
Law 11 1966b, c. f. Yunis, Martinez and Good11 1964) yet some of the 
hosts were able to reject tumour and skin allografts and respond to 
sheep erythrccytes by producing significant amounts of haemolytic 
antibodies (Leuchars et al. 11 1965; Law, 1966b; Feldman and Glober-
son~~ 1964; Miller et al. ~ 1964). The epithelial cytoreticulum per-
sisted for several weeks following grafting but was ultimately rejected 
(Dukor et al. ~ 1965; Law 11 1966b). 
The immunological responsiveness of neonatally-thymectomized 
female mice was found to be improved following pregnancy Psoba, 1965b 11 
1968a) and wasting disease was averted temporarily in a proportion of 
mated females (Elders., Parkham and Hughes~~ 1968). Transplacental 
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migration of foetal cells has been reported to be undetectable 
(Miller and Osoba, 1967). It is possible, however, that the pregnant 
mice, by virtue of their ability to maintain pregnancy .. were a select 
group of animals in which the capacity to participate in immunological 
responses was greater, or was bound to, improve more, than in the 
overall population of neonatally-thymectomized mice. 
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The autonomous lymphopoietic behaviour of the thymus and 
thymus grafts has been discussed previously {Section IA). The mitotic 
index of host-derived lymphocytes in thymus grafts reflects the origin 
of the thymus graft donor and presumably the activity of the persisting 
epithelial cytoreticulum. Thymus grafts.. depleted of lymphocytes by 
irradiation {Miller et al ... 1966) or by maintenance in vitro or in 
diffusion chambers {Reese and Israel, 1967; Hays, 1967~ became 
infiltrated with lymphocytes on subsequent in vivo implantation and 
improved the immunological responsiveness of neonatally-thymectomized 
mice. Furthermore, some, but certainly not all {Vanderputte, 1967; 
Stutman, Yunis and Good, 1967).. polyoma virus or chemically-induced 
non-lymphoidal thymic tumours may be reconstitutive when implanted 
into neonatally-thymectomized mice (Law .. Dunn, Trainin and Levey, 
1964; Stutman et al ... 1967). It has yet to be resolved whether traffic 
of host lymphoid cells through the implanted tumour tissue is a necessary 
prerequisite of reconstitution. Recently .. the rapid recovery of PHA 
responsiveness of lymphocytes from a patient with DiGeorge' s synd-
rome following thymus grafting, has been used as evidence for a thymic 
humoral factor in immunogenesis {August, Rosen, Filler .. Janeway .. 
Markowski and Kay, 1968). The indirect evidence, obtained from the 
grafting experiments, supports the contention that the reticuloepithelial 
stroma of the thymus is intimately concerned with the lymphopoietic 
and immunological activity of the thymus. 
Several groups have been engaged in work designed to extract 
and characterise thymic factors with lymphopoietic- or competence-
homologous and isologous thymus extracts may stimulate lymphoid 
cells or increase peripheral blood lymphocyte levels in normal mice 
(Metcalf, 1956, c. f. Duplan, Foschi and Manson, 1962; de Somer 
~·. 1963; Klein, Goldstein and White, 1965; Goldstein, Slater 
and White, 1966; Trainin,,, Burger and Kaye, 1967; · Hand, Caster 
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and Luckey, 1967). "Thymosin" {Goldstein et al., 1966), and the 
extract of Trainin et al. (1967), increased the incorporation of tritiated 
thymidine into DNA of lymphoid cells in vivo and in vitro but Berliner, 
Garzon, Lonngi and Dougherty (1967) found that fibroblasts in vitro 
also incorporated more tritiated thymidine when "thymosin" was added 
to the cultures. 
In most of the experiments, extracts of thymus from sheep, 
calf and rabbit have been used and control preparations, when 
employed, have included lymph node and spleen extracts. The failure 
of the control extracts to induce lymphocytosis or promote thymidine 
incorporation into cells strongly suggests that the thymus extracts 
contain specific inducer substances. It is possible that these inducers 
are nothing more than potent foreign thymus antigens which are quanti-
tatively and/ or qualitatively different from antigenic material in 
extracts prepared from peripheral lymphoid tissues. The presence of 
antigens. apparently confined to the thymus environment in rats 
(TaUberg and Kosunen, 1966; Potworowski and Nairn, 1967) and mice 
(reviewed in Boyse, Miyazawa, Aoki and Old, 1968). has been well 
documented. 
The contribution of foreign thymus-specific antigens becomes 
important in the interpretation of those experiments in which thymus 
extracts have been used to reconstitute the immunological reactivity 
of neonatally-thymectomized mice and adult-thymectomized, irradiated 
mice {Trainin and Linker-Israeli, 1967). ·Multiple injections of calf 
thymus extracts, but not calf muscle or kidney extracts, reduced the 
mean survival time of allogeneic skin grafts and reduced the percentage 
of successful tumour transplants. Spleen cells from the reconstituted 
mice were able to mount GVH reactions in appropriate F 1 hybrid 
recipients. If thymus-specific antigens cross react with mouse histo-
compatibility antigens then the continuous stimulation imposed by the 
multiple injection regime may have sensitized the thymectomized 
recipient mice to antigens present on allogeneic cells. A precedent 
for the operation of such a mechanism may be the finding that multiple 
injections of sheep erythrocytes increase , to normal levels, the 
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specific haemolytic and haemagglutinating antibody respons~n neonatally-
thymectomized mice (Takeya and Nomoto, 1967a). A search for 
"antithymus extract" antibodies in reconstituted mice does not seem 
to have been undertaken. It is equally feasible, of course, that 
antigens in extracts of nonthymic heterologous organs differ from 
thymic antigens in that they compete with foreign histocompatibility 
antigens for the relatively few immunocompetent cells presumed to be 
present in the tissues of immunologically defective mice. 
Simple saline extracts of syngeneic thymus have not reversed 
the immunological deficiency in neonatally-thymectomized mice 
(Dalmasso et al., 1963; Miller, 1964a; Miller J. F.A.P., personal 
communication) but a reduced incidence of a fatal adenovirus 
infection (de Somer et al., 1963) and wasting disease (Trainin, Bejerano, 
Strahilevitch, Goldring and Small., 1966) has been recorded in 
neonatally-thymectomized mice injected with heterologous thymus 
extracts. Law arid Agnew (1968) prepared thymus and spleen extracts, 
containing a few viable cells, from neonatal C57BL mice and injected 
them subcutaneously into syngeneic neonatally-thymectomized recipients. 
Spleen cells from the recipients of thymus extract, but not those from 
recipients of spleen extract, killed a large number of Balb/c mice 
when injected in the neonatal period. In contrast to the findings of 
Trainin et al. (1966) and Trainin and Linker-Israeli (1967). wasting 
,, 
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II: 
disease was not obviated and lymphopenia persisted. Small and 
Trainin (1967) injected neonatally-thymectomized mice with extracts 
of calf thymus and challenged them with sheep erythrocytes. The 
· -increase in splenic PFC and serum haemolysin titres was most 
unimpressive and kidney extracts, rather than nonthymic lymphoid 
tissue extracts, were used as control preparations. 
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In conclusion, it seernsthat no convincing evidence for a thymus 
specific competence-inducing factor, operating under physiological 
conditions, is as yet available. In all of the various systems, however, 
a substantial improvement has been achieved in a proportion of the 
immunologically deficient animals. Conceivably, factors may indeed 
be secreted by cells of the thymus epithelial cytoreticulum. There 
is a suggestion in the recent literature that thymic humoral factors 
are concerned with the ability of lymphocytes to respond to PHA, to 
mount GVH reactions and to participate in homograft reactions. 
The amelioration of defective antibody responses with thymus extracts 
has been far less impressive. If some thymus lymphocytes are 
immunologically competent, and are destined to leave the organ, then 
a relatively simple hypothesis may be formulated which embraces both 
cellular and humoral mechanisms of thymus activity in immunogenesis. 
Diffusable factors, elaborated by the epithelial cells may act locally on 
thymus lymphocytes and impart a strong proliferative stimulus to such 
cells and/ or induce competence under conditions of proliferation, 
selection, differentiation and maturation. The mechanisms whereby 
competence is induced in thymus lymphocytes, and the nature of the 
events at the genomic level, must remain speculative (Jerne, 1967c}. 
Alternatively, the factors may act at a distance and promote maturation 
of antigen-reactive faculties in peripheral cells which may or may not 
be thymus derived. 
1'1 
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II. EXPERIMENTAL 
A. Statement of the Problem and Purpose of the Experiments 
At the time of commencing the experiments~ several reports 
from various laboratories had clearly shown that young adult 
neonatally-thymectomized mice failed to respond in normalfashion 
to a primary injection of sheep erythrocytes. The peak number of 
splenic plaque-forming cells was usually much less than that in the 
spleen of intact mice of the same age. Reconstitution experiments, 
using thymus tissue enclosed in millipore diffusion chambers, had 
indicated that the thymus may exert its effect in immunogenesis 
partly by means of a humoral factor. To account for the decreased 
number of antibody-producing cells in thymectomized mice, two 
mechanisms of thymus activity had been proposed. Both hypotheses 
embraced the thymus humoral factor. The factor(s) could either 
act in concert with antigen to accelerate the proliferative and differen-
tiative response of antigen-reactive cells (Metcalf and Brumby, 1966), 
or be responsible for the maturation of antigen-reactive cells from 
some precursor cell population (Miller et al., 1965). In the former 
case the number of antigen-reactive cells in the peripheral tissues 
of neonatally-thymectomized mice would not be expected to be very 
different from that in normal mice but the latter hypothesis infers that 
the number of such cells is reduced. 
The initial experimental undertaking was to determine the 
number of antigen-reactive cells in peripheral lymphocyte populations 
of neonatally-thymectomized CBA mice. The recently described 
haemolytic focus assays for antigen -reactive cells seemed suitable 
for this purpose (Kennedy ·et al., 1965a; Playfair et al., 1965). 
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Gowans and his colleagues had shown that some thoracic duct 
small lymphocytes responded to histocompatibility antigens by under-
going blast transformation and that the population was involved in the 
initiation of certain antibody responses. The small lymphocyte 
seemed to be an outstanding candidate for the antigen-reactive cell 
and the popular notion had arisen that the long-lived recirculating 
lymphocyte responded to antigens, such as sheep erythrocytes, by 
undergoing blastoid transformation and subsequent proliferation and 
maturation into antibody-producing cell types. By injecting thoracic 
duct lymphocytes together with sheep erythrocytes into irradiated as 
well as neonatally-thymectomized mice, it was hoped that answers to 
the following questions would be forthcoming:-
( 1) Are thoracic duct lymphocytes able to reconstitute neonatally-
thymectomized mice with respect to plaque-forming cell 
production? 
(2) Does the thoracic duct lymphocyte population contain antigen-
reactive cells? 
(3) If so, are the antigen-reactive cells able to proliferate and 
differentiate into antibody-producing progeny in the 
environment of the neonatally-thymectomized mouse and 
thus in the absence of the thymus? 
It was thought that by enumerating antigen-reactive cells and 
studying their behaviour in neonatally-thymectomized mice, the 
primary site of action of the thymus would be pinpointed to one or 
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other of two locations in the postulated genesis of the immune response:-
r------ -Thymus -------------T Antigen 
I Antigen-Reactive 
I 
J Bone Marrow Cell J ~ Antibody-Cell Producing 
Cell 
Depending on the results of these investigations, attention would be 
focussed on the nature of the cooperation between the thymus humoral 
factor and antigen or on the bone marrow and thymus as possible sources 
of antigen-reactive cells. 
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The reported ease with which thoracic duct fistulae could 
be established using cyanoacrylate adhesives (Boak and Woodruff, 
1965) prompted attempts to quantitate the lymphocyte deficiency so 
clearly apparent in the peripheral lymphoid organs of neonatally-
thymectomized mice. Previous work had indicated that the number 
of thoracic duct lymphocytes was indeed diminished after thymectomy 
at any age. The output determinations were, however, performed 
in anaesthetized rats, guinea pigs, and mice over short periods of 
time. Immunological defects following neonatal thymectomy were 
known to be more severe than those displayed by adult-thymectomized 
mice and a study of this difference, at the level of the recirculating 
lymphocyte population, was initiated. Finally, it was planned to 
extend these output studies to include neonatally-thymectomized mice 
injected with marked thymus cells and to determine whether these 
inocula contribute cells to the pool of recirculating lymphocytes. 
B. Materials and Methods 
(1) Animals 
Mice of the highly inbred strains CBA~ C57BL~ CBA/T6T6 and 
the (CBA x C57BL)F 1 hybrid were used in the experiments. CBA and 
CBA/T6T6 mice were obtained originally from the Radiobiological 
Research Unit~ Harwell, Didcot, Berkshire, England and the C57BL 
were obtained by Dr. R. Bradley, of the University of Melbourne, 
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from Dr. L. W. Law, National Institutes of Health, Bethesda, Ma~land, 
USA. The degree of inbreeding in the mice of the Hall Institute 
colonies was preserved by strict stemline brother-sister mating and 
the number of available mice was increased by two to three or, on 
rare occasions, four (but never more than four) generations of random 
matings. All mice were fed Barastoc dog pellets and tap water 
ad libitum with an occasional greenfeed supplement of cabbage leaves. 
Six to 10 weeks old CBA mal~ which were weaned and separated at 
5 weeks of age, were used in the vast majority of the experiments. 
In the case of neonatally-thymectomized or sham-operated mice, the 
limited availability of animals of any one age resulted in the use of 
both males and females as donors and/ or recipients. 
(2) Neonatal thymectomy 
CBA mice·were thymectomized within 24 to 36 hours of birth 
by the method devised originally by Miller (1960). After cooling for 
5 minutes at -10°C, the neonates were placed in dorsal recumbency 
with a pad to arch the back and with the fore limbs secured laterally 
by rubber bands (Figure 1). Using a No. 11 scalpel bladeJ a 5 to 6 mm 
midline incision was made, commencing at the second sternebra and 
terminating 2 to 3 mm anterior to the sternal notch. The sternal 
notch was exposed by anteriorly retracting the posterior pole of the 
submaxillary salivary gland and a V -shaped portion of the sternum 
isolated by cutting from the sternal notch to the region of the second 
costochondral junction on both sides. By grasping and elevating the 
point of the sternum the mediastinal and fascial strands lying ventral 
to the thymus lobes were torn away using forceps or scissors. After 
removing the triangular piece of sternum~ the thymus lobes could 
be brought into view by pressure on the abdomen (Figure 1). Using 
a glass nozzle fitted to a water pump, the posterior poles of the 
thymus lobes were retracted and sucked anteriorly away from the 
auricles of the heart. The nozzle diameter was similar to the 
transverse diameter of each thymus lobe and the suction pressure 
was carefully adjusted to preserve the integrity of the capsule during 
the manipulation of each lobe. Under 2x magnification~ the lobes 
were removed individually~ care being taken to prevent disruption 
of the major blood vessels in the neck. Sham thymectomy involved 
removing portion of the sternum and the fascial strands but leaving 
the thymus in situ and untouched. 
After thymectomy or sham operation~ the mice were removed 
from the operating field and the wound closed with a horizontal 
mattress suture. The suture material was 4-0 black braided silk 
fitted to a round-bodied, non-cutting~ atraumatic needle. Mter 
swabbing the wound free of blood~ the mice were warmed under a 
100 watt lamp and fostered on to Hall Institute outbred mothers when 
fully active and breathing normally. Some mice occasionally failed 
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to commence breathing because of pneumothorax. Air could be 
expelled from the chest and the mice revived by the application of 
intermittent pressure to the thoracic cage and abdomen. The actual 
loss of mice at surgery was slight but losses due to cannibalism and 
maternal neglect were substantial. When the mice were 1 to 2 weeks 
old~ oxytetracycline (Terramycin~ Pfizer Pty Ltd.~ Sydney, Australia) 
at a dose level of 100 mgm per litre or~ in the earliest experiments, 
penicillin G~ at a dose level of 600~ 000 units per litre~ was added to 
the drinking water each day. 
Figure 1. 
.... 
. ~~ 
4 
l 
Extirpation of the thymus in newborn mice. 
The immobilized neonate is restrained in 
dorsal recumbency and finger pressure applied 
to the abdomen to force the heart and adjacent 
thymus lobes anteriorly. The posterior poles 
of the thymus lobes are teased away from the 
pericardium and the lobes aspirated individually 
into a glass nozzle attached to a water pump. 
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The presence or absence of residual thymus tissue was 
ascertained whenever neonatally-thymectomized mice were killed. 
The entire sternum was removed and the thymus area examined 
macroscopically in a bloodless field. Suspect thymus tissue was 
fixed in Bouin1 s fixative for 1 to 2 hours and transferred to 70o/o 
ethanol prior to embedding and serial cutting in the Histology 
Department of the Hall Institute. All mice with thymus remnants 
were discarded from the experiments. The number of such mice 
amounted to no more than 5 and the low incidence was ascribed to 
the ease with which thymectomy could be performed in CBA mice 
and to the policy of rejecting mice whenever the thymus capsule 
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was broken or if the lobes could not be adequately visualized throughout 
the entire procedure. 
(3) Adult thymectomy 
The method used for removing the thymuses in adult mice was 
essentially the same as that used in neonates. Under ether anaes-
thesia each mouse was placed in dorsal recumbency with the four 
legs pulled laterally. A small pad of cotton wool was used to arch 
the back and, by means of a thread attached to the upper incisions, 
the head was pulledibrward. The skin and sternal incisions were 
made with scissors but, in contrast to the neonatal operation, the 
piece of sternum removed was relatively small and was restricted 
to a 5 mm x 2 mm segment in the midline. The muscles and fascia 
lying ventral to the thymus were underrun with one cutting arm of the 
scissors and severed. The thymus lobes were forced to the surface 
of the wound by applying considerable pres sure (with the fingers of the 
left hand) to the abdomen and hence the diaphragm. Each lobe was 
removed individually using more suction pressure than was the case 
in the neonatal operation. 
In order to prevent pneumothorax and subsequent death of the 
mouse, it was absolutely essential to maintain a degree of pressure 
on the abdomen immediately after thymectomy. This pressure was 
discontinued only after the "back pad" had been removed and the front 
leg retractors released. Finally the skin incision was closed with 
two Michel clips# and the mice left to recover in a warm environment. 
The large thymus lobes of 4 to 8 weeks old mice separated 
quite readily from the surrounding organs and tissues such as the 
heart, trachea, salivary gland and the .pleural reflections adjacent 
to the apical lobes of the lungs. Losses at surgery amounted to no 
more than 5% of the operated mice and were usually the result of 
pneumothorax or excessive blood loss. They occurred more 
frequent_ly in aged or stressed mice mainly because of the difficulty 
in separating the thymus lobes from the surrounding tissues. 
(4) Preparation and injection of cell suspensions 
Single cell suspensions of spleen# thymus and bone marrow 
were prepared in a manner similar to that described by Billingham 
and Brent {1959). 
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(i) Spleen cells. After stunning the mouse and dislocating the 
cervical vertebrae, the skin was swabbed with 70% ethanol and the 
spleen removed and placed on an 80 mesh, 0. 005 gauge stainless steel 
sieve contained in a 9 em plastic petri dish. Small curved forceps 
were used to disrupt the capsule and to teaseihe splenic contents 
through the sieve into single strength medium 199 (Tissue Culture 
medium 199 with 100 units penicillin and 100 f,..tg streptomycin per ml, 
Commonwealth Serum Laboratories, Melbourne# Australia). Further 
disruption was achieved by aspiration of the filtrate through Pasteur 
pipettes. The residual tissue remaining on the sieve was teased gently 
and washed with medium 199 until only the fibrous stroma remained. 
The contents of the petri dish were transferred into sterile graduated 
centrifuge tubes contained in a beaker of ice and water. The single 
cell suspension was spun in the cold at 400 to 450 g for 5 minutes. 
the supernatant discarded, and the pellet of cells resuspended in 5 to 
10 ml of fresh medium 199. After respinning. the pellet was made 
up in medium 199 if the cells were to be used in the plaque-forming 
cell assays. or Dulbecco' s phosphate buffered saline (PBS) if for 
injection into mice. Nucleated cell counts were then performed in 
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a Neubauer haemocytometer. using 2% acetic acid as the diluent. and 
the volume of the suspension adjusted so that the required number of 
cells was contained in 0. 1 to 0. 2 ml. Single cell suspensions of cranial 
mesenteric. axillary and/or subiliac lymph nodes (Kawashima. 
Sugimura, Hwang and Kudo, 1964) were prepared and washed in a 
manner similar to that described above. 
(ii) Thymus cells. Thymus lobes were removed from mice 
pinned in dorsal recumbency with the fore legs stretched laterally and 
the head extended. To ensure adequate exposure of the thymus area, 
the entire sternum was removed. care being taken to avoid cutting 
major blood vessels in thEJbervical and brachial regions. The thymus 
lobes wer:e peeled and cut from the surrounding tissues and organs in 
a bloodless field, placed in a petri dish containing medium 199. and 
checked for fascial tags which might contain parathymic lymph nodes. 
Single cell suspensions of thymus were prepared as previously 
described for spleen but were always washed three times in medium 
199. \ Clumps were removed each time the pellet was resuspended 
and the cells were finally resuspended in PBS. 
(iii) Bone marrow cells. The long bones. of the leg were removed, 
after cutting the skin from the metatarsus to the umbilicus, by tearing 
and cutting the adherent muscles and the ligamentous attachments to 
the acetabulum and tarsus. Residual musculature was scraped from 
the femurs and tibiae using a No. 21 scalpel blade and the shafts cut 
at each end through the epiphyses. By forcing a 25 or 26 G needle 
into the severed ends, the marrow could be flushed out with medium 
199 delivered from a 1 ml tuberculin syringe. Dissociation of the 
bone marrow plugs was achieved by aspiration through the needle 
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and the cell suspension finally transferred to a sterile graduated 
centrifuge tube contained in ice and water. The entire procedure 
was performed in petri dishes containing cold medium 199 and resting 
on ice trays. The cells were washed once, resuspended in PBS. 
colillnted, and the volume for injection adjusted to 0. 2 to 0. 3 ml. 
(iv) Erythrocyte suspensions. Jugular blood was obtained from 
a single sheep at weekly intervals. Mter collection into Alsever' s 
solution the cells were allowed to stand at 4°C for 7 days. Sheep 
erythrocytes (SRBC) were only used between 1 and 2 weeks after 
collection whether for immunization purposes. tolerance induction, 
or for the haemolytic antibody assays. Prior to use the cells were 
washed in normal saline until the supernatant was clear. 
Horse blood cells were obtained from the Commonwealth Serum 
Laboratories~ Melbourne~ Australia., stored at 4°C 1 and used within 
5 weeks of collection. Care was taken to ensure that the same sample 
of blood was used for immunization and in the haemolytic antibody 
assays. The dose of sheep and horse erythrocytes injected into mice 
for immunization purposes was usually 0. 1 ml of a 20o/o suspension 
and contained from 1 to 2 x 108 erythrocytes. 
(v) Parenteral injections in adult and newborn mice. Five 
to ten minutes before ip.travenous injection~ adult mice were placed 
in a 37° C incubator to dilate the lateral tail veins. With the mouse 
restrained in a narrow cylinder the veins were occluded at the base 
of the tail using the first and second fingers of the left hand. By 
rotating the tail 90° 1 one vein could be brought into full view. All 
inJections were made with a 25 or 26G needle attached to a 1 ml tuber-
culin syringe. Washed lymphoid cell suspensions for injection purposes 
were always finally resuspended in PBS and were contained in tubes 
kept in an ice bath. When necessary, heterologous erythrocytes were 
added to, and mixed with, the cell suspension immediately prior to 
injection. The total injection volume varied from 0. 1 to 0. 6 ml. 
Large numbers of thymus cells were injected intravenously in a 
volume of from 0. 4 to 0. 6 ml. If, in addition, the cells were injected 
slowly over a period of 2 to 3 minutes, deaths in recipient mice from 
embolus formation · could be obviated. 
The intravenous injection of cells into newborn mice was per-
formed according to the method described by Billingham and Brent 
{1956, 1959). The mice were held in the fingers of the left hand such 
that the skin over the right side of the head and neck was drawn taut 
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·and the right jugular vein compressed. The injection volume of o. 05 ml 
was expressed through a 30G needle into the orbital branch of the right 
anterior facial vein immediately aboral to the eye. When the needle 
was correctly placed, the inoculated medium could be seen, under 
2 -fold magnification, to blanch the venous plexus in the region of the 
injection site. Bleeding was profuse after the needle was removed and 
could be minimized by resting the ends of artery forceps bound in 
cotton wool on to the puncture wound. For identification purposes the 
toes were cut and the mice returned to the nest when bleeding had 
ceased. 
Cells were inj ected intraperitoneally into mice younger than 
1 week old by running a 30G needle subcutaneously from the anterior 
sternum to the area of the stomach and piercing the peritoneum. 
Injection volumes were restricted to 0. 05 ml. Intraperitoneal injections 
in older mice were performed using a 2 6G needle to pi{ce the skin and 
abdominal muscles in the umbilical region. Subcutaneous injections 
were performed with an assistant holding the mouse by_ the tail and 
nape of the neck. The inoculum was deposited over the side of the 
thorax after underrunning the skin with a 2 6G needle for a distance 
of 1 to 2 em. 
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(5) Thoracic duct cannulation and collection of thoracic duct cells 
The technique used to establish a thoracic duct fistula was a 
modification of the method described originally by Boak and Woodruff 
{1965)and more recently by Morse and Riester (1967) and Mandel (1967). 
The use of cyanoacrylate tissue adhesives to secure polythene cannulae 
into position has greatly increased the operative success rate inmice. 
The short intraabdominal portion of the thoracic duct cannot be disso ... 
ciated from the aortaJ and this anatomical feature makes it difficult 
to affix cannulae into position by means of ligatures as described in 
the rat by BollmanJ Cain and Grindlay { 1948). Nevertheless J two 
reports have indicated thatJ with slight modificationJ the technique 
used in rats can be successful in mice (ShrewsburyJ 1959; Gesner 
and GowansJ 1962a). 
The most satisfactory anaesthetic agent was found to be Avertin 
(Avertin with amylene hydrateJ Winthrop Laboratories# N.Y. J at a 
dose level of 0. 1 ml per 10gm body weight of a 2o/o solution in 10o/o 
ethanol) sinceJ after intraperitoneal injectionJ the duration of surgical 
anaesthesia was restricted to about 10 minutes. Restrained mice were 
invariably able to run on the modified Bollman cages (BollmanJ 1948) 
within 60 minutes of the induction of anaesthesia provided they were kept 
warm in the postoperative period. This short recovery phase and the 
return of muscular activity markedly increased the rate of lymph flow 
and assisted in the removal of clots from the cannula. Ten to twenty 
minutes prior to commencing the operationJ 0. 3 to 0. 4 ml of cream 
or olive oil was fed ;by intraoesophageal instillation. The presence of 
chylomicrons in the lymph demarcated the thoracic duct throughout the 
course of the operation. 
With the anaesthetised mouse in right lateral recumbencyJ the 
left, or uppermostJ fore and hind legs were extended anteriorly and 
posteriorly with retractors. The hair was clipped from the left lateral 
aspect of the thorax and abdomen extending posteriorly to the hip. 
This area was swabbed with 70% ethanol and a 2 em skin incision 
made with scissors from the costal arch to the region of the tuber 
coxae immediately lateral to the left kidney and parallel to~ and 
5 mm from~- the line of the transverse lumbar processes. An 
incision of similar size could then be made in the abdominal muscles 
and peritoneum. Four curved pins attached to rubber bands served 
106. 
as retractors to extend the edges of the wound and to display the 
spleen~ kidney and portions of the intestines~ stomach and liver 
(Figure 2). With blunt dissection using two cotton buds~ the kidney_ 
and perirenal tissues were reflected ventrally away from the sub-
lumbar muscles and the thoracic duct approached retroperitoneally. 
Locating the short abdominal portion of the duct involved careful 
disruption of tissues lying medial to the left adrenal gland and lateral 
to the abdominal aorta. By retracting the "floating" kidney ventrally 
with one cotton bud, considerable tension could be applied to the aorta 
and the attached thoracic duct. The left wall of the duct was then 
_gently cleared of laterally-associated fascia~ and the sublumbar 
muscles pushed dorsally~ with the other cotton bud. 
At this stage the cotton buds were removed from the abdominal 
cavity and the short arm of the J-shaped polythene cannula (Portex 
Boak Thoracic Cannulae for mice~ Portland Plastics Limited~ Hythe~ 
Kent~ England) cut at an angle about 0. 5 em distal to the 180° curva-
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ture. Placing the cannula through the skin and muscles of the posterior 
paralumbar region was achieved by piercing these tissues with an 18 
gauge needle~ feeding the long arm of the cannula into the bevelled end 
of the needle within the abdominal cavity~ and removing the needle. 
The point of emergence was high enough in the flank to prevent fouling 
of the cannula by movement of the left hind leg when the mouse was 
restrained on the exercise wheel. The long arm of the cannula was 
attached to a 2 5 gauge needle fitted to a 2 ml syringe filled with heparin 
saline (100 units/ml). The syringe was placed in a plasticine mould 
so that it could be used to rotate the cannula within the abdominal 
cavity at will. The entire length of the cannula was then filled with 
the anticoagulant solution. 
With the intraabdominal portion of the cannula lying slightly 
lateral to its definitive position, the thoracic duct was relocated and 
the lateral wall tensed by downward (ventral) pressure on the left 
kidney. A small, sharp pointed pair of jewellers forceps was used 
to pierce the wall between two small lumbar arteries and veins which 
lie adjacent to the duct. If tension was maintained whilst puncturing 
the duct, air was drawn in and the chylous lymph displaced. This 
manipulation was found to be important since it clearly defined the 
position of the hole and the width of the duct. The bevelled end of the 
cannula was then fed into the duct for a distance of approximately 2 mm 
(Figure 3) and the cotton bud pressure on the kidney relaxed. This 
method of insertion was shown to be far more positive than the usual 
practice of stabbing the duct with the pointed end of the cannula and 
reduced the risk of lacerating the duct or penetrating the right lateral 
wall which lies adjacent to the posterior vena cava. 
Lymph either entered the tubing of its own accord or could be 
aspirated by slight extrusion of the plunger of the syringe. A small 
drop of tissue adhesive (Ethicon methyl or isobutyl 2 -cyanoacrylate 
monomer, Ethicon Inc. , Sommerville, N.J., U.S. A.) sealed the 
fistula and was allowed to polymerise in the area of union between duct 
and cannula for 1/2 to 1 minute. The abdominal contents were swabbed 
with a generous amount of warm physiological saline and the kidney 
returned to its preoperative position. Finally, the syringe was 
disengaged from the free end of the cannula and the wound and leg 
retractors removed. 
Figure 2. Anaesthetized mouse after laparotomy and extension 
of wound edges. 
a, ·· pair of jewellers forceps; 
b, '' cotton buds; 
c, wound retractor; 
d, leg retractor. 
The spleen, left kidney and portions of the large and 
small intestines are visible, nithin the limits of the 
wound. 
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Figure 3. Site of insertion of polythene cannula into the short 
intraabdominal portion of the thoracic duct. 
a, ' long arm of cannula resting against the sub-
lumbar muscles; 
b, - thoracic duct filled with chylous lymph; 
c, -- intraabdominal aorta; 
d, cotton bud used to retract the left kidney (e), 
spleen and intestines, and to exert tension 
on the aorta and attached thoracic duct wall. 
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Restrained, unanaesthetized mice on modified Bollman 
cages after establishment of thoracic duct fistulae. 
a, - drinking bottle filled with glucose-saline and nozzle 
b, polythene cannulae; of same; 
c, collection tube in ice and water; 
d, Barastoc dog pellet; 
e, ' exercise wheel. 
The muscle layers were sutured with silk (Deknatel Cardio-
vascular 4-0 black braided silk# J. A. Deknatel and Son. Inc., N.Y., 
U.S. A. ) and the skin wound closed with 3 Michel clips and painted 
with collodion flexile. The entire operation could be completed in 
3 to 4 minutes without magnification provided a powerful light source 
was available to illuminate the depths of the wound. 
As a dressing, and for the purposes of restraint, the thorax 
and abdomen were bound in tape which was in turn secured to a rod. 
The mouse, with its tail fixed to the rod to prevent continual brushing 
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of t~:Ie cannula# was transferred to the modified Bollman exercise cages 
and allowed to recover (Figure 4). Collection into 10o/o normal mouse 
serum or foeta~ calf serum (Commonwealth Serum Laboratories, 
Melbourne, Australia) in PBS containing 50 to 100 units of preservative-
free heparin (Evans Medical Limited, Liverpool, England) per ml, 
was commenced after the lymph had displaced the heparin-saline within 
the cannula. The siliconised collection tubes were immersed for the 
greater part of their length in vacuum flasks filled with ice and water 
(Figure 4). 
Although 5o/o glucose saline and Barastoc dog pellets were available 
to the mice at all times, forced feeding with glucose saline (1 to 2 ml 
in 4 or 5 small doses) by intraoes ophageal instillation was found 
necessary in many cases during the first 24 hours. The liquid intake 
fluctuated during the course of chronic thoracic duct drainage and was 
reflected in the volume of lymph collected. To obtain adequate numbers 
of lymphocytes or meaningful output data, constant attention to the cannulae 
was necessary to remove lymph clots. These clots commonly occurred 
during the first 24 hours when the mice showed a reluctance to drink. 
They could be removed readily by passing a fine pointed horse hair up 
and down the cannula. When obstruction involved the inaccessible 
short arm of the cannula, lymph flow could often be recommenced 
by forcing the collection medium or heparin-saline a short distance 
into the cannula by means of a syringe. In some cases~ 0. 3 ml 
saline containing 4 units of heparin was injected subcutaneously 
immediately after the operation and 12 and 24 hours later. The 
drainage of lymph was not always immediate and at times commenced 
only after the mice became active on the wheels. 
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The great majority of inbred CBA and C57BL mice tolerated 
the anaesthetic~ operation~ and restraint and only 5 to 10o/o failed to 
drain from the outset. Failures in hybrid mice were slightly higher 
mainly because of their vigorous activity on the wheels which caused 
the rupture of small or large blood vessles adjacent to the cannula. 
When traces of blood were apparent, the mice were discarded or the 
collection of lymph recommenced when the contents of the cannula had 
cleared. 
Mouse thoracic duct cells were never left for long periods 
in vitro even at 0 to 4° C. The viability of the cells. as measured 
by their capacity to exclude trypan blue or eosin dyes. was found to be 
reduced when the collection time exceeded 12 hours. Viability tests 
on mouse thoracic duct cells collected for 8 to 12 hours were performed 
on 6 occasions and the percentage of stained cells was never greater than 
7o/o. Smears of thoracic duct cells were found to be unsatisfactory unless 
the cells were first spun out of 1 to 2 ml of foetal calf serum. The 
pellet was resuspended in the small volume of foetal calf serum remaining 
in the bottom of the tube after the supernatant had been discarded. 
Smears of cells on glass slide were stained with Wright's stain and 
differential cell counts and measurements of lymphocyte diameter 
performed under oil immersion using an ocular grid with micrometre 
graduations. For each thoracic duct cell suspension at least 1, 000 cells 
in not more than 4 smears were examined and measured. 
(6) Irradiation of mice and cells 
CBA and (CBA x C57BL)F 1 hybrid mice received 800 rads or 
900 rads whole body x-irradiation depending on the machine used. 
In the early experiments. mice received 900 rads at the Peter Mac-
Callum Clinic. At the Hall Institute. all mice received 800 rads. 
In the former case. the Philips deep X-ray machine delivered a beam 
with a half value layer (HVL) of 1. 0 mm Cu and was operated under 
conditions of 250 kV. 15mA, 0.25 mmCu and 1 mmAl filtration and a 
F. S.D. of 30 ems with full backscatter conditions. The dose rate at 
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the treatment surface was 300 rads per minute and the dose at the central 
point in the treatment volume was taken as the dose delivered to the 
mice. Maximum deviations from this central dose were +14o/o and -8o/o 
throughout the treatment volume. The mice. contained in a perspex 
box, were irradiated in groups of eight by a single x-ray field. 
The irradiation procedures, and the conditions under which the 
Hall Institute Philips RT 2 50 machine was operated, were similar to 
these described above. The x-ray beam had a HVL of 1. 0 mm Cu. 
the F. S.D. was 50 em and the absorbed dose rate 170 rads /minute. 
Thoracic duct cells and thymus cells were irradiated (1, 000 rads) in 
cold 30 mm plastic dishes at a dose rate of 120 rads/minute. The 
cells were suspended in ice cold Eisen's balanced salt solution containing 
10o/o foetal calf serum in a volume which completely filled the dish. 
To obtain mortality data following large doses of x-irradiation, 
male and female CBA mice received 800 and 910 rads and deaths were 
recorded each day. Losses were first noticed at 7 days following 800 
rads, and 100o/o were dead· by 13 days (30 mice). 910 rads killed 15 I 15 
mice within 11 days. All irradiated mice were fed oxytetracycline 
(100 mgm/litre) in the drinking water. 
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{7) Haemolysin plaque-forming cell assays 
Two techniques were used to enumerate cells in a single cell 
suspension which form plaques of haemolysis when incubated with 
erythrocytes and complement~ The more extensively used technique 
was that described originally by Jerne et al. {1963) in which cell sus-
pensions containing plaque-forming cells {PFC) are suspended in agar 
together with the appropriate erythrocytes. Plaques are developed 
by adding complement after a period of incubation. When assaying 
for the number of anti-horse erythrocyte plaque-forming cells~ the agar-
free method of Cunningham and Szenberg (1968) was used invariably. 
(i) The Jerne PFC assay 
Preparation of agar base plates. A 2. 8% Difco agar solution 
in distilled water was autoclaved for 10 minutes at 5 lbs pressure and 
0 
cooled to 60 C. Eagle's medium (Eagle's {Basal) Medium 10x concen-
trate with 500 meg streptomycin and 500 units penicillin per ml~ 
Commonwealth Serum Laboratories, Melbourne, Australia) at 2x 
concentration was he~ted to 45° C in a water bath and 5. 5% sodium 
bicarbonate added in a ratio of 1 : 100 {v/v). Equal volumes of Eagle's 
medium and molten agar were mixed thoroughly by swirling in a flask 
and the mixture left for 10 minutes at 45°C. Bubbles were removed from 
the surface of the· mixture at this stage. Finally~ a volume of 8 to 10 
ml of the Eagle's agar mixture was poured into 9 em plastic petri 
dishes and allowed to solidify. These agar base plates .were stored 
0 
at 4 C and used from 1 to 7 days after preparation. 
Preparation of soft agar. A 1. 4% Difco agar solution in distilled 
water was autoclaved and decanted, with a preheated measuring cylinder, 
into preheated 30 ml bottles. These bottles, which usually contained 
12.5 ml agar~ were autoclaved for 10 minutes at 5 lbs pressure and 
allowed to cool to room temperature. 
Preparation of dextran. 100 mgm DEAE dextran {Pharmacia, 
Uppsala, Sweden) was dissolved in 10 ml distilled water with vigorous 
and prolonged agitation. The dextran solution was used within one week of 
nrPn::l r::Jti on_ 
Preparation of overlay mixture. A 12. 5 ml sterile aliquot of 
soft agar was heated to 100°C and allowed to cool in a water bath to 
45°C. Two and a half mls of 10x concentrated Eagle's medium was 
made up to 12 mls with distilled water and warmed to 45°C after the 
addition of 0. 5 mls of 5. 5% sodium bicarbonate. The 12.5 ml volumes 
of Eagle's and soft agar were mixed and 1. 9 ml aliquots added to 
0. 1 ml dextran in clean tubes heated to 45°C. 
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Plating technique. After removing condensations, the agar base 
plates were placed in a 37°C incubator for approximately 30 minutes. 
To the tubes containing dextran and Eagle's agar~ volumes of 0. 1 ml 
of 30% sheep erythrocytes in saline and 0. 1 ml of the cell suspension 
containing PFC~ were added and mixed by inverting the tube once after 
placing a piece of "Parafilm" over the top of the tube. The mixed contents 
of the tube were poured onto the preheated agar base plates, spread by 
revolving and tilting the plate~ and allowed to solidify for at least 10 
minutes. Duplicate plates were prepared for each cell sample. 
Development of plagues. The plates were incubated for 1 to 2 
hours at 37° C after which time 2 ml of a 1 : 10 dilution of guinea pig 
serum in saline was poured on to each plate. Bubbles were avoided 
and care was taken to ensure that the whole plate was covered with 
complement. After a further incubation period of 0. 5 to 1 hour the 
and 
complement was poured offlthe plates washed with cold normal saline. 
The plaques were counted under a dissecting microscope on the same 
day or after storing the plates overnight at 4°C. Finally, the number 
of PFC per spleen was calculated by multiplying the average number 
of plaques per plate by the appropriate dilution factor. 
Technical failures were rarely encountered but when faults 
did occur they could usually be ascribed to mosaic formation (moving 
the plates during solidifi'cation of the soft agar overlay), separation of 
the top layer (agar base layer too fresh~ dilute or not prewarmed), 
appearance of flakes (unclean glassware) or the presence of unmelted 
agar in the overlay. 
(ii) The Cunningham PFC assay. 
The agar-free technique for the detection and enumeration of 
PFC has several advantages over that described by Jerne et al. It is 
___....... 
simpler and less time consuming and~ because horse erythrocytes 
do not spread evenly in agar~ the technique can be used in anti-horse 
erythrocyte plaque-forming cell assays. 
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Preparation of slide· chambers. Glass slides (75 x 25 mm) were 
washed in RBS and rinsed in tap and distilled water. Three pieces of 
"double sided" 3M scotch tape No. 410 were laid across the ends and 
middle of the slide. Another slide of similar size was pressed firmly 
on to the taped slide forming two chambers of similar volume (Figure 5). 
Filling of chambers and development of plaques. Small tubes or 
the wells of haemagglutination trays (Figure 5} were used to prepare a 
mixture of 0. 1 ml of spleen cells in medium 199~ 0. 01 ml of undiluted 
guinea pig serum~· 0. 01 ml of 25o/o erythrocytes in normal saline_, and 
0. 04 ml of 2. 5o/o erythrocytes in medium 199. This mixture was drawn 
up into a Pasteur pipette an·d expressed into the chambers which were 
"topped up" when necessary with 2. 5o/o erythrocytes (Figure 5}. The 
edges of the slide chamber were sealed with mo~en paraffin-"Vaseline" 
(1 : 1} which was allowed to solidify. Mter incubation at 37°C for 30to 45 
minutes~ the plaques were counted under a dissecting microscope. The 
only disadvantage of the method is that the plaques are unstable. The 
chambers must therefore be handled with care after incubation and the 
plaques counted immediately. 
(8) The haemolytic focus assay 
Kennedy et al. (1965o) and Playfair et al. (1965) independently 
described similar techniques for the detection of discrete areas of 
haemolysis in the spleens of irradiated mice injected with lymphoid cells 
and sheep erythrocytes (Section IB). The method developed in this laboratory 
Figure 5. The technique used for filling slide chambers in the 
Cunningham plaque-forming cell assay. A mixture of 
~pleen cells. heterologous erythrocytes and complement 
is prepared in the well of a plastic tray (a). taken up 
with a pipette (b), and expelled into the chamber (c). 
The open edges of the chamber are sealed with paraffin-
"Vaseline" and the plaques developed over a 45 minute 
incubation period. 
(d). spleen cell suspensions in graduated centrifuge 
tubes contained in ice and water; (e). numbered slide 
chambers ready for use. 
-------------------- ----------------
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was a modification of both techniques. Spleens were removed from 
mice and placed on the stage of a tissue chopper (Mcilwain tissue 
chopper~ Mickle Laboratory Engineering Co.~ Mill Works~ Gomshall~ 
Surrey~ England) and moistened with phosphate buffered saline pH 7. 3. 
2 50 M sec~ions were cut and sequentially transferred with jewellers 
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0 forceps to regular agar base plates cooled to 4 C. Much care was taken 
to ensure that the sequential order of the spleen slices was maintained. 
The plates were warmed to 37°C prior to pouring the Eagle's soft agar 
overlay~ prepared as for the Jerne assay. A volume of 3. 8 ml was 
added to the tubes containing 0. 2 ml DEAE dextran, and to this was 
added 0. 2 ml of 20o/o sheep erythrocytes. The tubes were inverted to 
mix the contents and the mixture poured over the spleen slices on the 
agar plates. When the top layer had solidified the plates were incubated 
0 
at 37 C for 1. 5 to 2 hours. After the addition of complement (1 : 10 
guinea pig serum) and further incubation for 1 hour~ the plates were 
washed with saline and cooled to 4°C. 
Haemolytic foci could not be counted accurately unless the red 
cells were stained with a benzidine stain (Jerne ~· ~ 1963). Two and 
a half ml of a mixture of 1 part 5o/o hydrogen peroxide to 9 parts benzidine 
{0. 5 gm in 12. 5o/o acetic acid) at 4°C was added to the plates and allowed 
to stand for 1 to 2 minutes. After washing the stain from the plates 
with normal saline~ the number of haemolytic foci was determined with 
the aid of a dissecting microscope. True haemolysis could be readily 
differentiated from the yellowish-green discolouration around many of 
the slices provided the plates were examined immediately after staining 
the red cells. rr:he majority of haemolytic areas were apparent around 
the edges of the "active" slices but occasionally an area was detected 
in the top layer overlying the slice. The discolouration~ which was 
more apparent around sections cut from spleens undergoing myeloid 
regeneration~ could be minimised by absorbing the phosphate buffered 
saline and tissue juices from the cut spleens prior to placing the sections 
on to the agar plates. Technical difficulties in the plating technique could 
-------------------------------------------
be expected if attention was not given to the precautions outlined in ihe 
description of the Jerne PFC assay. 
(9) Cyclophosphamide-induced tolerance to heterologous erythrocytes 
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The method used to induce immunological tolerance to hetero .. 
logous erythrocytes was that described by Dietrich and Dukor {1967). 
CBA male mice were injected intraperitoneally 1 when 7 to 8 weeks old1 
with 0. 5 ml packed sheep or horse erythrocytes. Cyclophosphamide 
(Endoxan Asta1 Charles McDonald~ Caringbah1 N. S. W. ~ AustraliaL at 
a dose level of 1 mgm per 10 gm body weight~ was injected subcutaneously 
24 hours later. Mice were injected in groups of 10 1 the total cyclophos-
phamide for the group having been dissolved in phosphate buffered saline 
pH 7. 3 immediately prior to commencing the injections. Control mice 
did not receive erythrocytes and were injected with cyclophosphamide 
only. The reactivity of mice from both groups was tested 2 3 to 2 8 days 
later by challenging intravenously with 0. 1 ml of a 20o/o suspension of 
either sheep or horse erythrocytes or a mixture of both. The number 
of PFC appearing in the spleen was determined 4 to 5 days after erythro-
cyte challenge. Thoracic duct cells were collected from nonchallenged 
mice at 4 weeks after ' · cyclophosphamide administration. Thoracic 
duct fistulae were maintained for 16 to 24 hours and all donor mice were 
challenged with the appropriate erythrocytes 24 hours after closing the 
fistula and removing the mice from the exercise wheels. 
(10) Skin grafting 
The half-thickness~ "open-style" skin grafting technique described 
by Billingham and Medawar (1951) was used throughout. Donor mice 
were selected after ensuring that a cycle of new hair growth did not 
involve the area of dorsal skin to be taken. Mice were killed, pinned 
in ventral recumbency, and the dorsum shaved and swabbed with 70o/o 
ethanol. Using small,nontoothed forceps the skin was raised into a 
cone and a piece removed with small curved scissors. The area of the 
skin pieces was approximately 1 square em and 8 to 12 pieces were 
obtained from each donor mouse. The subcutaneous fascia was 
scraped from the dermis and. with the epidermis uppermost. the 
pieces of donor skin were stored in a cooled, sterile, glass petri dish 
containing a filter paper moistened with normal saline. 
Recipient mice were anaesthetised with ether and restrained 
in ventral recumbency with leg retractors extending the four legs 
laterally. The clipped area of skin over the lateral aspect of the 
thorax was swabbed with alcohol and tensed by pinching the skin on the 
contralateral side. A portion of dermis and epidermis. measuring in 
excess of 1 square em. was removed using small. sharp. curved 
scissors. care being taken to preserve the panniculus adiposus and the 
contained blood vessels. This was effected most satisfactorily by 
placing the scissors flat on the skin and removing small segments with 
each cut. 
A piece of donor skin of suitable size was placed on the graft 
bed such that overlap with recipient epidermis did not occur. Two 
sterilized squares of rice papers were next selected, one was placed 
over the graft site and the other on the adhesive surface of a 30 to 
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40 em strip of sellotape. The edges of this strip were underrun to prevent 
abrasion of the axillae and abdomen when subsequently placed, as a 
dressing~ around the thorax of the mouse. The rice paper adhered 
to. and covered, the graft and limits of the graft bed, and ipso facto 
provided protection to the site and prevented side-slip of the graft. 
With the fore legs pulled· anteriorly. the head of the mouse was elevated 
and the sellotape strip placed under the chest. By folding the strip 
such that the two squares of rice paper were superimposed, the dressing 
was tightly wrapped around the thorax. Care was taken to ensure that 
the only pressure exerted on the graft was perpendicular to its surface. 
Tensions in any other direction often led to side-slip with the graft 
overlying a portion of the recipient epidermis. The grafted mice were 
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allowed to recover under a warming lamp and were carefully observed 
to ensure that respiration was not impeded. 
Six to eight days after placing the graft the dressing was removed 
under ether anaesthesia. Grafts were examined for signs of rejection~ 
and the state of the homograft recorded~ every 12 to 24 hours. Technical 
failures were infrequent provided much attention was paid to surgical 
sterility and care was taken not to disturb the graft site when placing 
or removing the dressing. 
(11) Preparation of isoantisera 
Antisera were raised by injecting~ at 2 to 4 weekly intervals. 
CBA and C57BL mice with 20 to 100 million cells from pooled spleen. 
thymus and mesenteric lymph nodes obtained from 6 to 10 weeks old 
C57BL and CBA mice. respectively. The intraperitoneal injections 
were commenced at 6 weeks of age and the number varied from 3 to 6. 
Each mouse received an appropriate allogeneic skin graft between the 
second and third injections. The majority of mice were kill-bled 7 to 
10 days after the last. of the immunizing injections. Other mice were bled 
from the eye and received another lymphoid cell injection up to 4 weeks 
later. These mice were kill-bled 6 to 9 days later. 
All antisera· and normal CBA and C57BL sera were inactivated at 
56°C for 30 minutes and stored at -20°C in aliquots of approximately 
0. 5 ml. 
(12) Incubation of PFC with isoantisera 
In order to develop a technique for the inhibition of PFC and to 
test the efficacy of the isoantisera~ normal CBA and C57BL mice were 
immunized with sheep erythrocytes and spleen cell preparations were 
prepared 4 days later. 0. 15 ml aliquots of spleen cells~ containing 
between 100 and 1~ 000 PFC were suspended in various media and 
incubated at 37°C with undiluted anti-CBA~ anti-C57BL~ normal CBA 
or normal C57BL serum in the presence or absence of complement. 
The cells were spun in the cold after 30 minutes incubation. washed 
once. plated onto regular Jerne agar plates. and the plaques developed 
122. 
in the manner previously described. Maximum inhibition of PFC with 
specific isoantisera. coupled with minimum losses when PFC were 
incubated with nonspecific antisera or normal mouse sera. were obtained 
by using a supporting medium of 10% foetal calf serum in Eisen's 
balanced salt solution and a ratio of spleen cells: serum : complement 
of 3 ; 1 : 1 {v/v/v). The inclusion of complement {undiluted guinea pig 
serum) was found to be essential • 
. During the course of the experiments using isoantisera. a tech-
nique for the inhibition of PFC and the determination of inhibitory 
antibody titres appeared inihe literature {Harris. Harris and Ogburn. 
1967). The method used by these investigators was almost identical 
to that developed in this laboratory. 
{13) Chromosome analysis of spleen cell suspensions 
The technique used to prepare chromosome spreads of spleen 
cells was that described originally by Ford {1966b). Ninety to 105 
minutes before death. the mice were injected intraperitoneally with 
4/.lg Colcemid {Ciba) per gm body weight. Spleens were disrupted 
inq~idually in 1% sodium citrate and the single cell suspension left 
in small Dreyer tubes for 15 minutes. After gentle centrifugation 
{circa 2 5 g). the hypotonic citrate solution was removed with a fine 
bore pipette and the pellet of cells loosened by flicking the end of the 
tube with the fore finger. A single drop of a freshly prepared solution 
of ethyl alcohol : glacial acetic acid {3 : 1. v/v) was run down the side 
of the tube. Immediately after contact between the fixative and the 
cells. the bottom of the tube was flicked for several seconds. Further 
drops were then added with constant but gentle agitation of the tube. At 
times the suspension was very gently aspirated through a pipette. care 
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being taken to avoid bubbles. The tube was then filled with thE\fixative 
and allowed to stand for 15 minutes. 
After moderate centrifugation# the fixative was removed and the 
pellet resuspended in a small volume of 60o/o acetic acid. Four droplets 
of this cloudy suspension were added to a carefully cleaned slide which 
was then held over the tip of a small gas flame. When the volume of the 
drops had decreased by a factor of about 2 or 3. heating was discontinued 
and the slide waved about vigorously. The heating and shaking were 
repeated until the slide was dry. Finally. the cells were stained with 
1 : 2 May-GrUnwald (2 minutes) and 1 : 10 Geimsa (7 minutes) stains. 
coverslips mounted using DPX. and the number of mitotic figures per 
2 • 000 cells counted under high power magnification (x312 ). The presence 
or absence of marker chromosomes in suitably spread mitotic metaphase 
preparations was ascertained, and chromosome counts performed, under 
oil immersion (x1250). 
(14) Statistical analyses 
Each set of observations was summarized using the statistics 
arithmetic mean (i) and the standard error of the mean (SE ). The 
following computing formulae for the estimation of the variance (S2 ) 
and SE iiere used:- (.~>i r 
2 1 = 1 X.-
1 
S2= . = 1 n 
n - 1 
andSE" ~ 
where x . is the numerical value obtained from the ith observation and 
1 
n is the number of observations. 
When the value of the ratio of the variances of 2 groups (A+B) 
was less than the value in the F-table corresponding to the 5o/o probability 
level. a standard 2 -tailed Student 1 s "t" test for small group sizes was 
used in the analysis of the data: 
------------------------------
- X B 
t = ------------
X 
where SS A and SSB are the sums of squares of deviations about the 
means in group A and B, nA and xA are the number and mean of 
the observations in group A, and ~ and xB are the number and 
mean of the observations in group B, respectively. 
A modified "t" test, which had the overall effect of reducing 
the number of degrees offreedom, was used when the value of the 
variance ratio was greater than the value in the F-table correspon-
ding to the 5% probability level (Smith, 1936; Bailey, 1959): 
XA -~ 
t = df js! s2 
+ 
B 
nA ~ 
where S~ is the variance of group A, S~ is the variance of group B 
and df is the number of degrees of freedom. This latter value was 
obtained by using the following formulae:-
1 c2 
+ 
(1 - C)2 
= df n - 1 ~- 1 A 
s2 
A 
c 
nA 
= 2. s2 SA 
+ 
B 
nA ~ 
In the comparison of the means of any two groups of observations, a 
significance level of 0. 05 was chosen. 
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C. Results 
( 1) Effect of thymectomy on the number of cells in the thoracic duct lymph 
(i) Output of cells from the thoracic duct in normal mice. 
Thoracic duct fistulae were established in 8 weeks old CBA male mice 
and the output of cells and lymph measured every 6 to 12 hours over 
a 10 day drainage period. No attempt was made to reinfuse the mice 
with cell-free lymph or nutrient solutions during the course of chronic 
thoracic duct drainage. The results, shown in Figure 6 and expressed 
as the output per day indicate that there can be no correlation between 
the number of cells and the volume of lymph drained on any one day. 
Whereas the output of cells decreased from an average of 91.7 million 
on day 1 to 2 5 million on day 5 and then remained constant between 
days 6 and 10 at approximately 10 million per day, the volume of lymph 
increased to a maximum of 19.2 ml on day 5 after which time it fell to 
5. 6 ml and increased progressively thereafter. The impression was 
gained from observing the mice that the output of lymph simply reflected 
the volume of glucose saline consumed. The average total number of 
cells drained in 10 days was 276. 3 million of which 139 million (43o/o) 
had emerged in the first 48 hours. In output studies involving thymecto-
mized mice (vide infra), the period of drainage was, in general, restricted 
to 48 hours. 
The results of differential cell counts, performed on air dried 
smears of thoracic duct cells collected at various times, are shown in 
Table 1, group 1. 96. 3o/o of the cells emerging from the fistulae on the 
first day were small lymphocytes (cell diameter < 8~) and this figure 
had fallen to 79o/o by day 9. The proportion of medium lymphocytes 
(cell diameter 8 to 10~) and large lymphocytes (cell diameter > 10~) 
increased from 3 to 18. 6o/o in this time and the relative number of other 
cells, classified as smudges, unidentifiable cells and polymorpho-
nuclear leucocytes, also increased, albeit slightly. From the data in 
Figure 6. 
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Table 1 
Differential Counts of Cells in Thoracic Duct Lymph from Intact 
and Thymectomized CBA Mice 
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IAge at I Hours Differential cell counts* 
Group Operation cannulation of % lymphocytes % neutrophils, 
(weeks} drainage Medium smudges and 
Small and others 
large unidentifiable 
1 Unoperated 8 0 - 6 96.3 3.5 0.2 
70 -74 91.3 6.8 L9 
98 - 102 85.5 10.5 4.0 
192- 198 79.0 18.6 2.4 
2 Neonatal 5 - 6 0 - 6 66.5 25.7 7.8 
thymectomy 24-36 68.5 22.9 8.6 
3 Sham neonatal 0 - 6 93.3 3.7 3.0 
thymectomy 5 ...; 6 24-36 91. 3 6.3 2.4 
4 Thymectomy at 13 36-48 91.7 5.4 2.9 
7 weeks of age 43 36-48 83.4 14.4 2.2 
102 36-48 74.5 20. 1 5.4 
5 Sham thymectomy 13 36 ... 48 96.0 3. 4 o. 6 
at 7 weeks of age 43 36-48 87.8 10.6 2.6 
102 36-48 90.0 8.8 1.2 
6 Thymectomy at 
6 weeks of age, 7 12 12-24 64.6 19.3 16. 1 900 rads and 10 
marrow cells at 16 12-24 80.3 16.9 2.8 8 weeks 
7 Sham thymectomy 
at 6 weeks of a~, 12 12-24 75.3 16.3 8.4 
900 rads and 10 
marrow cells at 16 12-24 84.9 11. 6 3.5 
8 weeks of age 
*- 1, 000 to 12,000 cells counted on smears of pooled samples from 2 - 8 mice. 
Small lymphocyte with cell diameter < 8tJ., medium and large lymphocytes 
with cell diameters > 8f.J.. 
Figure 6 and Table 1, group 1, it can be calculated that the absolute 
number of medium and large lymphocytes decreased from 3. 2 million 
on day 1 to 1. 5 million on day 9. This 53% reduction contrasts with 
the 92% reduction in the absolute number of small lymphocytes drained 
on day 9 as against the number emerging on day 1. 
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During the course of investigations into the capacity of thoracic 
duct cells to transfer immunological reactivity adoptively. it became 
necessary to look for anti-sheep erythrocyte haemolysin plaque-forming 
cells (PFC) in the thoracic duct lymph of normal mice. In three experi-
ments, 10 to 25 million thoracic duct cells collected over 6 hour periods 
from normal mice, were assayed for their content of PFC. PFC were 
not detected in this population of cells. Eight weeks old CBA mice 
were then injected with 2 x 108 sheep erythrocytes by intraperitoneal 
injection and divided into 3 groups of 3 animals each. These groups of 
mice were cannulated on either day 3, 4 or 5 after immunization. Cells 
were collected every 8 hours and the number of PFC determined. The 
results of this experiment, performed in collaboration with Dr. T. J. 
Barclay, are shown in Figure 7. The time of cannulation did not alter 
the time of appearance of PFC in the thoracic duct; these cells appeared 
4 to 6 days after sheep erythrocyte challenge in a well defined pulse. 
The peak number of PFC per million thoracic duct cells in the group of 
mice cannulated on day 3 was approximately three times higher than 
that in the group cannulated on day 5. From the data in Figure 6, the 
total output of cells in the former group could be expected to have fallen 
by a similar factor on the third day of drainage. Although total cell 
counts were not performed, and the effect of sheep erythrocyte inoculation 
on the output of thoracic duct cells 3 to 7 days later is unknown, it is 
unlikely that the absolute number of emergent PFC was very different in 
any of the 3 groups of mice. 
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DAYS AFTER S R BC 
Eight-hourly output of plaque-forming cells (PFC) from 
the thoracic duct (TD) of normal CBA mice injected 
intraperitoneally with sheep erythrocytes (SRBC) and 
cannulated 3 ( • ), 4 ( • } and 5 { e ) days later. 
Each point represents the value obtained from a pooled 
sample of lymph collected from 1 to 3 mice. 
12 9. 
(ii) Output of cells from the thoracic duct in neonatally-
thymectomized mice. CBA mice which had been thymectomized 
within 24 hours of birth had their thoracic duct cannulated at 5 to 10 
weeks of age. In this laboratory, some neonatally-thymectomized 
mice show signs of wasting disease at 6 to 7 weeks of age. In one 
experiment, losses from wasting disease were recorded in a group 
of 14 neonatally-thymectomized CBA mice. The first death occurred 
at 7 weeks of age, 9 were dead by 10 weeks, and all had died by 12 
weeks. Only mice with comparable body weights to those of sham-
operated litter mates were used in the output studies. In preliminary 
experiments, output determinations were performed on a total of 12 
thymectomized and 13 5 weeks old sham-operated control mice. Over 
a 24 hour drainage period an average of 0. 96 million cells (with a 
standard error of the mean of 0. 16) was drained from thymectomized 
+ 
mice in contrast to 41.3 - 5. 8 million from the controls (P < o. 001). 
A more detailed study using 5 to 6 weeks old CBA mice was 
then undertaken. Thoracic duct cannulations were performed in 4 
+ 
neonatally-thymectomized mice (mean body weight of 15.8 - 1. 1 gm) 
and 4 sham neonatally-thymectomized controls (mean body weight of 
+ 16.5 - 1. 1 gm) and the output of lymph and cells measured every 
3 hours for 48 hours. The results are shown in Figure 8, and the 
differential counts of cells collected between 0 to 6 and 24 to 36 hours 
are presented in Table 1, groups 2 and 3. It can be seen in the figure 
that the output of cells from neonatally-thymectomized mice in each 
3 hour collection period remained well below 1 million whereas that 
130. 
from control mice varied from 1. 5 to 17 million. + In 48 hours, 86. 0 - 19. 5 
million cells were drained from nonthymectomized mice. The thymec-
+ tomized mice, on the other hand, produced 2. 65 - 0. 15 million cells, 
the 
this reduced output being significantly different from that in/control 
group (P < 0. 02 ). From the table it is evident that there is a further 
reduction in the number of small lymphocytes in the thoracic duct of 
neonatally-thymectomized mice. In fact, the output of small lymphocytes 
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HOURS OF DRAINAGE 
I 
Three-hourly output of cells and lymph from the 
thoracic duct of 5 to 6 weeks old CBA mice, 
sham-thymectomized {unshaded blocks) or thy-
mectomized (shaded blocks) within 24 hours of 
birth. Each block in the histograms represents 
the average output from 4 mice. 
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can be calculated to be approximately 2o/o of that from intact mice of 
similar age and body weight. This paucity of lymphocytes is reflected 
in the peripheral blood. The average total peripheral blood leucocyte 
+ 
count was lowered by 77o/o from 13,000 - 2, 500 in 6 sham-thymectomized 
mice to 3, 000 't 500 (12 mice) in the neonatally-thymectomized group. 
Neutrophils were reduced in number by about 50o/o and lymphocytes by 
almost 90o/o. 
The 3 -hourly output of lymph fluctuated and in general could 
not be correlated with the output of cells. The average total volume 
+ 
of lymph drained was 2. 23 - 0. 16 ml in the thymectomized group 
+ 
and 6. 84 - 3. 4 ml in the sham-operated controls, this difference 
being not significant. 
(iii) Output of cells from the thoracic duct in adult-thymectomized 
mice. Male CBA mice were thymectomized or sham thymectomized at 
7 weeks of age and at various times after the operation, 6 to 12 mice 
were taken from each group for thoracic duct cannulation. The total 
numbers of cells and volumes of lymph drained in 48 hours at 1, 6, 10, 
36, 52 and 95 weeks after thymectomy or sham thymectomy are shown 
in Figure 9. Considerable difficulty was encountered in maintaining 
a functional fistula in older mice and many were discarded because of 
the appearance of blood in the cannula or because of the cessation of 
lymph flow for prolonged periods of time. The average number of cells 
drained from thymectomized mice fell from 107.7 million one week 
after thymectomy to 18. 9 million 94 weeks later. The output from 
intact mice also decreased over this 2 year period from 103. 9 million 
to 43.4 million. The mean output of cells from thymectomized mice 
was less than that from the control mice at all time points other than 
1 week after thymectomy. This difference was statistically significant 
only at 52 weeks (P < 0. 0 1) and 95 weeks (P < 0. 02 ). A significant 
difference in the output of lymph from the 2 groups was not apparent 
at any one of the time points. 
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WEEKS AFTER OPERATION 
Total 48 -hour output of cells and lymph from the thoracic 
duct of CBA mice thymectomized ( 6. and unshaded blocks) 
or sham thymectomized ( 0 and shaded blocks) at 7 weeks 
of age and subjected to thoracic duct cannulation at various 
times thereafter. The number of mice contributing to each 
point is shown in brackets and the limits of two standard 
errors of each mean are indicated by the vertical bars. 
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Differential counts of thoracic duct cells were performed at 
6., 36 and 95 weeks after operation and the results are shown in 
Table 1., groups 4 and 5. It is apparent that only at a time when 
134 •. 
the total number of cells from thymectomized mice was significantly 
reduced was the proportion of small lymphocytes noticeably diminished. 
It can be calculated from Figure 9 and the table that the output of 
thoracic duct small lymphocytes from 2 year old adult-thymectomized 
mice was approximately 36o/o of that from intact mice of the same age. 
In an attempt to detect any physiological changes in the popula-
tion of thoracic duct cells following adult thymectomy., groups of 36 
weeks old adult-thymectomized and sham adult-thymectomized mice 
received 5 intraperitoneal injections of tritiated thymidine (2. 5 f.JC/ gm 
body weight per injection of Thymidine -6 -T (n)., Batch 2 6., The Radio-
chemical Centre., Amersham., England, specific activity 18, 100mc/mM) 
at 12-hourly intervals. Immediately after the last thymidine injection 
the mice were cannulated and smears prepared from the first 12 hours 
collection of cells. The slides were processed autoradiographically 
by Miss M. Dorr using Kodak NTB/2 dipping emulsion, according to 
the technique routinely used in these laboratories and described by 
Prescott, 1964. Representative slides were developed after an 
exposure time of 4 weeks and labelled cells enumerated. Sections of 
spleen., mesenteric lymph node and Peyer' s patch were processed and 
developed in parallel. 
Heavily-labelled cells were present in large numbers in the red 
pulp of the spleen and were abundant in the white pulp of the spleen and 
in the lymph nodes and Peyer' s patches. Virtually all epithelial cells 
of the gut mucosa had numerous grains over the nuclei and grains 
were scattered diffusely over germinal centre cells in the lymph nodes 
and Peyer1 s patches. No lightly-labelled cells were detected in counts 
of 2, 000 cells in smears of thoracic duct cells from either adult-
thymectomized or sham-operated mice. Thoracic duct cell smears 
from 2 adult-thymectomized mice contained an average of 4. 6o/o heavily-
labelled cells and those from 2 sham-thymectomized mice contained 
an average of 3. 4o/~. It is apparent that very little difference in the 
pattern of in vivo tritiated thymidine incorporation could be detected 
in thoracic duct cells from mice thymectomized or sham operated as 
adults~ 2 9 weeks previously. The results of this single experiment 
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do not support the contention that the output of cells in adult-thymectomized 
mice is maintained. for some months after the operation. by an increase 
in the number of short-lived cells or cells newly formed within lymphoid 
organs. 
(iv) Output of cells from the thoracic duct in heavily-irradiated 
mice. Thoracic duct output studies were next performed in irradiated 
CBA male mice which had been thymectomized or sham thymectomized 
at 6 weeks of age. The mice received 900 rads whole body x-irradiation 
at 8 weeks of age and were injected intravenously, on the day of irradia-
tion. with 10 million syngeneic bone marrow cells from 8 weeks old 
donors. Groups of mice had their thoracic duct cannulated at either 
2 days or 2 ~ 3, 4 or 8 weeks after irradiation and bone marrow protection. 
The 48 hour cell and lymph outputs are shown in Figure 10. The output 
of cells from intact mice had fallen from an expected 100 million 
(Figure 9) to 5 million 2 days after irradiation. At two weeks the 48 
hour output had not changed but. over the ensuing 6 weeks, the size of 
the pool increased progressively to approximately 60 million cells. 
By contrast, no significant increase in the size of the pool was recorded 
from 2 to 8 weeks after irradiation and marrow protection .in adult-
thymectomized mice. The number of cells recovered at 4 and 8 weeks 
from such mice was significantly less than the number harvested from 
nonthymectomized mice (P < 0. 01 and P < 0. 05, respectively). No 
significant difference in the output of lymph from the 2 host types was 
detected at any one time. 
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WEEKS AFTER IRRADIATION 
Figure 10. Total 48 hour output of cells and lymph from the thoracic 
duct of adult thymectomized ( and unshaded blocks) 
and sham adult thymectomized ( e and shaded blocks) 
CBA mice, heavily irradiated at 8 weeks of age and pro-
tected with 10 million syngeneic bone marrow cells. Groups 
of mice had their thoracic duct cannulated at 2 days to 8 
weeks after irradiation and marrow injection. The number 
of mice contributing to each point is shown in brackets and 
the limits of two standard errors of each mean are indicated 
by the vertical bars. 
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Differential counts of thoracic duct cells (Table 1 ~ groups 
6 and 7) indicate that the percentage of small lymphocytes in non-
thymectomized mice had not~ at 8 weeks~ reached the expected pre-
irradiation level of> 90%. The difference between the two groups~ 
in the proportion of smalllymphocytes 1 was impressive only at 
137. 
4 weeks after irradiation. The high number of smudges in the smears 
of cells from thymectomized mice may have accentuated this difference. 
By 8 weeks~ smears from both groups contained in excess of 80% 
small lymphocytes. 
(v) Effect of multiple injeCtions of thymus cells on the thoracic 
duct cell output in neonatally-thymectomized mice. Neonatally-
thymectomized CBA mice were injected intraperitoneally with 110 to 
200 million thymus cells from 1 to 10 day old CBA/T6T6 donors in 
5 or 6 doses of 10 to 40 million cells. At 6 weeks of age the mice 
had their thoracic duct cannulated~ the output of cells measured over 
a 48 hour drainage period~ and the cells injected into irradiated (800 
rads) 5 weeks old (CBA x C57BL)F 1 hybrid recipients. The spleens 
and mesenteric lymph nodes of these irradiated mice were removed 
4 days later and chromosome cytological analyses performed. Twenty 
eight of 31 suitably-spread mitotic figures carried the marker chromo-
somes of the original thymus donor type. The mean output of cells 
from 4 mice which drained for 48 hours was 2 3. 8 ':!:" 2. 9 million and 
+ the volume of lymph drained was 6. 45 - 0. 73 mls. Both these values 
differ significantly (P < 0. 0 1) from the 2. 6 5 million cells and 2. 2 3 ml 
lymph drained from uninjected neonatally-thymectomized CBA mice. 
In another experiment~ designed simply as a control of the 
cytological analyses~ neonatally-thymectomized CBA/T6T6 mice were 
injected intraperitoneally with 350 million thymus cells from 1 to 10 
day old CBA mice in 7 doses of 10 to 150 million cells. One mouse 
was subjected to thoracic duct cannulation at 6 weeks of age. The 
12 million thoracic duct cells~ emerging in the first 16 hours of drainage~ 
were injected into a single irradiated F 1 mouse as in the experiment 
described above. The spleen and mesenteric lymph node were 
removed 4 days after injection and cell smears prepared for chromo-
some identification. Of the 21 mitotic figures scored, only 3 carried 
the T6T6 marker chromosomes. Since no mitotic figures were seen 
in uninjected irradiated (CBA x C57BL)F 1 hybrid mice, the 18 nonT6T6 
cells were most probably CBA cells and thus of the thymus donor type. 
The finding that the majority of thoracic duct cells stimulated 
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into division were of thymus donor type, does not give any indication of 
the proportion of thymus donor type cells in the thoracic duct cell 
population. The availability of specific anti-C57BL and anti-CBA sera 
led to an attempt to increase the thoracic duct cell output in neonatally-
thymectomized CBA mice with (CBA x C57BL)F 1 thymus cells. It was 
thought that, by using cytotoxicity tests or flu ores cent antibody tech-
niques, the proportion of thymus or thymus -derived cells in the thoracic 
duct lymphocyte population could be measured directly. Accordingly, 
7 neonatally-thymectomized CBA mice were injected with 340 million 
(CBA x C57BL)F 1 thymus cells from 1 to 7 day old donors in a total of 
12 injections. The intra-peritoneal injections were commenced on the 
second day of life and were continued for 14 weeks at which time thoracic 
duct fistulae were established. Surprisingly, the output of lymphocytes 
_was not increased over that from uninjected 5 weeks old neonatally-
thymectomized CBA mice. The mice did not show any signs of wasting 
disease but, at the time of cannulation, the spleens were noticed to 
be grossly enlarged. Two unoperated mice were then grafted with 
C57BL and Balb/c skin. The Balb/c skin was rejected within 17 days 
without any evidence of hair growth but the C57BL skin grafts are still 
intact, with luxuriant growths of hair, 4 months after grafting. On 
the basis of these findings it seems that the mice were not sensitized 
against C57BL histocompatibility antigens and were thus unlikely to 
have eliminated the injected (CBA x C57BL)F 1 hybrid thymus cells. 
The enlarged spleens, on histological examination, exhibited signs 
of gross myeloid hyperplasia. The implications of these findings 
will be discussed in Section III. · 
139. 
(2) Investigations into the immunological defects in thymectomized mice 
Thoracic duct lymphocytes have been implicated in certain 
immunological responses (Section IB). Hence, the reduced number of 
cells in the thoracic duct lymph of neonatally-thymectomized mice 
may contribute to the inability of such mice to respond in normal 
fashion to a variety of antigenic stimuli (Section IC). Before embarking 
on studies to compare the immunological performance of thoracic duct 
cells from normal and neonatally-thymectomized mice, it was first 
necessary to determine the immunological status of neonatally-thymec-
tomized mice from the CBA colony maintained at the Hall Institute. 
(i) Immunological reactivity of neonatally-thymectomized 
CBA mice. Mice which had been thymectomized or sham thymectomized 
within 24 hours of birth were made available to Dr. N. S. Weiss who 
injected them intraperitoneally at various ages with sheep erythrocytes 
6 (SRBC). The data on the peak number of PFC produced per 10 nucleated 
spleen cells and per spleen have been published (Weiss, Mitchell and 
Miller, 1967). At 10 days of age the neonatally-thymectomized mice 
failed to respond to SRBC by producing PFC in excess of the number 
in the spleens of unimmuniz ed mice but control mice were already able 
3 4 
to produce from 10 to 10 PFC per spleen. 
At 3 weeks of age about 10 3 PFC were detected in the spleens 
of thymectomized mice and numbers exceeding 104 were present in the 
spleens of controls. From 3 to 8 weeks of age, the mean peak number 
of PFC in the spleens of thymectomized mice did not change and was 
> 1 log10 lower than that in sham-thymectomized mice. Neonatally-
thymectomized CBA mice thus exhibited both a delay in the development 
of SRBC reactivity and a splenic PFC response which was, at all ages, 
that 
lower than/in non-thymectomized mice. 
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Defects in homograft immunity following neonatal thymectomy 
have been well documented. The capacity of the neonatally-thymectomized 
CBA mice in this laboratory to reject foreign skin grafts was tested by 
grafting 7 of these mice at 4 weeks of age and 3 at 10 days of age with 
C57BL skin. This particular donor strain was chosen since CBA and 
C57BL mice differ at the strong H2 histocompatibility locus. All mice 
died of wasting disease between 6. 5 and 10 weeks of age with the grafts 
intact. By contrast~ six normal mice grafted with C57BL skin at 4 
weeks of age rejected the grafts within 14 days (mean survival time of 
11 days). 
(ii) Immunological competence of thoracic duct cells from 
neonatally-thymectomized mice. Two assay systems were chosen 
to test the immunocompetence of cells in the thoracic duct lymph of 
thymectomized and normal mice. The graft-versus-host reaction was 
employed as a means of assessing the overall competence of lymphocyte 
populations. In addition~ the haemolytic focus assay was used to 
compare populations of cells for their content of antigen-reactive cells 
{ARC). 
(a) Graft-versus -host .activity of thoracic duct cells. Thoracic 
duct cells were collected from 5 to 6 weeks old neonatally-thymectomized 
and sham-thymectomized CBA mice. Because of the markedly reduced 
number of cells in the thoracic duct of neonatally-thymectomized mice~ 
many more of these mice were cannulated compared with the number of 
nonthymectomized cell donors. From 0. 1 to 2 million cells in 0. 05 ml 
PBS were injected intravenously into (CBA x C57BL)F 
1 
hybrid mice 
within 24 hours of birth. Some of the F 1 newborns were injected with 
PBS and appropriate numbers of F 1 thoracic duct cells. Such control 
mice were always included in the same litter as recipients of parental 
thoracic duct cells. 
The effect of the inoculated cells was determined 9 days after 
injection by measuring the degree of splenomegaly in relation to the total 
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body weight. The splenic index is the spleen : body weight ratio 
in F 1 recipients of parental cells divided by the spleen : body weight 
ratio in control mice. An index of 1. 5 or more is considered evidence 
of a graft-versus-host reaction. It can be seen in Figure 11 that 
thoracic duct cells from sham-thymectomized mice, in numbers >0. 5 
million, uniformly produced such a reaction. By contrast, inocula 
of 0. 4 to 1. 0 million thoracic duct cells from neonatally-thymectomized 
CBA mice failed to induce significant splenomegaly in newborn F 1 
recipients. 
(b) Antigen-reactive cells in thoracic duct lymph. As mentioned 
previously (Section IB), the number of ARC in a population of cells 
can be determined by injecting various numbers of the cells, together 
with SRBC, into irradiated mice and enumerating the haemolytic foci 
appearing in the spleens 8 days later. The haemolytic focus-
producing capacity of spleen and thoracic duct cells from sham neonatally-
thymectomized mice was first determined. One half to 5 million spleen 
cells or 0. 25 to 1. 2 million thoracic duct cells were injected together 
with SRBC into 8 to 10 weeks old syngeneic recipients which had received 
900 rads total body x-irradiation not more than 6 hours previou~ly. 
Other heavily-irradiated mice were injected with SRBC only, lymphoid 
cells only, or were left uninjected. The spleens were sectioned 8 days 
later and the "active areas" or haemolytic foci enumerated. The 
results are presented in Figure 12. A linear relationship exists 
between the number of nucleated spleen or thoracic duct cells injected 
and the number of foci appearing in the spleen. The average number 
of foci in the spleens of uninjected irradiated mice or in those receiving 
cells or SRBC was < 1. By extrapolating to the ordinate, the lines of 
SRBCand 
best fit obtained with/various numbers of spleen and thoracic duct cells, 
the point of intersection was found to be not significantly different from 
one haemolytic focus. From these results, and also those from other 
laboratories (Section IB). the "background" number of foci in these and 
subsequent experiments was considered to be one and was subtracted from 
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NUMBER OF THORACIC DUCT LYMPHOCYTESCXI0 6) 
Splenic indices of 9 day old {CBA x C57BL)F 
1 
hybrid 
mice injected at birth with various numbers of thoracic 
duct cells from 5 to 6 weeks old neonatally thymectomized 
{ A ) and sham neonatally thymectomized ( 0 } CBA 
mice. A spleen index of >,:.. 1. 5 is considered evidence of 
a graft -versus -host reaction and each point represents 
the value obtained from a single F 
1 
recipient. 
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Figure 12. Mean number of haemolytic foci appearing in the spleens of 
CBA mice 8 days after irradiation and injection of sheep erythro-
cytes (SR BC) and/ or syngeneic cells from various sources: 
( e ) spleen cells from intact mice + SRBC; ( • ) thoracic duct 
cells from intact mice + SRBC; ( A ) thoracic duct cells from 
neonatally thymectomized mice + SRBC; ( 0 ) 1 to 6 million 
spleen cells only; ( 0 ) 1 to 3 million thoracic duct cells only; 
( 6 ) SRBC only; ( X ) no injection. The number of mice 
contributing to each point is shown in brackets and the limits of 
two standard errors of the mean are represented by the vertical 
bars. 
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all the experimental results. 
It is apparent from Figure 12 that the slope of the line for thoracic 
duct cells is steeper than that for spleen cells. There is thus a higher 
proportion of ARC in the thoracic duct lymph. Thoracic duct cells from 
5 to 6 weeks old neonatally-thymectomized donors were next tested for 
their content of ARC. The mean number of foci following an injection 
of one million cells was 0. 6 and this number contrasts with approximately 
6 following an injection of an equivalent number of thoracic duct cells 
from nonthymectomized mice. 
By using a double transplantation technique in which spleens 
from inoculated irradiated mice were transferred after 2 hours into 
further irradiated mice, Kennedy et al. (1965a) and other workers have 
shown that approximately 10o/o of the total ARC in the inoculum localize 
in the spleen (Section IB). This figure cannot be expected to be correct 
since it does not take into account further recruitment of ARC after 2 
hours and hence the total number of ARC in a particular population of 
cells cannot be determined accurately. There seems to be no reason, 
however, for not using this figure when comparing two populations of 
cells for their content of ARC. The reported figure of the fraction of 
ARC localizing in the spleen of irradiated mice was confirmed during 
the present investigations. Each irradiated mouse in a group of 10 
mice (A) was injected with 2 x 106 spleen cells together with SRBC. 
In another group (B), each irradiated recipient was injected with 20 x 106 
spleen cells. Group B mice were killed at 2 hours and spleen cells 
(2 0 million) transferred into further irradiated mice (group :B) together 
with SRBC. The average number of foci appearing in the spleens 8 days 
later in group A was divided by the average number in the spleens of 
I group B multiplied by 10. This ratio, expressed as a percentage, was 
7o/o. Furthermore, in a small experiment involving only 4 group B 1 
mice, the fraction of ARC in thoracic duct cell.inocula localizing in 
the spleen was found to have a mean value of slightly less than 10o/o. 
In all subsequent calculations the localization percentage was considered 
to be 10 for both spleen and thoracic duct cell inocula. 
Figure 12 shows that 1 million thoracic duct cells from non-
thymectomized mice produced, on the average, 6 haemolytic foci. 
Assuming that 10o/o of the ARC lodge in the spleen and that the 48 hour 
thoracic duct lymphocyte pool in mice of this age is approximately 
80 million cells (Figure 8), the total number of ARC in the pool is 
4, 800. By applying these same considerations to the thoracic duct 
cells from neonatally-thymectomized mice, the number of ARC per 
million cells is 6. With a pool size of 3 million cells, the total 
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number of ARC is less than 20. The thoracic duct cell population 
following neonatal thymectomy is thus deficient, not only in the number 
of cells present, but also in the relative and absolute number of antigen-
reactive cells. 
Spleen cell inocula produced approximately 1. 2 foci per million 
injected cells in response to sheep erythrocytes in irradiated mice 
(Figure 12). The spleens of 5-6 weeks old sham-thymectomized mice 
contain in excess of 108 nucleated cells. The total number of ARC per 
spleen is therefore circa 1, 200. As mentioned, this figure may be 
misleading and could conceivably be grossly inaccurate. For compa-
rative purposes, however, the figure is useful and will be employed in 
studies to be described in the following section. 
(iii) Antigen-reactive cell precursors in bone marrow and thymus 
Since the number of thoracic duct ARC was markedly reduced following 
neonatal thymectomy, the thymus may be involved in the generation of 
these cells from some precursor cell population. The regeneration of 
the pool of thoracic duct lymphocytes in irradiated, marrow-protected 
CBA mice was dependent upon the presence of the thymus (Figure 10). 
Furthermore, the restoration of PFC reactivity to SRBC in such mice 
was found to be influenced by the presence of the thymus. In 4 separate 
experiments, 8 to 24 weeks old CBA male mice received 900 rads total 
body x-irradiation and 10 million syngeneic bone marrow cells 1 to 3 
hours after irradiation. Some of the mice had been thymectomized at 
6 to 7 weeks of age. At various times between 2 and 10 weeks after 
irradiation, groups of mice were injected intravenously with SRBC 
and the number of PFC in the spleens determined 4 to 5 days later. 
The results of the 4 experiments were similar and are combined in 
Figure 13. It can be seen that the number of PFC appearing in the 
spleens of both thymectomized and nonthymectomized irradiated and 
marrow protected mice was < 500 at 2 weeks after irradiation. By 
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4 weeks the number in the nonthymectomized group had reached 
20,305 while the number in the thymectomized group was still< 2, 000. 
The 4 - 5 day PFC response to SRBC at 6 to 10 weeks had returned to 
levels comparable with those in normal mice of similar age (Martin 
and Miller, 1968) only in the group of mice in which the thymus was 
present. The thymectomized mice could produce~ on the average, 
only about 3, 000 PFC in the spleen at these time po<ints. 
The results of a time course study of thymus regeneration 
after irradiation are shown in Figure 14. Normal mice received 
900 rads x;_irradiation at 7 to 8 weeks of age and were injected with 
10 million syngeneic bone marrow cells immediately after irradiation. 
The thymus weight fell from approximately 40 mgm at the time of 
irradiation to 10 mgm 2 days later. No increase was apparent until 
after 1 week and preirradiation thymus weights were attained 3 to 4 
weeks after irradiation. Studies on the population of ARC in the 
spleens of mice recovering from irradiation were then undertaken. 
Eight to 12 weeks old CBA male mice received 900 rads 
x-irradiation and injections of 103, 105 , 106 or 10 7 syngeneic bone 
marrow cells within 4 hours of irradiation. Some mice had been 
thymectomized at 6 weeks of age and others received bone marrow 
from neonatally-thymectomized donors. At 1 to 10 weeks after 
irradiation, bone marrow-incubating hosts were killed, the spleens 
·removed, and single cell suspensions prepared. Various numbers 
of cells from the spleen cell suspensions were injected together with 
Figure 13. 
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Appearance of plaque-forming cells in the spleens of 
sham adult thymectomized ( ••.._---llfll' ) and adult 
thymectomized ( ~) CBA mice at various times 
after receiving 900 rads x-irradiation and 10 million 
syngeneic bone marrow cells. Splenic plaque-forming 
cells were enumerated 4 to 5 days after the challenge 
injection of sheep erythrocytes. The number of mice 
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contributing to each point is shown in brackets and the 
limits of two standard errors of each mean are indicated 
by the vertical bars {semi-log scale). 
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Figure 14. Weight of the thymus in CBA mice at various times 
after 900 rads total body x-irradiation and injection 
of 10 million syngeneic bone marrow cells. Each 
point represents the mean value obtained from the 
number of mice shown in brackets and the vertical 
bars indicate the limits of two standard errors of 
the mean. 
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SRBC into further irradiated mice. Eight days later the spleens of 
the secondary hosts were removed and the number of haemolytic foci 
determined. From a knowledge of the average spleen cell number 
in the primary hosts~ the number of cells injected into the secondary 
hosts 1 and the number of foci produced~ the average total number of 
ARC in the spleens of the primary hosts can be calculated. 
The essential features of the experimental design are shown in 
Figure 15 and the numbers of ARC in the spleens of nonthymectomized 
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. irradiated mice incubating bone marrow cells from either normal or 
neonatally-thymectomized mice are shown in Tables 2 and 4 respectively. 
ARC in the spleens of adult thymectomized~ irradiated and marrow-
inoculated mice are indicated in Table 3 and all the results are summarized 
in Figure 16. This figure shows that no ARC could be detected in any 
of the spleens at 1 week after irradiation. At 2 weeks~ however 1 ARC 
had appeared in the spleens of nonthymectomized hosts incubating 106 
7 
to 10 normal bone marrow cells or bone marrow cells from neonatally-
thymectomized mice. By 3 1 4 and 5 weeks~ ARC could be found in 
numbers approximating the 11 000 or so expected to be present in the 
spleen of normal mice. The situation in thymectomized hosts was 
strikingly different. Even after 10 weeks of bone marrow incubation 
the number of ARC in the spleen had not increased above 200. The 
number of ARC in the spleen of one surviving nonthymectomized 
irradiated mouse~ inoculated with as few as 103 bone marrow cells~ 
had reached normal levels 10 weeks after irradiation (Table 2). 
These data indicate that the bone marrow of normal and neonatally 
thymectomized mice contains precursor cells which differentiate into 
ARC~ only under the influence of the thymus. As expected from the 
data in Figure 13, no thymus regeneration was evident either macro-
scopically or microscopically in any of the mice at autopsy until after 
1 week of bone marrow incubation. From the graphs in Figures 14 
and 16 it is evident that thymus regeneration coincides with the appearance 
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Figure 15. Experimental protocol for the detection of 
antigen-reactive cells in the spleens of 
irradiated mice incubating bone marrow 
cells. 
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Table 2 
Number of Antigen-Reactive Cells (ARC) in the Spleens of Heavily Irradiated 
CBA Mice Incubating 103 to 107 Bone Marrow Cells from Normal Syngeneic 
Donors for 1 to 10 Weeks 
Bone marrow incubating hosts ARC assay hosts 
No. of bone Weeks No. of Average No. of No. of No. of ARC 
marrow cells after 
mice cells per spleen mice per spleen injected irradiation (x 10-6 ) 
1 5 8 7 0 
1 X 103 
2 4 60 8 0 
3 6 160 8 150 
10 1 105 6 1360 
1 6 10 6 0 
1 X 105 2 9 (3)* 90 12 (3)* 50,200,240 
3 15 (3) 106 23 (3) 120,400,450 
1 11 (2) 58 10 (2) 0,0 
1 X 106 
2 38 (9) 109 80 (9) 90, 100, 130 
to 
1 X 107 
144,300,300 
380,420, 475 
3 12 (3) 103 24 (3) 270,1900,2100 
4 7 (2) 101 12 (2) 360,1200 
5 5 106 7 1250 
*- Number in brackets refers to the number of individual experiments. 
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Table 3 
Number of Antigen-Reactive Cells (ARC) in the Spleens of Heavily 
Irradiated CBA Mice Thymectomized in Adult Life and Incubating 
106 to 10 7 Bone Marrow Cells from Normal Syngeneic Donors for 
1 to 10 Weeks 
Bone marrow incubating hosts ARC assay hosts 
Weeks No. of Average No. of No. of No. of ARC 
after 
mice cells per spleen mice per spleen irradiation (x 10-6) 
1 5 15 5 0 
3 16 (5)* 86 36 (5)* 7,14,23,36,53 
6 10 (4) 121 28 (4) 50,110,145,210 
8 2 76 6 65 
9 3 157 8 15 
10 1 115 7 130 
* Number in brackets refers to the number of individual experiments. 
Table 4 
Number of Antigen-Reactive Cells (ARC) in the Spleens of Heavily Irradiated 
CBA Mice Incubating 106 to 107 Bone Marrow Cells from Neonatally Thymec-
tomized Syngeneic Donors for 1 to 3 Weeks 
Bone marrow incubating hosts ARC assay hosts 
Weeks No. of Average No. of No. of No. of ARC 
after cells per spleen 
irradiation mice (x 10-6 ) mice per spleen 
1 6 34 4 0 
2 20 (6)* 176 40 (6)* 73, 100, 120, 
250,400,600 
3 7 (2) 111 9 (2) 520, 1500 
* Number in brackets refers to the number of individual experiments. 
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Figure 16. Appearance of antigen-reactive cells in the spleens of 
adult mice over a 10 week period following 900 rads 
total body x-irradiation and injection of 106 to 10 7 
syngeneic bone marrow cells: { 0 } number in non-
thymectomized irradiated mice injected with bone 
marrow cells from normal donors; ( • ) number in 
non-thymectomized irradiated mice injected with bone 
marrow cells from neonatally thymectomized donors; 
{ fl ) number in adult thymectomized irradiated mice 
injected with bone marrow cells from normal donors. 
Each point represents the value obtained in a single 
experiment (Tables 2,3 and 4 }. 
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of ARC in the spleen of nonthymectomized~ irradiated and marrow 
protected mice. The simplest interpretation of this finding is as 
' 
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follows. Bone marrow cells~ or bone marrow-derived cells, repopulate 
the thymus and lymphocytes are exported as ARC or as cells which are 
destined to mature into ARC within peripheral lymphoid organs. If 
the hypothesis is correct then thymus cell populations should contain 
ARC or their immediate precursors~ and one might expect that incubating 
large numbers of thymus cells in irradiated mice would result in an 
early appearance of ARC in the spleens. 
Mice which had received 900 rads x-irradiation at 8 to 12 weeks 
of age~ were injected with 108 thymus cells. Since the thymus popu-
lation lacks haemopoietic stem cells, the mice were destined to die of 
haemopoietic failure. The spleens from thymus cell-incubating mice 
were therefore transferred at weekly intervals into successive sets of 
irradiated hosts~; At each passage an aliquot of the pooled spleen cell 
suspension was injected into other irradiated mice together with SRBC 
and the number of haemolytic foci determined 8 days later. From 
Table 5 it is apparent that virtually no ARC were present in the spleens 
even after 4 passages. In parallel, irradiated mice were injected 
with 10 8 bone marrow cells and the spleens were transferred at weekly 
intervals into further irradiated hosts. Aliquots were taken at each 
transfer and ARC assays performed. Table 5 shows that~ in contrast 
to the situation in which bone marrow cells were allowed to reside for 
3 weeks in a single host, the appearance of ARC from bone marrow 
precursors was largely inhibited by weekly transference of the spleens 
into sets of irradiated mice. The original inoculum of 108 cells must 
be diluted at each transfer. In this case the number of bone marrow 
cells incubated for 3 weeks (assuming a 10 fold dilution at each transfer) 
5 
would be 10 cells. Even if this is so, one would expect to find 12 0 to 
450 ARC in the spleen of the final host (Table 2 ). In none of the passage 
hosts was thymus regeneration apparent according to both histological 
and macroscopical criteria. 
155. 
Table 5 
Number of Antigen-Reactive Cells in the Spleens of Heavily Irradiated 
CBA Mice Incubating. for 1 Week. Spleen Cells Transferred at Weekly 
Intervals from Successive Sets of Irradiated Mice Initially Injected with 
Syngeneic Bone Marrow or Thymus Cells 
Cells injected Average No. of antigen-reactive cells 
into 
1st host 2nd transfer 3rd transfer 4th transfer 
host host host 
8 1 x 10 bone 
4>4> 
marrow cells NR 90 (10)* 0 (8) 
8 1 x 10 thymus 
cells 5 (8) 32 (8) 45 (7) 
4> 2 to 6 hosts were used at each repassage. 
4-4- NR = no result owing to death of assay hosts. 
*- Number in brackets refers to the number of antigen-reactive 
cell assay hosts. 
per spleen 
5th transfer 
host* 
0 (8) 
NR 
A fortuitious finding at this stage in these investigations 
hinted at the existence of a thymus-bone marrow interaction in the 
production of haemolysins. The experimental design was similar 
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to that of the transfer experiments described above. When thymus 
cells were stimulated with SRBC in irradiated mice, and the spleens 
transferred after 1 week to further irradiated mice, the PFC response 
in the secondary hosts was augmented by the presence of bone marrow 
cells. The results of a series of experiments employing this basic 
design are shown in Figure 17 and Table 6. It is evident from Figure 17 
that a significant response occurred in the secondary hosts only if 
8 10 thymus cells had been incubated with SRBC in the 1st host and if 
the spleens from these latter hosts were transferred together with bone 
marrow cells and SRBC. When SRBC in the primary hosts were 
replaced by horse or rabbit erythrocytes the response to sheep 
erythrocytes in the secondary hostswas not significantly above that 
in recipients of spleen cells from primary hosts incubating thymus 
cells alone (Table 6). Claman et al. (1966a, b) had reported that a 
mixture of thymus and bone marrow cells was far more effective in 
producing haemolysins to SRBC in irradiated mice than either cell 
population alone. The findings of the present study corroborate those 
of Claman et al. and in addition suggest that thymus cells have first 
to react with the specific antigen before combination with bone marrow 
can be expected to give rise to PFC. The results, however, do not 
provide any information as to which cell type is the immediate precursor 
of the haemolysin plaque-forming cell: - thymus or bone marrow. 
The population containing PFC precursors would, by definition 
(Kennedy et al., 1965a, 1966), contain the ARC. 
Table 6 
Number of Plaque-Forming Cells Produced in the Spleens of Heavily 
Irradiated Mice (Secondary Hosts) Injected with Sheep Erythrocytes~ 
Bone Marrow Cells and Spleens from Irradiated Mice Incubating~ for 
157. 
1 Week~ Thymus Cells and/ or Heterologous Erythrocytes (Primary Hosts) 
Primary Hosts Secondary Hosts * 
Group No. of No. of Erythrocytes Average No. of 
No. mice inoculated inoculated+ P Fe<¥-<~> per 
thymus cells spleen(±sE) 
1 X 108 + 1 26 SRBC 2~487 - 609 
2 19 1 X 108 - 299 + - 76 
+ 3 10 
- SRBC 200 - 105 
1 X 108 + 4 13 HRBC 151 
-
37 
1 X 108 + 5 7 RRBC 100 - 16 
iL Each secondary host received one spleen equivalent from the pool 
7 
of cells obtained from the primary hosts together with 10 bone 
marrow cells and sheep erythrocytes. 
<~> 0. 1 ml of a 20o/o erythrocyte suspension. Abbreviations: 
SRBC = sheep erythrocytes; HRBC = horse erythrocytes; 
RRBC = rabbit erythrocytes. 
P value 
(cf. group 1) 
-
< o. 01 
< o. 01 
< 0. 001 
< o. 001 
<!><!> PFC = number of antisheep erythrocyte plaque-forming cells determined 
7 days after irradiation. 
Figure 17. 
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4 6 8 
DAYS AFTER IRRADIATION OF SECOND HOST 
Thymus -marrow interaction in 2 host system. Details in text. 
Cells injected into first host Cells injected into second host 
108T 108 SRBC Spleen from 107BM 108SRBC 
first host 
+ + + + + 
+ + + + -
+ + + - + 
- + + + + 
- + + + -
-
+ + - + 
Each point represents the value obtained from a single determination made on 
a pool of spleens from 3 mice. Abbreviations: T = thymus cells; BM = bone 
marrow cells; SRBC = sheep erythrocytes. 
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(3) Cell to cell interaction in the immune response to sheep erythrocytes 
The evidence for a thymus -bone marrow cell interaction in 
irradiated mice~ together with the finding that the bone marrow of 
neonatally-thymectomized mice was normal according to one functional 
criterion~ prompted studies into the immunological activity of thymus 
cell inocula in neonatally-thymectomized mice. If cells present in~ 
or derived from~ the thymus and bone marrow are required in the 
immune response to sheep erythrocytes~ then this defective response 
in neonatally-thymectomized mice should be ameliorated by injections 
of thymus cells or thymus-derived cells. 
(i) Immunological activity of thymus and thoracic duct cells in 
neonatally-thymectomized mice. 
(a) Activity of syngeneic cells. In earlier experiments conduc-
ted in collaboration with Dr. N. S. Weiss~ {Weiss et al. ~ 1967) the 
PFC response to SRBC in 10 days old neonatally-thymectomized CBA 
mice was increased by injections of syngeneic thoracic duct cells in 
the newborn period. In the present studies 3 to 5 weeks old CBA miceJ 
which had been thymectomized within 36 hours of birth~ were injected 
intravenously with 10 million or 50 million thymus cells or 10 million 
thoracic duct cells together with SRBC. The donors of the lymphoid 
cells were 6 to 8 weeks old syngeneic mice. Other thymectomized 
mice and sham-operated litter mates received SRBC only. The 
number of PFC appearing in the spleen was determined at 2 J 4J 5 J 7 
and 10 days after injection and the results are presented in Figure 18. 
Neonatally-thymectomized mice produced on the average a peak number 
of 2 ~ 664 PFC whereas the response in shams reached a peak value of 
34J 240 PFC (Figure 18~(A) ). Injection of thymus and thoracic duct 
cells increased the response of neonatally-thymectomized mice to 
levels exceeding 20~ 000 PFC per spleen (Figure 18J (B) and (C)). The 
peak response in the group receiving 50 million thymus cells was similar 
to that in the sham -operated group. The kinetics of PFC production were 
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Number of plaque-forming cells in the spleens of 3 to 5 
weeks old neonatally thymectomized CBA mice at various 
times after injection of sheep erythrocytes (SRBC) and 
thymus or thoracic duct cells. 
(A) •------j•• sham neonatally thymectomized mice 
given SRBC only; 
e-------• neonatally thymectomized mice given 
SRBC only. 
(B) e--o-0----e neonatally thymectomized mice given 50 
million CBA thymus cells and SRBC; 
e-··-··-e neonatally thymectomized mice given 10 
million CBA thymus cells and SRBC; 
•· · ··· · · · · ··• neonatally thymectomized mice given 10 
i60. 
million (CBA x C57BL)F 1 thymus cells and SRBC 
(C) e--··-···-e neonatally thymectomized mice given 10 million 
CBA thoracic duct cells and SRBC; • 
e------e neonatally thymectomized mice given 10 million 
(CBA x C57BL)F 1 thoracic duct cells and SRBC. 
The number of mice contributing to each point is indicated 
and the vertical bars denote the limits of two standard errors 
of each mean. 
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similar in recipients of thymus cells and in nonthymectomized mice 
but the number of PFC in thoracic duct cell-inoculated mice remained 
elevated from 4 to 10 days after challenge with SRBC (Figure 18. (C)). 
The average number of PFC at 4 and 5 days in the spleens of 
mice receiving 10 million syngeneic thymus and thoracic duct cells 
was increased significantly over that in thymectomized mice receiving 
SRBC only (Table 7}. By contrast. the PFC response was not in-
creased significantly by an inoculum of 1. 5 million thoracic duct cells. 
The activity of 10 million thymus cells is thus unlikely to be the result 
of a "contaminant" population of blood-borne lymphocytes in the 
thymus cell preparation. It can also be seen in Table 7 that the 
number of "background" PFC in uninoculated neonatally-thymectomized 
and sham-operated mice was approximately 100 per spleen. Injections 
of 10 million thoracic duct or thymus cells. in the absence of sheep 
-erythrocytes. resulted in a slight increase in the average number of 
PFC. 
(b} Activity of allogeneic and s emiallogeneic cells. Groups 
of 3 to 5 weeks old neonatally-thymectomized CBA mice were next 
injected with thymus or thoracic duct cells from allogeneic (C57BL} 
and semi-allogeneic ((CBA x C57BL}F 1 hybrid} donor mice. The 
results of a time course study of the appearance of PFC in mice 
receiving SRBC and 10 million semi-allogeneic thymus or thoracic 
duct cells are included in Figure 18. As was the case with syngeneic 
inocula. s emiallogeneic cells elevated the PFC response of neonatally-
thymectomized mice. Furthermore. the response in mice injected 
with thoracic duct cells remained elevated when that in thymus-
inoculated mice had fallen. A time course study using C57BL thymus 
or thoracic duct cells was not attempted since the condition of the 
recipients deteriorated after 5 to 6 days presumably as a result of the 
effects of a graft-versus -host reaction. The numbers of PFC in the 
spleens at 4 to 5 days after injection of allogeneic and semiallogeneic 
Table 7 
Plaque-Forming Cell Response of Neonatally Thymectomized CBA Mice 
Injected with Sheep Erythrocytes and Syngeneic~ Allogeneic or Semi -
Allogeneic Thymus or Thoracic Duct Cells 
Group and Sheep No. Average No. of 
162. 
P values 
operation Inoculum erythro- of PFc• per spleen (cf. group 5 
cyte mice at 4-5 days (±SE) 
at birth 
challenge 
1. Tx* - - 5 106 ± 24 
STx* + 2. - - 9 123 - 29 
3. Tx 6 10 x 10 CBA thymus 
+ 
cells 
-
6 241 - 55 
6 CBA 4. Tx 10 x 10 /thoracic duct 
+ 
cells - 4 323 ... 87 
+ 5. Tx - + 16 2~356- 537 
6. Tx 6 10 x 10 CBA thymus 
+ 
cells + 20 19~ 160 - 3, 840 
7. Tx 6 50 x 10 CBA thymus 
-
+ 
cells + 22 38, 855 - 7, 448 
8. Tx 50 X 106 C57BL 
+ 
thymus cells + 11 17, 448 - 3, 901 
9. Tx 10 X 106(CBA X C57BL)F 1 
+ 
thymus cells + 10 22,380- 6,285 
10. Tx 10 x 106 CBA thoracic 
duct cells + 12 + 20,254 ... 3, 646 
11. Tx 1. 5 x 106 CBA thoracic 
duct cells + + 5 3, 510 - 1, 040 
12. Tx 10 X 106 C57BL 
thoracic duct cells + + 10 30,120-7,791 
13. Tx 10 x 106 (CBA xC57BL)F 1 + 
thoracic duct cells + 12 24,537 - 5, 519 
14. STx 
-
+ 36 + 32, 177 - 3, 550 
*: Abbreviations: PFC = plaque-forming cells; Tx =thymectomy; 
STx = sham-thvme~tomv. 
-
-
-
-
-
< o. 01 
< o. 01 
< o. 01 
< o. 01 
< o. 01 
NS 
< o. 01 
< o. 01 
< o. 01 
thoracic duct cells and thymus cells are presented in Table 7. It is 
apparent that the elevation, over and above the number of PFC in 
thymectomized mice injected with SRBC only, was statistically signi-
ficant. 10 million thoracic duct cells from these 2 donor types were 
as effective as syngeneic cells but 50 million C57BL thymus cells did 
not effect the appearance of as many PFC as 50 million syngeneic 
thymus cells. 
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Large-scale experiments to test the immunological activity of 
spleen cells were not performed. In a single experiment 50 x 106 
C57BL spleen cells were injected, together with SRBC, into 2 neonatally-
thymectomized CBA mice. The numbers of PFC in the spleens 5 days 
later were 29, 350 and 22, 400. In another experiment, (CBA x C57Bl) 
F 1 spleen cells also increased the 5 day PFC response to SRBC. 
These spleens, together with those from mice injected with C57BL or 
(CBA x C57BL) F 1 thoracic duct or thymus cells, were used in the PFC 
identification experiments to be described in the next section. 
(c) The identity of the PFC in reconstituted mice. Since C57BL 
and (CBA x C57BL) F 1 hybrid lymphoid cells increased the SRBC reacti-
vity of neonatally-thymectomized mice, anti-H2sera can be used to 
determine the immunogenetic identity of the antibody-producing cells 
in the spleens. Using such a technique one should be able to test 
the hypothesis that the inoculated cells had provided the precursors of 
the PFC. 
The capacity of isoantisera to specifically inhibit the appearance 
of plaques was first tested with spleen cells from intact CBA, C57BL 
and (CBA x C57BL) F 1 mice injected 4 days previously with SRBC. 
CBA and C57BL spleen cells containing PFC were incubated in vitro 
with normal CBA, normal C57BL, anti-CBA and anti-C57BL sera. 
( CBA x C57BL) F 1 hybrid spleen cells were incubated, in addition, with 
normal F 1 serum. Incubation with normal mouse sera caused a 
reduction in the number of PFC in spleen cell aliquots of from 0 to 49% 
with an average of 29% (22 determinations). These losses occurred 
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quite randomly and were presumably a result of non-specific factors 
operating during the incubation and washing procedures. In each 
experiment, the number of PFC remaining after incubation with 
either specific or nonspecific antisermti;was expressed as the percent 
reduction over that obtained with normal mouse sera in the same 
experiment. The results of a series of experiments, using various 
batches of antisera (Table 8), indicate that anti-CBA sera caused a 
reduction of 84 to 91 o/o in the number of CBA PFC in contrast to a 
0 to 17o/o reduction in the number of C57BL PFC. Anti-C57BL 
reduced the number of C57BL PFC by 83 to 99o/o and the number of 
CBA PFC by 0 to 26o/o. Anti-CBA and anti-C57BL sera both inhibited 
91 to 99o/o of (CBA x C57BL)F 1 PFC. The capacity of isoantisera to 
discriminate between CBA and C57BL PFC in a mixture of cells 
was neXt tested. Spleen cell suspensions containing 330 CBA PFC 
and 221 C57BL PFC were incubated with anti-C57BL and anti-CBA 
sera. The number remaining after incubation with anti-CBA serum 
was 205 and the number remaining after anti-C57BL serum was 285. 
Hence, each antiserum had reduced the number of PFC by a factor 
commensurate with the known number of PFC contained in the mixture. 
Spleen cells from allogeneically-and semi-allogeneically-
reconstituted neonatally-thymectomized CBA mice were incubated 
with normal mouse sera, anti-CBA, or anti-C57BL sera. The 
results of 12 experiments are shown in Table 9. Various numbers of 
mice were sacrificed and the spleens harvested at 4 to 5 days after 
lymphoid cell inoculation and SRBC challenge. Anti-CBA serum 
inhibited from 86 to 96o/o of the PFC in the spleen of mice reconstituted 
with 10 to 50 million C57BL thymus, thoracic duct or spleen cells but 
anti-C57BL serum only inhibited from 0 to 12o/o of the PFC. Similarly, 
in neonatally-thymectomized mice reconstituted with 10 to 50 million 
(CBA x C57BL)F 1 hybrid thymus, spleen or thoracic duct cells, 
anti -CBA (which is directed against both donor and host histocompatibility 
antigens) caused a reduction of 89 to 97o/o in the number of PFC whereas 
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Table 8 
Number of Plaque-Forming Cells (PFC) from Spleens of Normal Immunized 
Mice Remaining after Incubation with Isoantisera 
No. of PFC per aliquot remaining 
Spleen cell donor after incubation with:-
Normal mouse Anti-CBA Anti-C57BL 
sera serum serum 
310 50 (84%). 407 (0%) 
662 68 (90%) 550 (17%) 
CBA 529 48 (91%) 394 (26%) 
118 17 (86%) 131 (0%) 
• <!> 118 12 5 (0%) 106 (10%) 
•• ND 38 628 
317 360 (O%) 17 (95%) 
442 367 (17%) 74 (83%) 
1~ 566 1~ 350 (14%) 162 (90%) 
C57BL 2~ 118 ND 28 (99%) 
ND 2~353 87 
ND 2~ 118 28 
2~481 16 (99%) 41 (98%) 
(CBA X C57BL)F 1 815 31 (96%) 44 (95%) 
610 54 (91%) 46 (92%) 
ND 72 42 
* Number in brackets refers to percent reduction relative to the value 
obtained after incubation with normal mouse sera. 
<!> Spleen cell aliquot incubated with antisera in the absence of guinea pig 
serum. 
<I>+ No determination or accident. 
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Table 9 
Number of Plaque-Forming Cells (PFC) from Spleens of Reconstituted 
Neonatally Thymectomized CBA Mice Remaining after Incubation with 
Isoantis era 
No. of PFC per aliquot remaining 
No. of after incubation with:-Cells used for reconstitution 
spleens Normal ln Anti-CBA Anti-C57BL pool mouse 
sera serum serum 
C57BL thymus cells 5 460 37 (92o/o)* 407 ( 12o/o) 
C57BL thymus cells 3 363 36 (90o/o) 334 (8o/o) 
C57BL spleen cells 2 1~536 12 6 (92o/o) 1 ~ 512 (2o/o) 
C57BL thoracic duct cells 4 1, 612 60 (96o/o) 1~ 930 ( Oo/o) 
C57BL thoracic duct cells 6 142 20 (86o/o) 140 (1o/o) 
(CBA x C57BL)F 1 thymus cells 3 609 20 (97o/o) 571 (6o/o) 
(CBA x C57BL)F 1 spleen cells 2 880 12 7 (85o/o) 892 ( Oo/o) 
(CBA x C57BL)F 1 thoracic duct cells 6 130 7 (95o/o) 108 (17o/o) 
(CBA x C57BL)F 1 thoracic duct cells 4 744 84 (89o/o) 958 ( Oo/o) 
(CBA x C57BL)F 1 thoracic duct cells 2""" 1, 174 29 (98o/o) 1,454 ( Oo/o) .,. 
(CBA x C57BL)F 1 thoracic duct cells 3 90 0 (100o/o) 80 (11 o/o) 
(CBA x C57BL)F 1 thoracic duct cells 3""" 817 7 (99o/o) 796 (3o/o) 
*- Number in brackets refers to percent reduction relative to the value 
obtained after incubation with normal mouse sera. 
<+- Reconstituted mice killed 7 days after cell injection; all others were 
killed 4 - 5 days after cell injection. 
only 0 to 17% were affected by anti-C57BL serum. It can be seen 
in Figure 18 {C). that the peak response of neonatally-thymectomized 
CBA mice injected with F 1 thoracic duct cells and SRBC occurred 
on day 7 after inoculation. Spleens taken at this time contained PFC 
which were reduced by anti-CBA serum to the extent of 98-100% 
{Table 9) but which were largely unaffected by anti-C57BL serum 
{0 - 11% reduction). All the data indicate that isoantisera directed 
against the histocompatibility antigens of the host were effective in 
reducing the number of PFC whereas antisera directed specifically 
against the donor cell type were largely ineffective. 
{d) Activity of various cellular and noncellular inocula. 
Since the majority. if not all, of thePFC in mice reconstituted with 
allogeneic lymphoid cells were derived from a cell type resident in 
the neonatally-thymectomized host, it was necessary to test the re-
constitutive capacity of other inocula. Accordingly. 3 to 5 weeks old 
neonatally-thymectomized CBA mice were injected with SRBC and 
syngeneic and semiallogeneic thymus and thoracic duct cells which 
had received 1, 000 rads x-irradiation in vitro. Irradiated cells failed 
to significantly elevate the response of the recipient mice to SRBC 
{Table 10). Cell-free thymus extracts, prepared according to the 
method of Metcalf {1956), were also ineffective when injected intra-
peritoneally at the time of SRBC challenge. Fifty million cells 
prepared from commercial baker's yeast were without effect when 
injected with SRBC and a similar number of syngeneic bone marrow 
cells caused a slight but insignificant increase. The large standard 
error of the mean of the latter group of 11 mice was due to the 
response of one mouse which produced 2 5. 050 PFC in the spleen. 
This value exceeded all others in the group by at least 18, 600. Huge 
numbers of DA and Wistar rat thymus cells significantly increased 
the average PFC response but only by a factor of 3. Human thymus 
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cells were totally ineffective and a recent experiment has demonstrated 
that guinea pig thymus cells uniformly fail to elevate the PFC response 
Table 10 
Plaque-Forming Cell Response of Neonatally Thymectomized CBA Mice 
Injected with Sheep Erythrocytes and Various Cellular and Non-Cellular 
Inocula 
Sheep No. Average No. of 
168. 
P values 
Group Inoculum erythro- of PFC* per spleen (cf. group 1) 
cyte mice at 4-5 days (±SE) 
challenge 
+ 1 
- + 16 2,356 - 537 -
2 50 x 106 irradiated CBA 
thymus cells + 4 1 .. 160 + - 615 NS 
3 10 x 10 6 irradiated CBA 
thoracic duct cells + 5 3,776 + - 979 NS 
4 10 x 106 irradiated (CBA x 
C57BL)F 1 thoracic duct 
+ 
cells + 6 4,344 - 2, 540 NS 
5 Thymus extract + 6 1, 802 + .. 1~ 155 NS 
6 + 6 50 x 10 yeast cells + 6 2,270 
-
450 NS 
7 6 50 x 10 bone marrow 
cells + 11 3,814 + - 2, 189 NS 
6 + 8 100 x 10 rat thymus cells + 11 7,027 - 1, 400 < o. 01 
9 6 100x 10 human thymus 
cells + + 10 1, 713 - 576 NS 
it: PFC = plaque-forming cells. 
- ----- ----- --------------
of neonatally-thymectomized mice injected with SRBC. 
(e) Activity of thoracic duct cells from tolerant mice. 
Thoracic duct lymphocytes from rats specifically tolerant of sheep 
erythrocytes have been shown to be less effective than thoracic duct 
lymphocytes from nontolerant donors in adoptively transferring sheep 
erythrocyte reactivity to irradiated rats (Section IB). It was felt 
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that the use of thoracic duct cells from tolerant donors might shed light 
on the nature of the reconstitutive activity of lymphoid cell inocula in 
neonatally-thymectomized mice. Such inocula should disclose whether 
the inoculated lymphocytes are simply acting as trephocytes in this 
.. system. 
The degree and specificity of immunological tolerance induced 
in CBA mice using the cyclophosphamide method of Dietrich and 
Dukor (1967) were first determined. In mice previously treated 
with SRBC and cyclophosphamide# the number of PFC appearing 
4 to 5 days after a challenge injection of SRBC was approximately 
110 # 00 0 less than in cyclophosphamide treated controls (P < 0. 00 1) 
(Table 11). By contrast# mice from these two groups produced com-
parable numbers of PFC in the spleen in response to a challenge 
injection of horse erythrocytes (HRBC). The degree of cross-
reactivity between SRBC and HRBC has been reported to be slight 
(Radovich and Talmage# 1967) and this is also evident in the results 
presented in the table. Mice injected with one erythrocyze type failed 
to produce many PFC against the other erythrocyte type. When SRBC-
tolerant and HRBC-tolerant mice were challenged with both SRBC and 
HRBC a major response occurred only to erythrocytes against which 
the mice had not been rendered tolerant. Control mice challenged 
with both sheep and horse erythrocytes produced significantly less 
anti-SRBC PFC than when challenged with SRBC alone (P < 0. 02). 
The response to HRBC, however, was not significantly altered when 
such mice were challenged with both SRBC and HRBC. 
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Table 11 
Plaque-Forming Cell Response of CBA Mice Previously Injected with 
Cyclophosphamide with or without Heterologous Erythrocytes and 
Challenged with Sheep and/ or Horse Erythrocytes 
Treatment 
Day 1 Day 2 
SRBC Cyclo 
HRBC Cyclo 
-
Cyclo 
>!> Abbreviations: 
Challenge No. of PFC per spleen 4 to 5 days 
erythrocytes after challenge (± SE >""" 
(days 23 to 28) Anti-SRBC Anti-HRBC 
""" 
+ 187 (35)* + SRBC 1,939 - 165 - 75 
+ 28 (6) + HRBC 103 - 23,333 - 4, 609 
SRBC + HRBC + 390 (11) + 1,355 - 22,910- 3,982 
SRBC + HRBC 38,883 + - 14, 970 (6) + 967 - 401 
+ + SRBC 116,936 - 15. 6 52 (2 1) 283 - 60 
+ 150 (6) + HRBC 423 
-
30,264-7,312 
+ 7,678(15) + SRBC + HRBC 70,540 - 34,742 - 5, 349 
PFC ::: plaque-forming cells; 
SRBC ::: sheep erythrocytes (0. 1 ml of 2 Oo/o); 
HRBC :::horse erythrocytes (0. 1 ml of 20o/o) 
:1\ Number in brackets refers to the number of mice in the PFC assays. 
(4) 
(12) 
(11) 
(6) 
(6) 
(14) 
(15) 
The capacity of thoracic duct cells from SRBC -tolerant mice 
to transfer SRBC reactivity adoptively was tested by injecting 5 or 
10 million cells into 3 to 5 weeks old neonatally~thymectomized mice. 
Other thymectomized mice of the same age received an equivalent 
number of cells from cyclophosphamide-treated control mice. , The 
groups of mice were challenged with either SRBC or HRBC. or with 
both antigens simultaneously. The numbers of PFC in the spleens 
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of the thymectomized recipients were determined 4 to 5 days later and 
the results are presented in Table 12. Thoracic duct cells from mice 
tolerant of SRBC were inferior to cells from nontolerant mice in this 
transfer system. Thus. thymectomized mice inoculated with 10 million 
thoracic duct cells from tolerant mice produced, in their spleens. an 
average of 11,690 PFC. Ten million thoracic duct cells from control 
mice elevated the average number of PFC to 65.067. This difference, 
and also that obtained following injections of 5 million thoracic duct 
cells from the two donor types~ were statistically significant (P < 0. 01 
and P < 0. 001 respectively}. On the other hand, 10 million thoracic 
duct cells from both tolerant and control mice increased the average 
response of thymectomized mice challenged with HRBC to values 
exceeding 30, 000 PFC per spleen. By inoculating recipient mice with 
10 million thoracic duct cells from SRBC-tolerant mice and challenging 
with both SRBC and HRBC, the average anti-SRBC ,PFC response was 
elevated to 21, 106. This value. despite the relatively large group size, 
was not significantly different from the anti-SRBC PFC response of 
11; 690 in similar mice challenged with SRBC only (P < 0. 1). Ten 
million thoracic duct cells from nontolerant mice, when injected into 
thymectomized mice together with both SRBC and HRBC, effected the 
appearance of 57.789 anti-SRBC PFC, this figure being significantly 
different from the 21, 106 PFC per spleen in the group receiving cells 
from SRBC-tolerant mice (P < 0. 05}. In groups inoculated with thoracic 
duct cells from tolerant or control mice, the responses to HRBC were 
not affected by injecting both SRBC and HRBC. 
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Table 12 
Plaque-Forming Cell Response of Neonatally Thymectomized CBA Mice 
Injected with Heterologous Erythrocytes and Thoracic Duct Cells from 
either Sheep Erythrocyte- Tolerant or Non-Tolerant Syngeneic Mice 
No. of No. of PFC per spleen at 
Thoracic thoracic Challenge No. of 4 to 5 days (± SE)* 
duct cell duct cells erythro- recipient 
donor injected cytes mice Anti-SRBC Anti-HRBC 
(x 10-6) 
SRBC* + 5 5 29,590 - 2, 179 -
Non- 10 SRBC 9 + 65,067 - 14,704 -
+ 
tolerant 10 HRBC 5 - 36, 02 0 - 7,246 
+ + 10 SRBC + HRBC 9 57,789 - 13,866 33,877 - 9,660 
5 SRBC 5 6,660 + - 1,851 -
+ 10 SRBC 10 11,690 - 2,001 -
Tolerant + 10 HRBC 4 - 32,715 - 10,682 
+ + 
10 SRBC + HRBC 17 21,106 - 4,457 30,241 - 6,275 
+ 
SRBC 10 2~555 
-
659 
-
.p. + 
SRBC 7 1~ 657 - 1~ 092 -
- - + 
HRBC 6 - 2~812 - 1~ 480 
+ + 
SRBC +HRBl 7 3~814 - 1~ 660 1, 071 - 342 
* Abbreviations: PFC ;:: plaque forming cells; 
SRBC ;:: sheep erythrocytes (0. 1 ml of 2 Oo/o); 
HRBC ;:: horse erythrocytes (0. 1 ml of 20o/o) 
.p. 0. 5 ml of 50o/o erythrocyte suspension :: 9 2 x 10 erythrocytes. 
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By comparing the data in Tables 7 and 12 ~ it is evident that an 
inoculum of 10 million thoracic duct cells from 12 weeks old cyclo-
phosphamide treated mice was more effective than 10 million cells 
from normal 6 to 8 weeks old mice in elevating the SRBC respon-
siveness of neonatally-thymectomized mice. This may be due to 
the age difference between the 2 donor types~ or it may be a conse-
quence of recovery from cyclophosphamide. The PFC response to 
SRBC in cycle-treated mice is certainly higher than could be expected 
in 6 to 8 weeks old mice (Table 11 and reference Weiss et al. ~ 1967}. 
Thoracic duct cells from SRBC-tolerant mice were inferior to 
cells from nontolerant mice in transferring reactivity to the specific 
tolerising antigen. Nevertheless~ such inocula significantly increased 
the PFC response of neonatally-thymectomized mice to SRBC. This 
was especially so when thymectomized recipients were challenged with 
both SRBC and HRBC. The difference between the mean of the group 
not inoculated with lymphoid cells (3 # 814 PFC) and the mean of the 
group receiving 10 million thoracic duct cells from SRBC-tolerant 
mice (21 ~ f 06 PFC} was highly significant (P < 0. 02 }. An additional 
group was included at this stage. Neonatally-thymectomized mice 
were injected with approximately 10 times the number of erythrocytes 
in the standard immunizing dose of SRBC used throughout these 
experiments. As seen in Table 12~ the 4 to 5 day PFC response was 
not increased above that following the routine injection of 0. 1 ml of 
20% SRBC ( E 108 SRBC). 
(f) Attempts at breaking tolerance with thoracic duct lymphocytes 
From the results presented in Tables 11 and 12 ~ it is clear that the 
difference in the activity of thoracic duct cells from tolerant and control 
mice in neonatally-thymectomized recipients is not as great as would 
have been expected from an examination of the difference in the PFC 
response of the cell donors. Thus the difference in the PFC response 
to SRBC approached 2 log10 in the donor mice yet only a 6 fold difference 
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in the PFC response was recorded in neonatally-thymectomized mice 
injected with 10 million cells from the two donor types. One inter-
pretation of this observation is that tolerance in the donors does not 
only involve the thoracic duct lymphocyte population. Experiments 
were then set up to test whether thoracic duct cell inocula from 
normal mice were effective in breaking SRBC tolerance in SRBC-
cyclo treated mice. In addition, the efficacy of bone marrow cells, 
spleen cells, and a mixture of bone marrow and thoracic duct cells, 
was determined in other tolerant mice. The inocula were injected 
intravenously together with sheep erythrocytes and the splenic 
PFC response measured 5 days later. The results are presented 
in Table 13. 
Twenty million normal thoracic duct cells significantly increased 
the PFC response in tolerant mice but the increase was slight. Bone 
marrow cells were ineffective but a mixture of these two cell types 
increased the PFC number, albeit marginally once again. The finding 
that huge numbers of spleen cells were also unable to elevate the response 
to normal levels hints at the possibility that few of the competent cells 
in the inocula were responding to SRBC in the environment of the 
tolerant hosts. Many recipient mice in all groups did not produce 
PFC in numbers above the average response of tolerant mice injected 
with SRBC alone. By comparing the data in Tables 7 and 13, it is 
evident that neonatally-thymectomized mice and SRBC-cyclo treated 
mice were able to respond to SRBC by producing an average of 2, 356 PFC 
and 1,939 PFC at day 5, respectively. Ten million syngeneic thoracic 
duct cells increased this response in neonatally-thymectomized mice to an 
average of 20,254 PFC but 20 million syngeneic thoracic duct cells 
increased the response in tolerant mice to only 3,067 PFC. 
(ii) Immunological activity of thymus, thoracic duct, and bone 
marrow cells in irradiated mice. The experimental system employing 
reconstituted neonatally-thymectomized mice failed to detect the presence 
of PFC precursors in thymus, thoracic duct or spleen cell inocula. As 
Table 13 
Plaque-Forming Cell (PFC) Response of Sheep Erythrocyte-
Tolerant CBA Mice Injected with Sheep Erythrocytes (SRBC) 
and Various Inocula from Normal Syngeneic Mice 
Group Inoculum No. of No. of PFC 5 days 
mice after injection (±SE) 
SRBC + 1 35 1,939 - 187 
2 20 x 106 thoracic duct 
cells+ SRBC 16 3,067 + - 619 
3 6 2 0 x 10 bone marrow 
cells+ SRBC 9 2,280 + 
- 650 
4 2 0 x 10 6 thoracic duct 
6 
cells + 20 x 10 bone 
marrow cells + SRBC 9 7,617 + 
-
1. 951 . 
5 6 40 x 10 spleen cells 
+SRBC + 10 7.510 - 2,739 
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P values 
(c. f. Group1) 
-
< o. 05 
N. S. 
< o. 001 
< o. 001 
mentioned previously. discrete foci of haemolysis appeared in the 
spleens of heavily-irradiated mice injected with SRBC and thoracic 
duct or spleen cells. ThePFC in this situation must therefore be 
derived from the inoculated cells or from a radioresistant cell type 
in host tissues. The following experiments were designed to deter-
mine whether PFC precursors are present in cells from the thymus 
or thoracic duct. 
(a) Activity of syngeneic cells. Eight weeks old CBA mice 
were injected with 10 million thymus cells. bone marrow cells or 
thoracic duct cells together with SRBC within 6 hours of receiving 
800 rads x-irradiation. The CBA donor mice were aged 6 to 8 
weeks. Seven to 8 days later the spleens were removed and the 
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number of PFC determined. Thoracic duct cells significantly increased 
the average PFC response above that obtained in irradiated mice 
injected with SRBC only (P < 0. 01) whereas thymus and bone marrow 
cell inocula were ineffective (Table 14). Moreover. 1 million thymus 
cells did not increase the number of PFC but the 97 PFC following an 
injection of 1 million thoracic duct cells was significantly higher than 
the average number in the control group injected with SRBC only 
(P < 0. 05). Increasing the size of the thymus inoculum to 50 million 
cells did not significantly increase the PFC response and 25 million 
thoracic duct cells. injected in the absence of SRBC. were also without 
effect. Varying the dose of SRBC did not influence the negligible PFC-
producing capacity of bone marrow cells at 7 to 8 days after injection 
into irradiated recipients. 
It was of interest to examine the differences in the immunological 
activity of thymus. thoracic duct. and bone marrow cells at a cytolo-
gical level. Eight weeks old CBA mice were injected with either 
50 million CBA/T6T6 thymus cells. 10 million T6T6.thoracic duct cells. 
or 10 million T6T6 bone marrow cells together with SRBC. Some mice 
were injected with the three nucleated cell inocula alone. Cytological 
Table 14 
Number of Plaque-Forming Cells (PFC) in Spleens of Heavily Irradiated 
CBA Mice after Injection of Sheep Erythrocytes (SRBC) and Syngeneic 
Thymus Cells. Thoracic Duct Cells and Bone Marrow Cells 
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No. of Average No. of PFC per spleen Cells inoculated 
mice at 7 - 8 days+ postirradiation (- SE) 
SRBC only 36 18 + 
-
3.3 
6 + 1 x 10 thymus cells + SRBC 18 24 - 9.5 
6 + 10 x 10 thymus cells + SRBC 14 15 
-
3.0 
6 + 19.3 50 x 10 thymus cells + SRBC 20 52 
-
1 x 106 thoracic duct cells +SRBC 10 97 + 
-
34.7 
10 x 106 thoracic duct cells 
+ 
+ SRBC 23 1. 270 - 338 
2 5 x 10 6 thoracic duct cells only + 5 17 
-
4.4 
6 + 10 x 10 bone marrow cells +SRBC 34 47 
-
11. 1 
6 10 x 10 bone marrow cells 
+ 
+ SRBC k 6 20 - 8. 9 
6 ** + 10 x 10 bone marrow cells +SRBC 9 17 
-
7.5 
6 1 0 x 10 bone marrow cells 
+ 
+SRBC *-** 8 14 - 11. 1 
... 1 X 106 SRBC; *-*- 1 X 10 7 SRBC; *-** 1 X 109 SRBC. 
Other doses of SRBC ::: 1 x 108 
analyses were performed at 3, 4, 5, 6 and 7 days after irradiation 
and cell injection and the numbers of mitotic figures per 2, 000 
nucleated cells in the spleen cell smears are shown in Figure 19. 
Of 324 well-spread mitotic figures in spleen cell smears from 
thymus-and thoracic duct-incubating hosts only 7 could not be un-
equivocally identified as being of CBA/T6T6 type. No mitoses were 
found at any time in 10 irradiated mice injected with SRBC only. 
It can be seen in Figure 19 that no mitoses were detected in hosts of 
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50 million thymus cells but a few were present in the spleens of hosts 
incubating thoracic duct cells. The addition of SRBC increased the 
number of mitoses /2, 000 cells to peak values of 8 and 2 0 for thymus-
and thoracic duct cell-incubating hosts, respectively. Interestingly, 
mitotic figures were still present at day 7 when PFC might be expected 
{Table 14} but they were present in high numbers only in the mice 
injected with thoracic duct cells and SRBC. Mitoses were numerous 
on day 4 to 7 following bone marrow injection and little difference 
was apparent whether or not SRBC were included in the inoculum. 
Evidence of haemopoietic regeneration was apparent on day 5 when 
the spleens were visibly increased in size and by day 7 the spleens 
appeared to be of normal size~ By contrast, no signs of haemopoietic 
regeneration, including macroscopic colonies (Till and McCulloch, 
1961}, were detected in the spleens of either thymus- or thoracic duct 
cell-injected mice. The difference in the total number of splenic 
mitotic figures between bone marrow-incubating hosts and all others 
must thus be far greater than is indicated by the data on the number 
of mitoses/2, 000 cells. 
(b) Activity of semiallogeneic thoracic duct cells and identity 
of PFC. SRBC and 6 to 30 million thoracic duct cells from (CBA x 
C57BL}F 1 hybrid mice were injected into CBA mice which had received 
800 rads total body x-irradiation. The PFC in the spleens 7 days 
later were enumerated and aliquots of the spleen cell suspensions 
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DAYS AFTER IRRADIATION 
Number of dividing cells at 3 to 7 days postirradiation 
in the spleens of heavily irradiated CBA mice injected 
with SRBC only ( • ), 50 million CBA/T6T6 thymus 
cells only ( ..&. ), 10 million CBA/T6T6 thoracic duct 
cells only ( e ), 10 million CBA/T6T6 bone marrow 
cells only ( + ), thymus cells + SRBC ( 6 ), thoracic 
duct cells + SRBC ( 0 ), and bone marrow cells + SRBC 
( 0 ). Each point represents the number of mitoses 
counted in smears prepared from a single spleen. 
~------~~-~-----~-~~~~~~~~-----------------------------
incubated with normal mouse sera and anti-CBA and anti-C57BL 
isoantisera. It is evident in Table 15 that both isoantisera reduced 
the number of PFC appearing in the spleen by 85 to 95o/o. The PFC 
in this situation are therefore derived from the inoculated thoracic 
duct cells. 
(c) Interaction between thoracic duct cells and bone marrow 
cells in irradiated mice. During the haemolytic focus assays for 
the detection of ARC in lymphoid populations 1 it wa~oticed that the 
foci resulting from spleen cell inocula extended over more slices 
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than was the case following injections of thoracic duct cells. A most 
obvious difference between the spleens of irradiated mice injected 
with either of these two cell types was that myeloid regeneration had 
occurred after spleen cell injection but not after thoracic duct cell 
injection. The effect of myeloid regeneration on the size of "thoracic 
duct foci" was determined in preliminary experiments using (CBA x 
C57BL)F 1 mice. One million thoracic duct cells and/or 10 million 
bone· marrow cells were injected on the day of irradiation into 
syngeneic recipients which had received 800 rads x-irradiation. The 
numbers of foci appearing in response to SRBC in the spleens of 
recipients of the mixture were not increased over those in recipients 
of thoracic duct cells (Table 16). Other mice had their spleens 
assayed for PFC. The average number of PFC in the spleens of mice 
receiving thoracic duct and bone marrow cells was far greater than 
that in spleens of mice injected with either thoracic duct or bone 
marrow cells alone. 
The phenomenon was then studied more thoroughly in CBA mice. 
Groups of irradiated 8 weeks old CBA mice were injected with SRBC 
together with either 1 million syngeneic thoracic duct cells 1 10 million 
bone marrow cells 1 or a mixture of both cell types. Mice were killed 
4, 5, 6, 7 1 8 and 9 days after irradiation and the spleens assayed for 
their content of PFC or haemolytic foci. The results of these time 
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Table 15 
Plaque-Forming Cells (PFC) Remaining after Incubation of Spleen Cells 
from Heavily Irradiated CBA Mice Injected with Sheep Erythrocytes (SRBC} 
and (CBA x C57BL)F 1 Thoracic Duct Cells 
I 
Average No. of PFC remaining after No. of No. of incubation with:-
Inoculum spleens PFC in in 
spleen at Normal. Anti-cBA Anti-pool mouse C57BL 7 days serum 
sera serum 
SRBC only 10 19 - - -
6 x 106 thoracic duct 
cells + SRBC 3 593 98 14 (85%} 11 (89%} 
10 x 10 6 thoracic duct 
cells+ SRBC 7 822 72 6 (92%) 11 (85%) 
3 0 x 1 0 6 thoracic duct 
cells+ SRBC 4 5~655 432 32 (93%) 21 (95%) 
Table 16 
Haemolytic Foci and Plaque-Forming Cells (PFC) Produced in the Spleens 
of Heavily Irradiated (CBA x C57BL)F 1 Mice after Injection of Sheep 
Erythrocytes (SRBC) and Syngeneic Thoracic Duct Cells and/or Bone Marrow Cell 
\ 
Haemolytic foci 8 days PFC 8 days postirradiatior 
J20Stirradiation Average No. of 
Inoculum No. No. of foci per spleen No. of PFC per 
of (Individual No.+ or mice 
spleen (~SE) 
mice Average No. - SE} 
SRBC only 10 0~ 0~ 0~ 0~ 0~ 0~ 0~ 1~ 1~ 1 8 + 12 - 3. 5 
6 10 x 1 0 bone marrow 
+ 
cells+ SRBC 4 0~0~0~1 4 31 
-
2.9 
1 x 1 0 6 thoracic duct 
+ + 
cells+ SRBC 12 5.3 - o. 5 13 44 - 12. 3 
1 x 10 6 thoracic duct 
cells + 10 x 106 bone 
' + + 
marrow cells + SRBC 13 5.2 .. 0.7 16 527 - 75.4 
course studies are shown in Figures 2 0 and 2 1. Since thoracic duct 
inocula do not contain haemopoietic stem cells~ recipients of such 
cells were destined to die of haemopoietic failure. The data for day 
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9 in the group of mice injected with thoracic duct cells and SRBC were 
therefore incomplete and are not shown in the figures. The average 
peak number of haemolytic foci following thoracic duct cell injection 
was 5 and this was not increased significantly by a simultaneous 
injection of bone marrow cells. At the peak of the response (day 8), 
the average number of foci produced by thoracic duct cells or the 
mixed inoculum was significantly greater than that produced by bone 
marrow cells (P < 0. 001). Ten million bone marrow cells effected 
the appearance of< 2 haemolytic foci on all days after irradiation 
and the mean number at the peak was not significantly above the back-
ground number of haemolytic foci in mice injected with SRBC only 
(Figure 20). Bone marrow therefore lacks focus-producing cells 
and it does not increase the number of foci resulting from an injection 
of thoracic duct cells. 
It can be seen in Figure 21 that either 1 million thoracic duct 
cells or 10 million bone marrow cells produced about 100 PFC in the 
spleens of irradiated mice in response to SRBC. By contrast~ 
recipients of a mixture of these 2 cell types~ contained approximately 
900 PFC in the spleen at the peak of the response. This figure was 
significantly different from the maximum average number of PFC 
in the spleens of recipients of either bone marrow cells or thoracic 
duct cells (F<:O. 0 1). If each haemolytic focus in the spleen represents 
a cluster of PFC then it can be calculated from Figures 2 0 and 21 that 
bone marrow cells had increased the number of PFC per focus in the 
spleens of thoracic duct cell .. inoculated mice from< 20 to 160. 
(d) Interaction between combinations of semiallogeneic cells in 
irradiated mice. Semiallogeneic cells were next tested for their 
capacity to act synergistically in irradiated mice in the production of 
PFC, the aim being to use anti-H2 sera in the identification of the 
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Figure 20. Hae:nolytic foci produced in the spleens of heavily irradiated CBA 
mice injected on the day of irradiation with sheep erythrocytes 
(SRBC) only ( !:::. L syngeneic thoracic duct cells only ( (3 ), or a 
combination of SRBC and either 1 million syngeneic thoracic duct 
cells { e e ), 10 million syngeneic bone marrow cells <•······•), 
or a mixed inoculum of 1 million syngeneic thoracic duct cells and 
10 million syngeneic bone marrow cells { 0---- -0 ). The magni-
tude of twice the standard error of each mean is shown by the 
vertical bars. Each point at 4, 5 and 9 days represents the mean 
of determinations made on 2-4 mice and at 6, 7 and 8 days on 
6 - 14 mice. 
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Figure 21. Plaque-forming cells produced in the spleens of heavily 
irradiated CBA mice injected on the day of irradiation 
with 'sheep erythrocytes (SRBC) only ( {j, ), or a combina-
tion of SRBC and either 1 million syngeneic thoracic duct 
cells ( ••t------;e• ), 10 million syngeneic bone marrow cells 
( & ........ & }, or a mixed inoculum of 1 million syngeneic 
thoracic duct cells and 10 million syngeneic bone marrow 
cells ( O----- 0 }. The magnitude of twice the standard 
error of each mean is shown by the vertical bars. Each 
point at 4, 5 and 9 days represents the mean of determina-
tions made on 2-5 mice and at 6,7 and 8 days on 6-13 mice. 
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resulting PFC. It was felt that these experiments should provide 
an answer to the question of whether bone marrow cells promote 
the differentiation of PFC from precursors in the thoracic duct cell 
population or whether they themselves provide such precursor cells. 
Accordingly. 8 to 10 week old CBA or (CBA x C57BL)F 1 mice received 
800 rads x-irradiation and were injected with 10 million CBA bone 
marrow cells, 1 to 6 million F 1 thoracic duct cells. and SRBC. This 
particular combination of cells was chosen to reduce the risk of an 
immunological reaction between the cells of the mixture and also 
against the irradiated host. Bone marrow cells rather than thoracic 
duct cells were always of CBA type. since they are much less active 
in graft-versus-host reactions (Section IC). In a series of 
experiments no synergism in the production of PFC was detected in 
irradiated mice injected 7 to 8 days previously with mixtures of semi-
allogeneic cells. Allowing the bone marrow to reside in the irradiated 
host for a period of 2 days prior to injecting the F 
1 
thoracic duct cells 
and SRBC did not result in any interaction and again the activity of 
the thoracic duct-bone marrow cell combination could be accounted for 
by summating the activities of thoracic duct cells and bone marrow 
cells alone. 
The adult-thymectomized, irradiated and bone marrow protected 
mouse was then chosen as a host in order to test the activity of combi-
nations of semiallogeneic cells in the irradiated mouse environment. 
CBA mice were thymectomized at 6 weeks of age and 1 to 3 weeks later 
were irradiated (800 rads) and injected with 2 to 5 million CBA bone 
marrow cells. Two weeks after irradiation the Ir?-ice were injected 
with 10 million thoracic duct or thymus cells from (CBA x C57BL)F 
1 
mice together with SRBC. Other recipients received SRBC and syn-
geneic thymus or thoracic duct cells. The numbers of PFC appearing 
in the spleens were determined 2, 4, 5, 7. and 10 days later. The 
results are plotted in Figures 22 and 23. The average response of 
adult-thymectomized irradiated CBA mice incubating CBA bone marrow 
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Number of plaque-forming cells in the spleens of heavily 
irradiated adult thymectomized CBA mice injected on the 
day of irradiation with syngeneic bone marrow cells 
followed two weeks lat~r by injections of SRBC only 
(. ~), 10 million syngeneic thymus cells and SRBC 
(o---o), or 10 million syngeneic thoracic duct cells 
and SRBC ( ••~-----•• ). The magnitude of twice the 
standard error of -each mean is shown by the vertical 
bars and each point represents the mean of determinations 
made on 3 to 10 (average 5. 3) mice. 
for two weeks was < 300 PFC per spleen at all time points following 
SRBC injection. Semiallogeneic thymus cells were totally ineffective 
in elevating the PFC response to SRBC. Syngeneic thymus cells 
resulted in an average response of 5, 756 PFC per spleen on day 7, 
188. 
this value being not significantly different from the average peak number 
after SRBC injection (P < 0. 1 ); Ten million CBA or F 1 thoracic duct 
cells increased the number of PFC per spleen to average peak values, 
on day 5, of 72,037 and 19,800 respectively. Hence, the number of 
PFC following an injection of 10 million thoracic duct cells and SRBC 
was far greater in adult-thymectomized, irradiated mice injected with 
CBA bone marrow than in irradiated mice not receiving bone marrow 
(Figures 22 and 23, c. f. Tables 14 and 15). The superiority of 
thoracic duct cells over thymus cells in the adult-thymectomized, 
, irradiated and marrow protected hosts contr§Lsts with the situation in 
neonatally-thymectomized mice (Table 7). One difference between 
these two host types is in the size of the spleen. Thus, in 17 neonatally-
+ thymectomized 3 to 4 weeks old mice the spleen contained 148 - 12.2 
million nucleated cells whereas in 7 thymectomized radiation chimaeras, 
+ the spleen contained 81 - 7. 0 million cells two weeks after irradiation. 
It is conceivable, therefore, that more injected thymus cells were 
trapped and recruited in the spleen of the neonatally-thymectomized 
mouse than in the spleen of the irradiated chimaeric host. This 
possibility will be discussed in Section III. 
Thymus and thoracic duct cells were tested for. their capacity 
to elevate the PFC response in thymectomized radiation chimaeras 
at 4 and 6 weeks after irradiation and marrow protection. As can be 
seen in '!'able. 17~ thymus cells were vastly inferio~ to thoracic duct 
cells at 4 and 6 weeks after establishment of the chimaera. Thymus 
cells incr~ased ~he response of well-established chimaeras above that 
which could be expected in SRBC-injected hosts (Figure 13) but this 
~ncrease was significant only at 4 weeks ( P < 0. 01). 

{c) Identity of PFC in thymectomized radiation chimaeras. 
Aliquots of spleen cells were taken from adult-thymectomized, irra-
diated mice injected with CBA bone marrow, (CBA x C57BL}F 1 
thoracic duct cells, and SRBC, and incubated with isoantisera in the 
manner previously described. Ten or 35 million F 1 thoracic duct 
cells had been injected together,with SRBC two weeks after irradiation 
and marrow protection. The results of incubating the spleen cell 
aliquots with the various sera are shown in Table 18. Anti-CBA 
sera {directed against both thoracic duct and bone marrow cell donor 
types} caused a reduction in the number of PFC, relative to that 
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following incubation with normal sera, of from 95 to 97o/o. Incubation 
with ·anti-C57BL sera resulted in losses of up to 5%. The majority 
of PFC produced in these hosts were not ofF 1 type and must therefore 
be CBA in type. 
The antisera data indicate that either the CBA bone marrow or 
the irradiated CBA host had provided the precursors of PFC in 
syngeneic CBA radiation chimaeras injected with F 1 thoracic duct 
cells and SRBC. The restoration of immunological reactivity on 
the part of the host is rendered unlikely by the finding that these 
hosts, when not injected with thoracic duct cells, were unable to 
respond to SRBC by producing PFC in the spleen. To test whether 
the host was contributing PFC precursors, 7 weeks old {CBA x 
C57BL}F 1 mice were thymectomized and irradiated 2 weeks later. 
Immediately after irradiation 5 to 6 million CBA bone marrow cells 
were injected followed 2 weeks later by 10 million {CBA x C57BL}F 1 
thoracic duct cells and SRBC. PFC in the spleen were enumerated 
5 days later and aliquots of the spleen cells incubated with normal 
CBA, C57BL and F 1 sera and the two isoantisera. The results of 
3 experiments are included in Table 18. In only one of three ex peri-
ments was the number of PFC increased to levels attained in syn-
geneic radiation chimaeras. Nevertheless, PFC numbers in two of 
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Table 18 
Plaque-Forming Cells (PFC) Remaining after Incubation of Spleen 
Cells from Adult Thymectomized, Irradiated CBA or (CBA x C57BL)F 
1 
Mice Injected with CBA Bone Marrow Cells, (CBA x C57BL)F 1 Thoracic 
Duct Cells, and Sheep Erythrocytes (SRBC) 
No. of No. of P FC remaining after Host Inoculum Average incubation with:-spleens N f 
strain . o. 0 
Anti-CBl 
ln PFC per' Normal pool Anti-
spleen mouse C57BL serum 
sera 
serum 
SRBC 5 158 - - -
10 x 106 F 1thoracic duct cells + SRBC 5 10,980 80 4 (95%)"'" 8~ (Oo/o) 
10 x 106 F 1thoracic 5 18,262* 139 6 (96o/o) 140 (Oo/o) CBA duct cells + SRBC 
. 6 ' 
35 x 10 F 1thoracic 2 69,300 604 2 0 (97o/o) 571 (5o/o) duct cells + SRBC 
35 x 106F 1 thoracic duct cells + SRBC 2 85,850 1, 454 70 (95o/o) 1660 (Oo/o) 
. ! 
~RBC 6 2 100 - -(1) 10 x 10 F 1 thoracic ~uct cells + SRBC 4 925 - ... 
(CBA ~RBC 6 1 260 - -
X (2) 10 x 10 F 1tP:oracic· C57BL)F 1 duct cells + SRBC 3 18,633 624 18 (96o/o) 
SRBC 6 3 130 - -(3) 10 x 10 F 1thoracic 
duct cells + SRBC 6 2,288 65 0 (100o/o) 
if- Number in brackets refers to the percent reduction relative to the 
value obtained after incubation with normal mouse sera. 
* Spleens assayed 7 days after thoracic duct cell injection; all others 
were assayed 5 days after cell injection. 
-
... 
... 
473 (24o/o) 
-
I 
57 (12o/o) 
I 
! 
the three experiments were increased substantially above the number 
following injection of SRBC only. Since only 12 and 24% of the PFC 
were inhibited by anti-C57BL serum, the majority must have been of 
CBA type and thus derived from the bone marrow inoculum. 
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III. DISCUSSION 
It is evident from the experimental results presented in this 
dissertation that the term 11 sheep erythrocyte antigen-reactive cell" 
·(ARC) can no longer be used in its original form and must therefore 
be clearly defined. Kennedy et al. (1965 a, 1966) proposed that the 
ARC was a founder cell in a clone of haemolysin plaque-forming cells 
(PFC). In irradiated mice this cell was assumed to localise in the 
spleen, react to antigen or processed antigen, and produce a progeny 
of PFC through mechanisms involving several sequential mitotic 
divisions associated with differentiation. This concept led to the 
construction of the following minimal model of thymus-influenced 
immunogenesis, expressed in terms of a differentiative cell lineage: 
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ThY?UUS 
Bone Marrow 1-1---..L!----i,~J ARC .I 
Antigen 
* ~I PFCl 
As mentioned in Section IIA, this scheme was the basic working model 
behind many of the early experiments described in this thesis. 
Two assumptions implicit in the Kennedy .definition have yet 
to be proven. Firstly, it has not been shown that the haemolytic foci 
in the Kennedy assay represent the sites of PFC clones. The data of 
Cunningham (1968b) and Kind and Campbell (1968) indicate that the 
distribution of PFC in the spleens of irradiated mice is not nearly as 
sharply defined as the focus assay suggests. Secondly, the relationship 
between the cells responding to sheep erythrocytes (SRBC) and the 
resultant population of PFC has not been determined. The cell which 
initiates focus formation may or may not be of the same cell lineage as 
the PFC. If the precursors of the PFC do not respond to antigen and 
if the cells which respond to SRBC do not produce progeny PFC then 
neither cell type qualifies for the name antigen-reactive cell. It is 
because of these considerations that the term "focus-forming .. -cell" 
(FFC1 Gregory and Lajtha1 1968) will be. substituted for ARC in those 
discussions in. which the focus-producing capacity of lymphoid cell 
populations is under examination. 
The most obvious histological consequence of thymectomy in 
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the mouse is a reduction in the number of small lymphocytes in the 
blood and in organs such as the spleen and lymph nodes. These sites 
are known to be within the "orbit" traversed by recirculating small 
lymphocytes. (Section !A). The thoracic duct cannulation experiments 
have demonstrated that the thoracic duct lymphocyte population in 
young adult mice is in_deed affected by the absence of the thymus from 
birth. The lymphocyte deficiency recorded here is of the same order 
of magnitude as that reported in neonatally-thymectomized rats. Agnew 
(1967L Rieke and Schwarz (1967) and Goldschneider and McGregor 
( 1968a) noted a reduction of up to 75% in the number of thoracic duct 
lymphocytes drained over periods of 12 to 72 hours from young adult 
neonatally-thymectomized Lewis rats. Moreover~ Rieke and Schwarz 
( 1967) calculated from the results of their tritiated thymidine studies 
(Section IA) that the deficiency in the thoracic duct lymphocyte 
population following neonatal thymectomy in the rat was restricted to the 
long-lived cells. These quantitative studies on the thoracic duct 
lymphocyte population have substantiated the claims of :the histologists 
that one of the hallmarks of neonatal thymectomy is a reduction in the 
number of long-lived,recirculating small lymphocytes. 
The chronic output determinationshave demonstrated quite 
clearly that thymectomy in adult life is not followed by a dramatic fall in 
the number of thoracic duct small lymphocytes until many months after 
thymectomy. This finding contrasts with the data of Schooley and 
Shrewsbury (1967) in which a 50% reduction in lymphocyte number 
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was apparent 3 days after adult thymectomy. Their experiments differ 
from those reported here in that measurements were made over 
drainage periods of only 10 to 15 minutes in anaesthetized mice. 
Lymph-borne lymphocytes increase in number soon after birth 
(Heath 1964, Morris 1968) and small lymphocytes are not plentiful in the 
spleen and lymph nodes of neonatal mice (Archer et al. 1964). The 
difference in the number of lymphocytes in the thoracic duct of neonatally-
thymectomized and adult-thymectomized mice suggests that the effects 
of thymectomy are more pronounced when performed before the 
appearance of significant numbers of recirculating lymphocytes. Once 
the pool has been established, no immediate effect on cell numbers can 
be expected to result from thymectomy. It must be. emphasized, however, 
that, although the 5 to 6 weeks old neonatally-thymectomized mice were 
of normal body weight, they were presumably destined to die of wasting 
disease within 6 weeks or so. Intercurrent infections, by means of 
some unknown mechanism, may therefore contribute to the paucity of 
lymphocytes in the recirculating pool of such mice. 
Changes in the 48 hour "mobilizable pool" are reflected in the 
splenic PFC response to SRBC and the correlation between the two 
measurements is quite striking. The peak PFC response in young 
neonatally-thymectomized CBA mice is reduced when compared with 
that in sham-operated controls by 93 o/o, the output of lymphocytes· by 98%. 
In two years old CBA mice the PFC response is reduced over that in two 
months old mice by about 50% (Wigzell and Stjernward, 1966; Aisenberg 
and Davis, 1968), the output of lymphocytes by about 60%. The SRBC 
resporni veness of young adult-thymectomized mice is normal (Metcalf, 
1965~ Miller, 1965; Aisenberg and Davis, 1968) but the PFC number is 
I' 
I• 
reduced to about 25% of that in sham adult-thymectomized CBA 
mice at 2 years of age {Aisenberg and Davis 1968). At this time the 
48 hour pool is reduced in size. to about 40% of that in sham-operated 
controls. 
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After an irradiation-induced depression in the thoracic duct 
lymphocyte number. the pool is increased perceptibly in size only at. 
or later than. 4 weeks after irradiation. .The PFC response in the 
spleen also increases markedly from 3 to 6 weeks after whole body 
irradiation. By contrast. both the output of lymphocytes and the splenic 
PFC response remain at. or near. postirradiation levels in adult-
thymectomized. irradiated mice protected from the lethal effects of 
haemopoi etic failure by an inoculum of bone marrow cells. 
This circumstantial evidence for the complicity of thoracic duct 
lymphocytes in haemolysin production is of the type provided by the 
experiments of McGregor and Gowans {1963) and Ford and Gowans {1967). 
These workers clearly demonstrated that.{1} chronically-drained rats 
fail to respond in normal fashion to a primary injection of SRBC. {2) the 
antibody response can be elevated by infusing purified populations of small 
lymphocytes. and {3) the haemolysin-producing capacity of cells from 
the isolated and perfused rat spleen is dependent upon the number of 
lymphocytes in the perfusate at the time of antigenic stimulation .. 
Much indirect evidence is available to suggest that some thymus 
lymphocytes are destined to join the circulating pool {Section !A). 
Attempts have been made in the present series to determine whether 
the thymus contributes cells directly to the thoracic duct lymphocyte 
population and whether the majority of circulating pool lymphocytes are 
thymus derived. Reconstitution experiments were designed in which 
neonatally-thymectomized CBA mice were injected with either 
chromosomally-marked or semiallogeneic thymus cells from neonatal 
donors. The results of one experiment were clear cut. The output of 
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lympl)ocytes was increased after multiple injections of CBA/T6T6 
thymus cells and almost all thoracic duct cells, stimulated into 
division and arrested in metaphase, carried the chromosome marker 
of the thymus cell donor. It might be objected that a certain number 
of circulating lymphocytes were contained in the thymus cell inocula 
from 1 to 10 day old donors and that these had replicated in host tissues. 
Young donors were purposely used to reduce the number of "contaminant" 
cells but the objection cannot be dismissed on the grounds that circulating 
lymphocytes could not have been contained in the thymus cell inocula. 
It is therefore not known with certainty whether lymphocytes :eroduced 
within the thymus cortex have the potential of behaving as long-lived 
lymphocytes in the circulating pool . 
Thymus lymphocytes differ from thoracic duct lymphocytes 
in that they do not elevate the output of lymphocytes when injected into 
draining rats (Everett, 1964~ Gowans, 1964~ Goldschneider and McGregor, 
1968 b). Experiments have been designed in this laboratory to determine 
whether thymus cells must first react with antigen before they, or their 
progeny, recirculate (Miller and Mitchell.19 69 a). Large numbers of 
adult thymus lymphocytes were injected together with SRBC into 
lethally-irradiated syngeneic recipients which in turn received multiple 
injections of tritiated thymidine. The spleen cells from these mice 
were injected into other mice in which a thoracic duct fistula had been 
established. A small number of labelled small lymphocytes, in the 
absence of labelled large lymphocytes, was detected. in smears of 
thoracic duct cells prepared from the draining recipients. Large 
pyroninophilic cells appeared in the irradiated recipients of thymus cells 
and SRBC and it was concluded that these cells incorporated H~thymidine 
and divided to produce a progeny of labelled small lymphocytes. This 
may well be so but the serious objection, based on "contaminant 11 
circulating lymphocytes and mentioned above, can also be raised in 
this instance. 
Attempts to increase the size of the mobilizable pool with 
newborn (CBA x C57BL)F 1 hybrid thymus cells were totally unsucc-
essful. Nevertheless, the mice were protected from the effects of 
wasting disease and were tolerant of C57BL skin. They were able 
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to reject Balb/c skin seemingly in the absence of an increased 
number of circulating lymphocytes. The splenomegaly a:pd myeloid 
hyperplasia noticed in the thymectomized recipients were suggestive 
of either a GVH reaction or myelogenous leukaemia. That inoculated 
F 1 cells should react against CBA cells is contrary to predictions 
based on the genetic laws of transplantation. Studies on the "poor 
growth phenomenon" in irradiated F 
1 
mice injected with parental bone 
marrow cells, led Cudkowicz (1965) to propose that some C57BL 
antigens controlled by the H2 locus were not expressed in th.e cells 
of F 1 hybrid mice. Even if this is so, no evidence for suppression 
of CBA antigens in F 1 hybrid cells has been presented.· 
Billingham and Brent (1959) found that some A strain mice 
injected with {C57BL x A)F 1 hybrid lymphoid cells died unexpectedly 
with gross splenomegaly. Spleen cells harvested from similarly 
treated A strain mice did not induce GVH reactions in other F 1 mice 
and thus could not have been sensitized against antigens of the other 
parental type. These authors favoured the interpretation that the mice 
were affected by leukaemia. In the present system, the neonatally-
thymectomized CBA mice injected from birth with newborn (CBA x 
C57BL)F 1 hybrid thymus cells were unable to reject. C57BL skin and 
were thus unlikely to be sensitized against C57BL histocompatibility 
antigens. It is possible that a reaction to weak histocompatibility 
antigens determined by the H-Y locus may have contributed to the 
observed pathology. No attempts were made to match newborn donors 
and recipients with respect to sex. In addition, the operation of allogeneic 
inhibition (Mtnler and M~ller, 1966) may have contributed to the 
unexpected findings in the semiallogeneic "reconstitution" experi-
ments. 
A reduction in cell number was not the only defect apparent 
in the thoracic duct lymphocyte population following neonatal thy-
mectomy. The population was less able to induce splenomegaly 
in newborn F 1 recipients and it contained a reduced number of FFC 
per million cells. The results of the GVH assays were similar to 
those reported by Rieke (Section IA) but this particular measure of 
immunocompetence does not provide any information on the number 
of cells competent to respond to foreign histocompatibility antigens. 
Likewise 1 the techniques at present in use for determining the total 
number of FFC in a population of lymphoid cells are incapable of 
achieving this aim (Section IB ). However 1 the values obtained are 
useful when comparing two populations of cells for their content of 
FFC. 
The 48 ·hour mobilizable pool in normal mice was found to 
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contain in excess of 4 1 000 FFC whereas that in neonatally-thymectomized 
mice contained< 20. Six FFC were detectable in 1 million thoracic 
duct lymphocytes from neonatally-thymectomized mice whereas an 
equivalent number of lymphocytes from normal mice contained 60. 
It is not known whether the other 54 cells were ( 1) incapable of homing 
to the spleen of the irradiated mouse in the assay system, (2) quali-
tatively deficient in their ability to respond to SRBC antigens, (3) pre-
committed to, or engaged in responses to, other antigens 1 or (4) totally 
absent from the population. Since FFC assays are performed in 
irradiated :mice which contain thymuses, it is unlikely that any FFC 
in the inoculum of lymphocytes from neonatally-thymectomized mice 
was unable to express itself because of the lack of a thymus humoral 
factor. Moreover, prior thymectomy did not influence the appea-
rance of splenic haemolytic foci· and PFC in the spleens of irradiated 
mice injected with SRBC and 1 million normal thoracic duct lymphocytes 
(Miller and Mitchell, 1968a). 
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The thoracic duct lymph of normal mice contained more FFC 
per million nucleated .cells than the spleen. The role of "background" 
splenic PFC in the response of normal mice to SRBC has been dis-
cussed in Section IC, and the bulk of the evidence does not support 
the notion that they are intimately involved in the immune response. 
Notwithstanding this evidence, the relationship between the splenic 
"background" PFC and the splenic FFC remains unknown. PFC were 
abundant in the thoracic duct of immunized mice but none was detected 
in the thoracic duct lymph of unimmuniz ed mice. The FFC in the 
thoracic duct are therefore not PFC or, at least, are not producing 
measurable amounts of 19S haemolysins. 
The deficiency of FFC in neonatally-thymectomized mice does 
not extend to the precursors of these cells. The bone marrow of both 
normal and neonatally-thymectomized mice has been shown to be a 
source of precursors which mature into FFC in irradiated mice only 
under the influence of the thymus. In nonthymectomized,~ irradiated 
mice incubating bone marrow cells_, a striking parallelism exists 
between the restoration of thymus weight (Figure 14_, Kaplan and 
Brown, 1957; Cross, Davies_, Doe and Leuchars, 1964) and the 
reestablishment of the splenic FFC compartment (Figure 16). This 
latter replenishment does not endow the radiation chimaera with the 
capacity to respond normally to SRBC. Restoration of the splenic 
PFC response is related more to the increase in circulating lympho-
cyte number (Figures 10 and 13). Till_, McCulloch_, Phillips and 
Siminovitch {1967) and Osoba (1968b) also showed that the PFC 
response in the spleen of radiation chimaeras had not returned to 
normal at 3 weeks after irradiation and marrow protection. With 
several assumptions 1 this data could be construed to support the 
contentions of Ford and Gowans (1967) that the SRBC responsiveness 
of the spleen is dependent upon the number of lymphocytes in the cir-
culation rather than the resident number. 
The lack of FFC precursors in the thymus does not support 
the hypothesis that bone marrow cells mature into FFC within the 
thymus environment. Nevertheless~ thymic lymphopoiesis was 
required in the bone marrow-incubating~ irradiated mouse system 
before FFC could be detected in the spleen. This observation led 
to experiments which were in essence the same as those conducted· 
by Claman et al. (Section IC). CelJsderived from the thymus and 
bone marrow appear to interact in the production of haemolysins in 
irradiated mice. Using a two host system~ however~ an additional 
finding has emerged. Thymus cells must react with the specific 
erythrocytes before combination with bone marrow cells and s·RBC 
can be expected to result in significant numbers of PFC (Figure 17 
and Table 6). Combinations of cells from semiallogeneic donors 
did not interact in this system (unpublished observation and Chaperon 
and Claman, 1967) and this precluded any attempt~ using isoantisera, 
to establish whether the thymus or the marrow provided the PFC 
precursors. 
FFC were present in thoracic duct lymphocyte inocula but 
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not in bone marrow inocula. Bone marrow cells~ however, increased 
the size~ but not the number~ of foci appearing in the spleens of 
irradiated mice injected with thoracic duct lymphocytes and SRBC. 
The peak number of PFC in i~radiated mice injected with a mixture 
of thoracic duct lymphocytes and bone marrow cells was far greater 
than the sum of the PFC responses of mice injected with SRBC and 
I 
either thoracic duct cells or bone marrow cells. Three interpreta-
tions of this effect in the case of the thymus-marrow interaction have 
appeared in the literature: 
(1) The bone marrow, by promoting haemopoietic regeneration, 
may provide a more favourable environment for the proliferation and 
differentiation of PFC from their precursors in the thymus (or thoracic 
duct lymphocyte) inoculum. This interpretation has been favoured 
by Radovich et al. (1968). 
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(2} The thymus or bone marrow cells may repair an essential 
antigen-trapping or antigen-processing system in the spleen of the 
irradiated mouse and thereby impart a more effective stimulus to the 
PFC precursors in the other cell population (Miller and Mitchell, 
1967b}. The follicles and marginal zones of the spleen trap antigens 
(Nossal, Austin, Pye and Mitchell, 1966) and the lymphoid elements 
in these areas are destroyed by irradiation (Keuning, van der Meer, 
Niewenhuis and Oudendijk, 1963}. Bone marrow cells (Balner and 
Dersjant, 1964}, but not thymus cells (Bos, 1967}, repopulate these 
areas after irradiation. One would predict therefore that the thymus 
cells provide PFC precursors in the thymus-marrow interaction. 
(3} The other interpretation is that the bone marrow contributes 
PFC precursors which differentiate into PFC only in those splenic 
areas in which thymus (or thoracic duct} cells have lodged (Miller and 
Mitchell, 1967b}. 
Immunoserological techniques could not be used to test the 
various hypotheses since no synergism was obtained in the acute 
adoptive transfer system with combinations of semiallogeneic thoracic 
duct or thymus cells and bone marrow cells. Evidence for cell 
mice 
collaboration was obtained in irradiated/incubating mixtures of SRBC 
and thoracic duct and bone marrow cells from CBA and CBA/T6T6 
donors. Of 22 scorable mitotic figures, 17 carried the chromosome 
marker of the bone marrow cells (Nossal, Cunningham, Mite hell and 
Miller, 1968}. Even though the number of cells examined was very 
small, the result is in line with the interpretation that the bone marrow 
does provide PFC precursors. 
Unlike the situation in the acute restoration experiments, an 
interaction occurred between semiallogeneic cells in adult-thymectomized, 
irradiated mice injected with thoracic duct cells two weeks after bone 
marrow injection (Figure 22 and Table 18}. In every case in which 
an interaction was apparent, the use of specific isoantisera unequivocally 
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identified the bone marrow as the major source of PFC precursors. 
On two occasions., (CBA x C57BL)F 1 thoracic duct cells were not 
particularly effective in increasing the PFC response in irradiated., 
adult-thymectomized., syngeneic F 1 mice protected with CBA bone 
marrow (Table 18). The regeneration of the spleen may have been 
incomplete possibly as a result of the inhibited growth of parental 
bone marrow in irradiated F 1 hosts (McCulloch and Till., 1963, 
Cudkowicz., 1~65). In one of these experiments (expt. (1J., a single 
chimaera was injected with 100 million F 1 thoracic duct cells together 
with SRBC. The PFC response was increased to 65., 600 PFC per 
spleen. The PFC were inhibited by both anti-CBA and anti-C57BL 
sera and were therefore ofF type (unpublished observation). This 
that 1 
one mouse illustrates/the lymphocytes in the thoracic duct inocula 
used in expt. (1) were viable and that excellent adoptive immune 
responses can be obtained with huge numbers of thoracic duct lympho-
cytes. 
The thoracic duct lymph contains many FFC and it is conceivable 
that these are true ARC as defined by Kennedy. In the haemolytic 
focus assay they may react with antigenic determinants on SRBC by 
producing focal accumulations of a few progeny PFC. If this is the 
case., it is difficult to explain why bone marrow PFC precursors should 
be stimulated into antibody production only in the areas of the irradiated 
spleen in which ARC had settled. On the other hand., the small number 
of PFC within each focus produced by thoracic duct cells is readily 
explained by postulating that two cell types are present in duct lymph. 
One cell responds to antigen ("reactor cell")., initiates focus formation 
and influences PFC precursors (bone marrow derived) in its vicinity. 
The thoracic duct contains an abundance of" reactor cells" but a limited 
number of PFC precursors. An injection of bone marrow cells supple-
ments the number of PFC precursors in thoracic duct cell inocula, and 
these increase the size of each "active area" in the haemolytic focus 
assay after recruitment in the area of the activated" reactor cell". The 
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focus assay. would then be a measure of the number of "reactor cells" 
in a population provided PFC precursors were also available to allow 
the expression of" reactor cells" in terms of haemolysin production. 
Thymus cells and thoracic duct cells qualify for the title of 
"reactor cell". When injected into irradiated mice~ very few mitoses 
were detected 3 to 7 days later but the number at 3 to 5 days after 
irradiation was increased substantially by a simultaneous injection 
of SRBC (Figure 19). More mitotic figures per 2, 000 cells were 
detected in the spleens of irradiated mice injected with SRBC and 
10 million thoracic duct cells than in mice injected with SRBC and 
50 million thymus cells. The thoracic duct lymph may therefore 
contain more "reactor cells" per million cells. Alternatively, 
the progeny of stimulated thymus cells may be nonviable or may not 
increase, subsequent to antigenic stimulation, at the same rate as 
thoracic duct "reactor cells". It is clear in Figure 19 that dividing 
cells were still present in the spleens at 7 days after an injection of 
thoracic duct lymphocytes and SRBC. Very few mitotic figures were 
present in thymus-injected, irradiated mice at this time. This is 
in happy agreement with the PFC data. Thymus cells, unlike thoracic 
duct cells~ do not give rise to PFC in the spleens of irradiated mice 
challenged with SRBC (Table 14). Similar experiments with bone 
marrow cells are meaningless since the abundance of mitotic figures 
in spleens undergoing haemopoietic regeneration masks any difference 
in the behaviour of bone marrow cells in antigen-injected and non-
challenged irradiated mice. 
A;n early burst of mitosis in thymus graft-derived cells has 
been described by Leuchars et al. (1964) and Davies et al. (1966) in 
the spleens of SRBC-challenged, adult-thymectomized, irradiated 
mice, injected with bone marrow cells and grafted with a chromo-
somally-marked thymus. A similar response of thymus graft-derived 
cells occurred in the regional lymph nodes of thymus-grafted radiation 
i 
\ 
chimaeras after local applications of oxazolone (Gershon 1 Wallis 1 
Davies and Leuchars 1 1968). Coupled with the evidence that many 
of the thoracic duct lymphocytes are thymus cell descendants~ this 
data strongly suggests that the 11 reactor cells" in the thoracic duct 
are derived from the thymus. 
Thymus and thoracic duct cells greatly increased the anti-
SRBC PFC response in neonatally-thymectomized mice but this 
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effect was not mediated through the simple phenomenon of direct 
transformation into PFC. This deduction rests heavily on the failure 
of specific anti-C57BL serum to inhibit PFC in allogeneically- and 
semiallogeneically-reconstituted neonatally-thymectomized CBA mice. 
Perhaps the situation is different in neonatally-thymectomized CBA 
mice reconstituted with CBA thymus or thoracic duct lymphocytes. 
Results obtained by Nossal et al. (.i968) in a syngeneic CBA-CBA/T6T6 
system confirm1 in all respects~ the present results using immune-
serological techniques in an allogeneic system. Hence, the conclusions 
drawn from.the ·· latter system most -probably apply to the syngeneically-
reconstituted mouse as well. Whether they apply to the cellular 
events of the response to SRBC in normal CBA mice remains to be 
determined. 
Perhaps many of the PFC in.allogeneically-reconstituted mice 
were derived from the inoculated cells but were not expressing histo-
compatibility antigens of C57BL type. Celada and Klein (1967) used 
techniques of PFC inhibition very similar to those described here and 
demonstrated that all or part of both parental H2 complexes .. were 
present in heterozygous (A x A. CA)F 1 PFC. They concluded that total 
allelic exclusion or selective inactivation at loci concerned with the 
expression of H2 antigens did not occur in heterozygous immunocytes 
as has been proposed for codominant alleles at loci concerned with 
antibody synthesis (Pernis 1 Chiappino1 Kelus and Gell 1 1965). ill 
keeping with the results of Celada and Klein, anti-CBA and anti-C57BL 
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sera eliminated# or at least inhibited antibody secretion from, 
{CBA x C57BL)F 1 PFC {Table 8). Do these findings necessarily apply 
to F 1 cells in the presence of CBA cells? It is apparent in Table 15 
that F 1 thoracic duct cells~ when injected into heavily-irradiated mice 
gave rise to a small number of PFC which were inhibited by both 
antisera. F 1 cells can therefore be detected in the environment of an 
abundance of CBA cells. In view of this demonstration# one cannot 
seriously entertain the proposal that F 1 cells had lost part of the H2 
complex in the neonatally-thymectomized CBA mouse. Such a proposal 
must infer a complete loss of all H2 complexes in those experiments in 
which C57BL lymphoid cells enhanced the PFC response in neonatally-
thymectomized CBA hosts. Complete suppression of antigens of the 
type determined by the H2 locus has not been recorded (Hellstrllm and 
Moller# 1965). 
The inoculated F 1 and allogeneic lymphoid cells may have induced 
a host-versus-graft reaction# which in the presence of SRBC# enabled 
host precursors to proliferate and mature into PFC. However# 
neonatally-thymectomized CBA mice were unable to reject C57BL skin 
grafts and irradiated F 1 thoracic duct cells did not restore the PFC 
response to SRBC. Furthermore# reconstitution was effected with 
syngeneic inocula in which case no histo-immunological stimulus would 
have been experienced by the host cells. 
Since host cells were responsible for antibody production in recon-
stituted thymectomized mice# it becomes important to test other inocula 
for their capacity to influence the responsiveness of the host. Non-
cellular inocula have been shown to partially abrogate the immuno-
suppressive effects of x-irradiation presumably by means of promoting 
recovery in# or affording protection to# host cells (Jaroslow and 
Taliaferro~ 1956; Jaroslow # 1960). Bergland {1965) and Braun and 
Nakano {1965) also reported an enhancing effect of oligodeoxyribonucleotides 
from thymus DNA~ spleen homogenates# and nuclei of thymus cells# in 
j 
I 
j. 
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the haemolysin response of rats and mice to SRBC. Large numbers 
of heavily-irradiated thymus and thoracic duct cells failed to elevate 
the peak number of PFC in neonatally-thymectomized mice injected 
with SRBC (Table 10}. Similar results have been reported using 
irradiated thymus cells in the ihymus -marrow interaction (Claman et al. ~ b -----
1966l; Cheng and Trentin1 1967b}. Yeast cells~ thymus extracts, and 
bone marrow cells were also ineffective in the present system. 
The controls suggest that the response of thymectomized mice 
cannot be increased simply by injecting large numbers of cells and that 
intact and viable lymphoid cells~ capable of cell division, are required 
for successful reconstitution. This latter point derives from the 
ascertion that " ••• the essential lesion produced by doses of X-rays 
in the range of 500 - 2 000 r is an impairment in the capacity for cell 
division" (Kaplan~ 1966}. It remains an open question1 however, 
whether the extreme radiation sensitivity of lymphocytes is a reflection 
of a direct effect of X-rays or whether it is a manifestation of cell death 
at mitosis. 
Human and guinea pig thymus cells were totally inactive in the 
reconstitution experiments and yet allogeneic thymus cells were most 
efficacious. Might not thymus cells from xenogeneic donors, not too 
distantly removed from the mouse in a genetic sense, result in a 
moderate number of PFC? As seen in Table 10, 100 million rat thymus 
cells significantly increased the PFC response in neonatally-thymectomized 
CBA mice~ albeit slightly. Anti-CBA serum inhibited the PFC in the 
spleens (unpublished observation} but no specific antirat serum was 
available to confirm that the PFC were not derived from rat thymus 
cells. 
The most satisfactory control preparation in this and related 
systems would seem to be an inoculum of cells from tolerant donors. 
In the experiments of Gowans and his colleagues (Section IB} ~ thoracic 
duct small lymphocytes increased the anti-SRBC haemolysin response 
in lethally- and sublethally-irradiated rats. Lymphocytes from fully 
tolerant donors were totally ineffective and were indeed less active 
than an injection of yeast extract in sublethally-irradiated rats 
(McGregor et al. ~ 1967}. This finding provides cogent proof that 
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the response of the irradiated host is not solely responsible for antibody 
production in lymphocyte-injected rats and~ by inference~ the lymphocytes 
from normal rats must be immunologically active. Tolerance in the 
rats was induced with multiple injections of SRBC~ the injections commen-
cing early in life. This method of tolerance induction is unsatisfactory 
in CBA mice (Miller~· J. F. A. P. ~ personal communication}. 
Dietrich and Dukor (1967}~ Aisenberg {1967} and Aisenberg and 
Davis {1968) demonstrated that mice injected with both SRBC and 
cyclophosphamide failed to respond~ by producing specific antibodies~ 
when subsequently injected with SRBC. Control mice~ injected with 
cyclophosphamide only~ recovered rapidly from the nonspecific drug-
induced suppression of immunological responsiveness. This method 
of tolerance induction was employed in experiments addressed to the 
question of whether lymphoid inocula increase the PFC response in 
neonatally-thymectomized mice in a nonspecific manner. 
The results of the reconstitution experiments using "tolerant 
lymphocytes" {Tables 11 and 12) may be summarized as follows:-
{1} The difference in the SRBC responsiveness of tolerant and 
nontolerant mice was particularly striking. 
{2) Tolerance was quite specific in that both SRBC-tolerant 
and nontolerant mice responded equally well to horse erythrocytes 
{HRBC). 
(3} Thoracic duct cells from SRBC -tolerant mice were as 
effective as cells from nontolerant mice in adoptively transferring 
HRBC responsiveness to neonatally-thymectomized mice but were far 
less effective in adoptively transferring SRBC responsiveness. 
(4) Thoracic duct cells from SRBC -tolerant mice were 
effective in significantly elevating the response of neonatally-
thymectomized mice to SRBC. 
The latter finding requires an explanation. Tolerance in 
the donors was by no means complete (c. f. McGregor et al., 1967) 
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and an unpublished observation is pertinent to the present discussion. 
On one occasion, six mice treated with SRBC-cyclo were cannulated, 
the lymphocytes pooled and injected into neonatally-thymectomized 
mice together with SRBC. The PFC responses in the recipients were 
markedly elevated and no thymus remnants were evident macroscopi-
cally. When the 6 donors were challenged with SRBC, one was found 
to have a normal splenic PFC response. The inoculum had been con-
taminated by thoracic duct lymphocytes from a single nontolerant 
mouse and the small number of cells was sufficient to effect a response 
of considerable magnitude in the thymectomized recipients. In no 
experiment was a difference recorded in the number of lymphocytes 
emerging from the thoracic duct of tolerant and nontolerant mice. The 
results suggest that only a few "nontolerant lymphocytes", in the presence 
of many "tolerant lymphocytes", are required in the inoculum in order 
to increase the SRBC responsiveness of neonatally-thymectomized mice. 
The failure of normal thoracic duct and spleen cells to effectively 
break tolerance and increase the response of tolerant mice to normal 
levels might, at first sight, tend not to support the aforementioned 
suggestion. "Nontolerant lymphocytes" would presumably be harboured 
in company with "tolerant lymphocytes" in the lymphoid tissues. It is 
not known, however, whether the inoculated spleen or thoracic duct 
cells homed to the spleen of the tolerant hosts there to be triggered 
by antigen. The tolerant mice, unlike neonatally-thymectomized mice1 
are not deficient in thoracic duct lymphocytes and the injected cells 
may have been unable to penetrate to sites where antigenic stimulation 
is presumed to occur. 
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It was not anticipated that 40 million spleen and thoracic 
duct-marrow cells would behave so erratically in tolerant hosts. 
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Such inocula could be expected to contain large numbers of both "reactor 
cells" and PFC precursors. 7S antibodies have been shown to inhibit 
the 19S PFC response to SRBC (Henry and Jerne. 1968; Uhr and Maller. 
1968). No haemagglutinating antibodies were detected in the sera of 
10 SRBC-cyclo treated mice prior to injections of spleen cells and 
SRBC (unpublished observation). 
The numerous unknown factors do not encourage an exhaustive 
discussion on the nature of the lesion of tolerance in SRBC-cyclo 
treated mice. There is. however. some evidence in this model that 
the thoracic duct lymphocytes may not be the only cells affected by 
tolerance induction. No information is available concerning the 
operation of extracellular mechanisms (Eisen and Karush. 1964; 
Hemphill. Segre and Myers. 1966) and the involvement of macrophages 
(e. g. Nachtigal. Greenberg and Feldman. 1968) in the maintenance of 
tolerance in this system. Interestingly. there is one report that 
normal rat thoracic duct cells are unable to break tolerance to SRBC 
in situations where mixtures of thoracic duct lymphocytes and peri-
toneal macrophages are quite successful (McCullagh. 1968). Moreover. 
Gallily and Feldman (1967) and Feldman and Gallily (1967) have clearly 
demonstrated that macrophages are involved in the adoptive antibody 
response to Shigella antigens in heavily-irradiated mice. 
It might be suggested that inducing a response to HRBC would 
elevate the SRBC -responsiveness of neonatally-thymectomized mice 
injected with lymphocytes from SRBC-tolerant mice. Four experiments 
were performed to test this hypothesis. The mean SRBC-PFC response 
of 17 neonatally-thymectomized mice injected with "SRBC-tolerant 
lymphocytes" and both SRBC and HRBC was increased above that in 
recipients challenged with SRBC only. The increase. however. was 
not significant. Moreover in the SRBC-tolerant mice. an injection of 
both SRBC and HRBC did not break tolerance to SRBC even though a 
normal PFC response to HRBC occurred. Control mice~ treated 
with cyclo only~ produced fewer PFC to SRBC when injected simul-
taneously with HRBC. The phenomenon of antigenic competition 
may have contributed to this observ~tion as has been inferred from 
the comparable effect of injecting SRBC and HRBC into normal mice 
(Radovich and Talmage~ 1967). 
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Thymus cells were as effective as thoracic duct cells in elevating 
the PFC response to SRBC in neonatally-thymectomized mice. This 
finding contrasts with the results. of many previous studies on the 
immunological activity of thymus cells (Section IC). In addition~ 
large numbers of thymus cells were unable to significantly increase the 
responsiveness of thymectomized radiation chimaeras challenged with 
SRBC two weeks after irradiation and marrow protection. Thoracic 
duct lymphocytes were most effective. in such hosts. It is highly 
improbable that the presence of'' contaminant'' circulating lymphocytes 
accounted for the effects observed with 10 and 50 million thymus cells 
in neonatally-thymectomized mice. Thus 1. 5 million thoracic duct 
cells (equivalent to a contamination level of 15o/o) produced by no means 
as great an effect as 10 million thymus cells. 
The spleens of 3 to 5 weeks old neonatally-thymectomized mice 
contained more nucleated cells than those of the radiation chimaeras 
and the spleens were visibly larger. The difference in spleen size 
was particularly noticeable at the time the mice were killed for the PFC 
assays. Since thymus cells home to the spleen in large numbers 
(Section IAL the enlarged spleen may trap and recruit more of the 
injected thymus cells. Thus contention is not supported by the results 
of more recent experiments. Cr 51 -labelled thymus cells were injected 
into groups of neonatally-thymectomized mice and thymectomized 
radiation chimaeras. The average percentage of recoverable radioactivity 
~ ) 
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in the spleens of neonatally-thymectomized mice at 4 and 24 hours 
after thymus cell injection was not increased above that in the spleens 
of the chimaeras. 
One suggestion which would resolve this dilemma is that thoracic 
duct cell inocula differ from thymus cell inocula in that they contain 
cells which repair a radiosensitive and essential antigen-processing 
system in irradiated mice. This cell system would presumably be 
present in the spleens of neonatally thymectomized mice. With the 
assumption that the antigen-processing cell compartment is thymus 
independent, one would expect regeneration of this system to be com-
plete in thymectomized radiation chimaeras at 6 weeks after irradiation 
and marrow protection. This time point coincides with the complete 
recovery of PFC responsiveness in nonthymectomized radiation 
chimaeras. At both 4 and 6 weeks after irradiation~ however~ thymus 
cells were inferior to thoracic duct lymphocytes in adoptively trans-
ferring SRBC responsiveness (Table 17). The underlying reason for 
the disparity of thymus cell behaviour in the two host types must 
remain unknown but will be raised again later in this discussion. 
The statement " ... thymus cells were as effective as thoracic 
duct cells ... :' applies only to the peak PFC response in reconstituted 
neonatally-thymectomized mice. It is evident in Figure 18 that the 
PFC number remained elevated in mice given thoracic duct cells at 
a time when the number in thymus-injected mice had fallen. This 
may reflect either a longer life span of PFC or continued recruitment 
of "reactor cells" or PFC precursors in: the spleens of thoracic duct 
cell recipients. Rat thymus and thoracic duct lymphocytes differ in 
their capacity to recirculate and in the present system~ the thoracic duct 
cells may have been recruited into the spleen, to initiate antibody 
production in host cells, for a longer period of time after antigen 
challenge. At variance with this conclusion is the finding that effective 
antigenic stimulation, in irradiated rats at least, is much reduced after 
the first 24 hours following 8RBC injection (Ford, 1968). 78 PFC 
analyses at later time points after thymus and thoracic duct cell 
injections into neonatally-thymectomized mice may be particularly 
illuminating. The elevated number of 198 PFC may be a result of 
a lack of inhibitory 78 antibody in the serum or. less conceivably. a 
failure of 198 PFC to convert to 78 PFC. 
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The results of several recent experiments have been interpreted 
in terms of cellular interactions in haemolysin production. A "premium 
effect" of large cell inocula in irradiated recipients was described by 
Celada (1967) in the adoptive secondary response to human serum 
albumin. Gregory and Lajtha (1968) observed a similar phenomenon 
using both the PFC assay and the haemolytic focus assay in the adoptive 
immune response to 8RBC in irradiated mice. The number of haemo-
lytic foci in the spleens of irradiated recipiEnts of spleen cells and 
8RBC was linearly related to the number of spleen cells injected,· 
the line of best fit having a slope of one. By contrast. the peak PFC 
· response. measured over a higher cell dose range. increased allo-
metrically with graft size. Of much interest is the statement in dis-
cussion that bone marrow cells produced a low but increasing number 
order 
of PFC with increasing cell dose. No evidence of a 2nd/interaction 
was reported to have been obtained with bone marrow cells. These 
authors concluded that the production of PFC from their precursors in 
the spleen could be explained in terms of a cellular cooperative process. 
Mosier and Coppleson (1968) have presented data which they 
believe is suggestive of a three cell interaction in the primary immune 
response to 8RBC in vitro. By using various numbers of fractionated 
and unfractionated spleen cells. they were able to construct log cell 
dose - log PFC response plots and measure the slope of the regression 
line. In cultures of spleen cells the slope of the line approached 3. 0. 
Taking advantage of the property of differential cell adherence to glass. 
two fractions of spleen cells were prepared. Various doses of non-
adherent cells were added to cultures containing a fixed number of 
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adherent cells and the slope of the dose ... response regression line was 
found to approximate 2. 0. Mosier and Coppleson concluded that 2~ 
if not 3~ cells were interacting in the in vitro immune response to 
SRBC. One of these cell types was probably a macrophage. The 
data published indicates that the number of PFC per culture was <100 
in most cases and thus much less than the responses obtained by 
Mishell and Dutton (1967) in an identical in vitro system. The conclu-
sions of Mosier and Coppleson are therefore based on very few PFC 
obtained in a system which is capable of promoting much higher PFC 
responses in isolated spleen cells. Furthermore, a time course 
study was not performed and only the 4 day PFC response was examined. 
The interpretations of these two sets of data, as well as those 
of the putative thoracic duct-marrow. and thymus-marrow cell interactions, 
may be altered by the recent work of Henry and Jerne (1968). Purified 
19S haemolysins; with immunological specificity rather than species 
specificity, have been shown to enhance the PFC response at certain 
concentrations. A positive feedback influence of 19S antibody may 
accelerate the generation of PFC from their precursors or effect the 
recruitment of more "reactor cells" or PFC precursors. As this 
effect is a dose dependent phenomenon, a threshold amount of 19S 
antibody (secreted by a certain number of PFC) may be required before 
increased numbers of PFC are produced (vide infra). 
What then is the nature of the interaction between thymus or 
thoracic duct lymphocytes (a number of which are probably thymus 
. cell descendants) and bone marrow-derived cells in the production of 
19S haemolysins in reconstituted CBA mice ? A number of possibilities 
will be discussed in succeeding paragraphs. 
Perhaps the interaction is more apparent than real, the lympho-
cytes acting as trephocytes (Section IA) which simply provide nutrient 
or precursor substances to the cells of the bone marrow cell line. 
Experimental results militating against the validity of this conclusion 
are ( 1) the negligible reconstitutive activity of irradiated thymus 
and ,thoracic duct cells. bone marrow cells. thymus extracts. yeast 
cells and xenogeneic thymus cells. and (2) the reduced efficacy of 
lymphocytes from specifically tolerant donors in the reconstituted 
neonatally-thymectomized mouse system. 
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Perhaps antigen -stimulated.thymus -derived cells manufacture 
and release substances which influence the differentiation of bone 
marrow-derived cells. The embryonic pancreas contains two sepa-
rable populations of cells; one is peripherally located in explants 
and incorporates tritiated thymidine. This proliferating population 
is essential for differentiation of cells. at the centre of the explant. 
into zymogen-producing cells (Bernfield and Fell. 1967). The nature 
of the influence of one cell type on the other remains to be determined. 
Thymus-derived. proliferating cells may elaborate nonspecific pharma-
cologically-active substances (Burnet. 1968a, b) akin to those associa-
ted with the various and diverse manifestations of delayed hypersensi-
tivity reactions in vivo and in vitro (Humphrey. 1967 # Lawrence# 1967). 
Several years ago. Dutton and Harris (1963) produced evidence 
that substances liberated by irradiated or nonirradiated spleen cells 
from primed rabbits. exposed momentari'ly to antigen in vitro. stimu-
lated DNA synthesis in nonir:vadiated unprimed spleen cells. Simple 
saline extracts of thymus do not substitute for thymus cells in the recon-
stituted thymectomized mouse system or the thymus-marrow system of 
Claman et al. (1968). Nevertheless. the possibility must be seriously 
entertained that proliferating. antigen-activated. thymus -derived 
lymphocytes produce nonspecific substances with adjuvant-like properties. 
There are two findings in the present series which are relevant to this 
point. Firstly. in the two host system. in which thymus cells were 
stimulat~d with heterologous erythrocytes and the spleens of the mice 
transferred to secondary irradiated hosts together with bone marrow 
cells. the homologous erythrocytes had to be given to the first host 
before a significant response occurred to that erythrocyte type in the 
second host (Figure 17 and Table 6). Secondly~ and more cogently~ 
a simuitaneous injection of SRBC and HRBC did not significantly 
elevate the PFC response in neonatally-thymectomized mice injected 
with "tolerant lymphocytes" above that obtained with SRBC only. 
Numerous HRBC "reactor cells" could be expected to be present in 
the inoculum since the anti-HRBC PFC response in the hosts was 
markedly increased. Any factor elaborated by thymus-derived cells 
responding to HRBC should have been available to nonspecifically 
induce anti -SRBC ~EE1C production in bone marrow-derived cells. 
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Perhaps thymus -derived lymphocytes elaborate specific 
inducer factors after interaction with erythrocyte antigens. The 
possible candidates include RNA (Fishman and Adler~ 1963; Gottlieb, 
Glisin and Doty~ 1967; Mosier and Cohen~ 1968), RNA-antigen com-
plexes (Askonas and Rhodes~ 1965; Friedman~ Stavitsky and Solomon~ 
1965; Fishman and Adler~ 1967; Pinchuck~ Fishman, Adler and 
Maurer, 1968L and far more speculatively, episomic genetic ele-
ments (Jacob, 1960) or "viral antibodies" (Smithies, 1965). The 
RNA-antigen complex may have inducer properties or the RNA may 
behave as an adjuvant, the complex then acting as a .. "superantigen". 
The macrophage has been implicated in the processing or presenta-
tion of antigen and in the production of informational low molecular 
weight RNA. The above speculation may therefore be extended to 
a consideration of whether thymus-derived lymphocytes have macro-
phage-like properties. 
On the basis of the observed histological consequences of 
cortisol ·:administration and the patterns of H3 thymidine incorporation 
into lymphocytes in various anatomical localities, Craddock, Winkel-
stein, Matsuyuki and Lawrence (1967a, b) have proposed that thymus 
and marrow lymphocytes are short-lived macrophage precursors. 
Many years earlier~ Trowell (1958) had suggested that lymph-borne 
lymphocytes were "pocket macrophages" and many morphologists 
have long contested that lymphocytes transform into macrophages in 
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sites of inflammation (e. g. Rebuck, 1947). Autoradiographic studies 
have established the bone marrow as the primary source of macrophage 
precursors (Spector, Walter.rand Willoughby, 1965; Volkman and 
Gowans, 1965a, b; Volkman, 1966; van Furth and Cohn, 1968). Viro-
lainen (1968) used a culture system which preferentially stimulated the 
growth and proliferation of macrophages in vitro and was unable to 
demonstrate macrophage precursors in the thymus or lymph nodes. 
The donors of the cultured cells were syngeneic radiation chimaeras 
injected with chromosomally-marked haemopoietic cells and lymphoid 
cells from various sources. 
In radiation chimaeras subjected to intensive stimulation of the 
reticuloendothelial system, and in the GVH reaction, some dividing 
liver macrophages may be derived from thoracic duct lymphocyte 
inocula (Boak, Christie, Ford and Howard, 1968). It would seem, 
therefore, that cells of lymphocyte morphology may under certain 
circumstances behave as macrophage precursors. The conclusion 
that macrophages derive from long-lived recirculating small lympho-
cytes cannot be justified of the basis of the findings of the Edinburgh 
group. The thoracic duct lymph of rats and mice may contain a variety 
of morphological cell types (e. g. Braunsteiner, H5fer and Sailer, 1961; 
Marchesi and Gowans, 1964; Morse and 
Riester, 1967), some of which may be phagocytic (Spector, W. G., 
personal communication). Thymus lymphocytes have not been shown 
to transform into macrophages and neonatally-thymectomized rats and 
mice are certainly not lacking in macrophages (Miller and Howard, 1964; 
Corsi and Giusti, 1967b). Nevertheless, the possibility cannot be 
discounted that a subclass of macrophages is absent in thymectomized 
animals. 
Bone marrow cells do not respond, by producing PFC, when 
injected together with large numbers of SRBC into irradiated mice 
(Table 14; Claman et al., 1966a, b; Shearer, Cudkowicz, Connell and 
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Priore~ 1968). Likewise~ neonatally thymectomized CBA mice do 
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not produce more PFC to 10 SRBC than to 10 SRBC {Table 12). 
Hence, large antigen doses do not obviate the requirement for thymus 
or thoracic duct lymphocytes in these two systems. The opposite 
conclusion was reached in the recent study of Sinclair and Elliott {1968b) 
in which neonatally-thymectomized~ sham-operated, and normal Swiss 
mice were challenged with 104 to109 SRBC. The peak titres and kinetics 
of 7S and 19S haemolysin production in young neonatally-thymectomized 
mice injected with 109 SRBC were similar to those in sham-operated 
mice injected with 10 7 SRBC. Neonatally-thymectomized Swiss mice 
were essentially unable to respond to 10 7 SRBC by producing antibodies. 
Direct comparisons between the results of Sinclair and Elliott 
and those presented here are not strictly possible since nothing is known 
of the cellular events of PFC production, or the number of PFC~ in 
Swiss mice injected with SRBC. It is possible that neonatally-thymecto-
mized Swiss mice do not have as severe a deficiency in" reactor cells" 
as do their CBA counterparts. Increasing the dose of SRBC may effect 
the triggering of more of these cells and thus increase the opportunity 
of collaboration between "reactor cells" and PFC precursors. The 
1, 000 to 3, 000 PFC in the spleen of the neonatally-thymectomized CBA · 
mouse may reflect maximal recruitment of the few available "reactor 
cells". The results were quite clear cut in the case of the acute 
adoptive response to SRBC·in irradiated mice injected with bone marrow 
cells. This cell population contains PFC precursors yet enormous 
numbers of SRBC did not stimulate any differentiation into PFC. If 
the PFC precursors in the bone marrow-derived cell population have no 
antigenic reactivity and have an essentially passive role to play in the 
interaction with thymus-derived cells, then the latter must be the more 
likely targets for tolerance induction and the more likely candidate for 
the carriage of specific immunological memory. 
It has been shown that the phenomena of tolerance and immuno-
logical memory are associated with the thoracic duct lymphocyte popu-
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lation in some antigenic systems (McGregor et al. ~ 1967; Gowans 
and Uhr~ 1966; Table 12). Smith~ Isakovic and Waksman (1966) 
were able to demonstrate an accentuated delay in the development of 
BSA responsiveness in adult-thymectomized~ irradiated rats injected 
with bone marrow and grafted with thymus from BSA-tblerant rats. 
Similar results using ByG were obtained by injecting the shielded 
thymus of irradiated rats with the specific antigen, but not by injec-
ting ByG intraperitoneally or intrasplenically (Staples, Gery and 
Waksman, 1966; Horiuchi and Waksman, 1968). It is not known 
whether tolerance was induced in the thymus lymphocyte population 
which was destined to peripheralise, or whether "low zone" tolero-
genic levels of antigen were liberated from the thymus which tempo-
rarily induced tolerance in the regenerating population of peripheral 
cells. 
Further experiments suggest that thymus graft-derived cells 
can be made unresponsive by antigen treatment. Gershon et al. (1968) 
used adult-thymectomized, irradiated, marrow pr<;>tected mice implan-
ted with a chromosomally-marked thymus graft and induced varying 
degrees of unresponsiveness to SRBC by multiple antigen injections 
during the immediate postirradiation period. They recorded a reduced 
mitotic response of thymus-graft derived cells in the spleen and lymph 
nodes after challenge with either SRBC or human RBC but a normal 
mitotic burst after oxazolone. The failure to elicit a mitotic response 
to human RBC does not indicate that the thymus graft-derived cells 
had been nonspecifically inactivated. Gershon et al. did not report 
data on the antibody response to human RBC and it is therefore not 
known whether cross tolerance to human RBC had been induced by the 
repeated injections of SRBC. 
Results pertaining to the susceptibility of thymus cells to 
tolerance induction have recently appeared. Taylor (1968) has reported 
that thymus and marrow cells interact in the immune response to BSA in 
irradiated mice. Thymus cells taken from mice injected with BSA 
24 hours previously did not collaborate with normal bone marrow in 
the production of antibodies. By contrast. antigen administration 
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to the donor mice did not affect the ability of marrow cells to interact 
with normal thymus cells. No data has been presented. however. and 
specificity control have not been included. It would be of interest to 
know whether thymus cells from mice injected with other heterologous 
serum proteins are able to collaborate with bone marrow cells in the 
production of anti-BSA antibodies. In the present series. thymus cells 
taken from mice challenged 24 hours previously with either SRBC or 
HRBC were quite capable of elevating the PFC response to SRBC in 
neonatally-thymectomized mice (unpublished observation). If BSA 
does induce specific immunological tolerance in the thymus lympho-
cyte population. then the difference in the two results may be related 
to differences in the penetrability of antigens into the thymus. 
Despite the apparent negative SRBC reactivity of bone marrow 
cells mentioned above, it is likely that the bone marrow .. derived cell 
is competent to respond to antigenic determinants. This conclusion 
stems from the numerous demonstrations that the absence of the thymus 
does not affect the humoral antibody response to many antigens. In 
view of the complexity of the SRBC 11 antigen" it might be anticipated 
that. after parenteral injection. many antigenic determinants are 
presented to the reactive cells with or without the intervention of 
macrophages. Studies with chemically-defined hapten-carrier com-
plexes in delayed sensitivity reactions and antibody production have 
indicated that the recognition of two or more antigenic determinants is 
involved. perhaps simultaneously. in the elicitation of a measurable 
response to a single determinant. Tolerance or genetically-based 
unresponsiveness to the protein or aoligopeptide carrier will inhibit 
a response to the hapten. The elicitation of secondary responses 
in vivo. or in lymphoid populations in vitro. requires the presence of 
the same carrier as was used in the primary stimulus. The "carrier 
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effect" is not absolute, however, and by increasing the concentration of 
hapten conjugated to nonhomologous carriers, the so-called "carrier 
specificity" may be overcome (e. g. Mitchison, 1967; Rajewsky and 
Rottlander, 1967; Benacerraf~ Green and Paul, 1967). 
As might be expected (Nossal1 1962 ), individual antibody-
forming cells do not produce antibodies against both carrier and hapten 
(Green, Vassalli, Nussenzweig and Benacerraf, 1967). This finding, 
and the results of Mitchison (1967), favour the notion that antigenic 
determinants in hapten-carrier conjugates are not regionally associated 
in the sense that recognition of the carrier need not necessarily involve 
a region of the protein molecule adjacent to the hapten. The diagrams 
of Levine (1965), do infer that the local environment of the hapten is all 
important in the expression of the "carrier effect". The one cell -
one basic receptor - one antibody dogma in antibody production insists 
that one must invoke the participation of at least two different cells 
in the recognition of the haptenic determinant and the carrier deter-
minants. Mitchison tentatively suggested that the macrophage was 
the cell type responsible for the absorption, if nat the recognition, of 
carrier protein, and hence the presentation of determinants to target 
hapten-reactive cells. In the system of Schierman and McBride (1967), 
chicken erythrocyte A 2 isoantigens were nonimmunogenic but when 
coupled with B 3 antigens, on the same erythrocytes, anti-A2 antibodies 
were produced. This finding suggests that a "carrier effect" may be 
involved in the immune response to determinants on foreign erythrocytes. 
The complicity of thymus-derived lymphocytes in the mediation 
of the "carrier effect" must. now be considered. All the evidence in the 
present series of experiments is in accord with the hypothesis that 
thymus-derived lymphocytes respond to antigenic determinants on SRBC 
other than those directly involved with haemolysin production. Thymus-
derived cells may therefore be carrier-reactive cells. The only 
satisfactory hypothesis which relates the excessive lymphopoietic activity 
of the thymus to the evidence that many lymphocytes die within the organ, 
is that cells with restricted reactivity patterns are generated and 
screened within the thymus (Section IC}. The 11 carrier effect" hypo-
thesis in the present system must therefore ascribe unispecific 
reactivity to both thymus -derived and bone marrow-derived cells and 
these two cell types must come into close association within lymphoid 
organs. 
Bretscher and Cohn (1968} have pointed out that it is difficult 
to conceive of the mechanism whereby two rare cells are focussed 
into close proximity in the presence of antigen. This as a conceptual 
difficulty must not go unchallenged. Young and Friedman (1966} 
demonstrated that early 19S PFC were associated with the white pulp 
in the spleen and suggested that they originated in follicles and 
germinal centres. If this is so then it tends to support the contentions 
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of Bretscher and Cohn. Large-scale migration of circulating lympho-
cytes through lymphoid follicles does not occur (Gowans and Knight. 
1964; Austin, 1968) and these antigen-containing sites (e. g. Nossal. 
Ada and Austin. 1964)'1 would not accommodate or promote a sufficient 
number of contacts between rare cells. More recently. Fitch and 
Rowley (1967) and Fitch. Stejskal and Rowley (1969) have demonstrated 
that PFC are not associated with lymphoid follicles and germinal 
centres and that PFC first appear in the marginal zones and periarte-
riolar lymphocyte sheaths. Germinal centres and lymphoid follicles 
may harbour haemolysins later in the response since in the papers of 
Young and Friedman (1966) and Bergland. Markey and Mergenhagen 
(1967) many haemolytic foci were present in the spleen at a time when 
19S PFC were almost undetectable. 
The peliarteriolar lymphocyte sheaths and marginal zones are 
sites of extensive cell migration (Section IA). Furthermore. the early 
burst of mitosis in thymus-derived cells may increase the number of 
specific carrier-reactive cells in the system. Both mechanisms would 
then providetre means of increasing the probability of contact between 
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the postulated carrier-reactive cell and the hapten-reactive cell. 
Moreover, it is likely that many of the multitude of antigenic deter-
minants on heterologous erythrocytes behave as carrier molecules. 
Hence, considerable numbers of clonally-individuated, thymus-derived, 
carrier-reactive cells may be involved in the presentation of haptenic 
determinants to bone marrow-derived PFC precursors. 
Bretscher and Cohn have retained the attractive idea that both 
carrier-reactive and hapten-reactive cells are unispecific in their 
antigenic reactivity. To overcome what they consider is the unlikely 
event of two rare cells coming into close anatomical association, these 
authors have proposed that certain cells passively absorb (preformed ? } 
carrier antibody molecules. These molecules by combining with the 
carrier portion of the antigenic molecule, present the hapten-reactive 
cell with exposed and suitably-oriented haptenic determinants. They 
further postulate that the presentation of the hapten is such that recep-
tors on the hapten-reactive cell are stretched. This physical distur-
bance at the cell surface presumably constitutes hapten recognition 
and the initial step in the process of cellular act·ivation which ultimately 
results in antibody production. 
The extended hypothesis of Bretscher and Cohn might infer that 
thymus-derived cells passively absorb carrier antibodies. This then 
clearly warrants a closer look at the report of Henry and Jerne ( 1968}. 
As mentioned previously, the work of this group indicates that immu-
nologically-specific, 198 haemolysin-containing preparations have 
positive feedback properties in haemolysin production. Might not 
the purified macroglobulin preparation of Henry and Jerne contain 
carrier antibodies ? Alternatively, is it not conceivable that thymus-
derived cells absorb 19S haemolysin molecules themselves which, in 
combination with the specific antigenic determinants and the carrier 
receptors on the thymus-derived cell, present, distort, or expose 
other hidden determinants to the target bone marrow-derived PFC 
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precursors? Henry and Jerne considered this possibility but adjudged 
the property of antibody absorption to be within the gamut of macro-
phage activity. 
It is equally conceivable that the enhancing effect of 198 haemo-
lysins in PFC production is simply to promote disintegration (e. g. 
Litt, 1967) or opsonization of foreign erythrocytes (e. g. Jenkin and 
Rowley, 1961). The uptake of erythrocyte antigenic material into 
macrophages may be a necessary prerequisite for the induction of 
the cellular events of haemolysin production (Ford et al., 1966). If 
this is the only function of 198 haemolysins in the system of Henry 
and Jerne, it might be anticipated that the increased number of PFC 
should be detected early in the response to 8RBC. This does not seem 
to be the case and increased numbers of PFC are only apparent at 
the peak of the response. Perhaps another cell type (e. g. thymus-
derived cell) is required in sufficient numbers before 198 haemolysins 
become operative in promoting PFC production. 
One interesting feature of the efficacy of thymus lymphocytes 
in the present study, is that the cells are only effective in hosts which 
are themselves capable of mounting a significant PFC response to 
8RBC. Mice treated with antilymphocyte serum (Martin and Miller, 
1968a), neonatally thymectomized mice, and well-established thy-
mectomized radiation chimaeras, produce PFC in the spleen after a 
primary injection of 8RBC and thymus cells further increase this response. 
By contrast, newly-established thymectomized radiation chimaeras do 
not respond to 8RBC by producing PFC and thymus cells, unlike 
thoracic duct cells, are virtually without effect in the adoptive transfer 
of 8RBC responsiveness. A certain titre of early 198 haemolysins 
(and thus a certain number of PFC) may be required in the system before 
significantl\ levels are absorbed onto thymus-derived "reactor cells 11 • 
In this situation the passively absorbed antibody may be in a position to 
expose or focus antigenic determinants onto other PFC precursors. 
Thoracic duct lymphocyte inocula are able to produce PF C 
in the spleens of irradiated mice. The PFC precursors in the 
thoracic duct lymph may be differentiated to the extent that they do 
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not require the influence of "reactor cells" to produce progeny PFC. 
Thoracic duct lymphocyte-derived PFC in thymectomized radiation 
chimaeras cannot be detected in the presence of abundant numbers of 
bone marrow-derived PFC. Nevertheless. thoracic duct cell inocula, 
unlike thymus cell inocula. may provide the necessary amount of early 
19S haemolysin to cascade the response mediated by "reactor cells" 
and bone marrow-derived PFC precursors. 
There is one interpretation of the thymus-marrow cell inter-
action which does not invoke information transfer between cells and 
which embraces the following facts and suggestions: 
(1} 19S haemolysins are required before it is possible to 
achieve the full expression of the interaction between thymus-derived 
"reactor cells" and bone marrow-derived PFC precursors. 
(2} A "carrier effect" is involved in the immune response to 
erythrocyte antigens. 
(3} The probability of contact between unispecific reactive 
cells is slight. 
(4} Specific tolerance can be induced in thymus or thymus-
derived "reactor cells". 
(5} The thymus is more intimately concerned with cell-
mediated immunities. 
(6} There is no evidence whatsoever that thymus or thymus-
derived cells secrete any known intact immunoglobulin molecule with 
antibody activity. 
This hypothesis is that thymus-derived cells are carrier-reactive cells 
in their own right and bear recognition units on their surface which are 
an expression of gene action within the cell. In the latent period of 
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the haemolysin response, some highly differentiated bone marrow-
derived PFC precursors in the spleen and/ or the circulating pool respond 
to the appropriate determinants and produce a small number of PFC. 
Alternatively, a "carrier effect" may be responsible for the production 
of relatively few PFC in the spleen in this period. During the expo-
nential phase of the response, activated thymus-derived cells passively 
absorb early 198 haemolysins and, following combination with antigen 
molecules, focus antigenic determinants onto other PFC precursors. 
If point (3) above is invalid, and if the positive feedback 
influence of 198 haemolysins is mediated by antigen-processing macro-
phages, it is most likely that a "carrier effect" is solely responsible 
for haemolysin production in combinations of thymus-derived and bone 
marrow-derived cells. The latter hypothesis has merits of simplicity 
and is all the more credible if many determinants on foreign erythro-
. cytes can serve as carrier molecules. 
There is one report which has relevance to point (6) mentioned 
above. Chou, Dubiski and Cinader (1967) increased the immunogeni-
city of human serum albumin (H8A) in rabbits by incubating the antigen 
with allogeneic red cells or viable nucleated lymphoid cells including 
thymus cells. By using donors and recipients which differed in the 
allotypic specificity of their immunoglobulins, Chou et al. demonstrated 
that only recipient-type anti-H8A antibodies were present in the sera 
at various times after neonatal injection of the cell-associated antigen. 
In contrast to the situation in recipients of lymph node cells, few 
thymus cell recipients contained donor type immunoglobulins in the sera 
at 14 days of age. Nevertheless, a largernumber of thymus cell reci-
pients contained a higher concentration of donor-type immunoglobulin 
throughout the 160 day observation period. The authors porposed that 
thymus cells, by virtue of their relative immaturity, possessed a 
greater potential for establishing cellular chimaerism and thus for 
producing immunoglobulins whilst resident in the tissues of the 
recipient. 
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Provided that the donor cells had not transferred specific 
information for the expression of allotypy to recipient cells, the data 
suggests that thymus-derived cells have the potential for synthesizing 
circulating immunoglobulins. ·This is contrary to the implications of 
the hypothesis developed above. It is possible that a certain propor-
tion of thymus cells have the ability to dedifferentiate into "stem cells" 
of the type which are thought to be sequestered into the thymus from the 
circulation (reviewed in Miller and Osoba, 1967). Alternatively, thymuses 
removed at any one particular time may contain a number of immigrant 
"stem cells" which have yet to come under the influence of the humoral 
factors elaborated by the epithelial cytoreticulum (Section IC). The 
"thymus-repopulating unit", which presumably originates in the bone 
marrow, could retain the potential for immunoglobulin synthesis prior 
to undergoing proliferation and differentiation within the thymus 
environment. Bone marrow cell inocula were not included in the 
experiments of Chou et al. and it would be of interest to know whether 
such inocula promote the appearance of large amounts of persisting 
donor-type immunoglobulins in a large proportion of the newborn 
recipients. 
The answers to two questions are required before a clear under-
standing of cellular interactions in haemolysin production will be 
possible. These questions are relevant to any proposal based on 
the transfer of information between thymus-derived cells and bone 
marrow-derived cells. Can tolerance to SRBC be induced in the 
bone marrow cell line and does the product of the bone marrow-derived 
PFC carry any marker distinctive for the thymus-derived cell? An 
additional question may be posed. If the majority of thoracic duct 
lymphocytes are thymus derived and if immunological memory is 
carried by populations of thoracic duct cells, what will be the result 
of combinations of primed thoracic duct lymphocytes and virgin bone 
marrow-derived cells? If the avidity of the antibody molecules 
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elaborated by cells of the bone-marrow inoculum is increased, then 
this must surely be good evidence for a transfer of information between 
the two cell types. The answers to such questions must await the in-
corporation of simpler antigens or hapten-carrier conjugates into the 
present system. The antigens must of necessity require the presence 
of thymus-derived cells to elicit an antibody response; that is the 
antibody responses must be "thymus dependent". 
Experimental and clinical evidence suggests that cell-mediated 
immunities, such as delayed-type hypersensitivity and the homograft 
reaction, are severely affected by the absence of the thymus. Further-
more, a strong case can be made out for the concept that recircu-
lating lymphocytes, and by inference, thymus-derived cells, are 
involved in the initiation of these particular responses (Section IB, IC 
and Coe, Feldman and Lee, 1966). Extrapolations from the results 
presented here may suggest that the sensitized effector cells in cell-
mediated immune responses are bone marrow-derived and not of the 
same cell lineage as the cells which initiate the response (thymus 
derived). Short-lived mononuclear cells predominate in lesions of 
delayed hypersensitivity (discussed by Waksman, 1964) and, in passive 
transfer systems, the majority of these cells are derived from the 
bone marrow (Lubaroff and Waksman, 1968). These cells may or may 
not be specifically-sensitized effector cells. The majority of mono-
nuclear cells most probably do not have specificity in the immunological 
sense and they apparently accumulate as a result of the liberation of 
pharmacologically-active substances such as the macrophage migration 
inhibitory factor (Bennett and Bloom, 1968). Obviously, the avail-
ability of techniques capable of enumerating sensitized effector cells 
in cell-mediated immunities must precede any type of reconstitution 
experiment, similar to those described in this thesis, and designed to 
test whether reconstitutive lymphoid cells provide effector cells or 
their precursors. 
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The complexity of the SRBC ''antigen" has been stressed and a 
large inoculum of intravenously injected SRBC is unlikely to resemble 
the type and dose of antigenic material which the normal immune system 
is called upon to counteract. Furthermore, the humoral antibody 
response to SRBC is one of very few which is affected by neonatal 
thymectomy in the mouse. In view of these considerations, is 
there any reason to suppose that the primary immune ref:>ponse to many 
immunological cues involves the activity of more than one lymphoid 
cell type as seems to be the case in the primary 19S haemolysin 
response to SRBC in CBA mice? 
Thymus-marrow interactions have been implicated in the 
response of mice to BSA (Taylor, 1968} and neonatal thymectomy 
depresses the response of mice to this antigen (Good et al •• 1962; 
Taylor, 1963; Basch, 1966). Interestingly, neonatal1ythymectomy 
has little effect on the capacity of mice to respond to Salmonella 
flagellin (Martin and Miller, 1968b}. and a thymus-marrow interaction 
cannot be demonstrated in irradiated mice (Armstrong and Diener, 
1968). Likewise, the primary immune response to SRBC is un-
affected by neonatal thymectomy in the rat (Pinnas and Fitch, 1966; 
Lind, P. and Steward, J .• personal communications) and no evidence 
for a thymus-marrow interaction in irradiated rats has been obtained 
by McCullagh (1968). Many of the results are preliminary, however, 
and it would be unwise to emphasise this apparent separation of primary 
antibody responses into "thymus independent" (mediated by nonthymus-
derived cells) and "thymus dependent" (mediated by cells, some of 
which are thymus-derived}. Furthermore, the numerous differences 
in experimental design do not augur well for the validity of any compa-
rison made between results obtained in various laboratories. 
If recirculating thymus-derived lymphocytes are involved in 
some antibody responses but not others, it might be anticipated 1hat 
adoptive transfers in irradiated recipients with normal thoracic duct 
lymphocytes may show differences depending on the antigen used. 
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However, the efficacy of thoracic duct cells in adoptively transferring 
. antibody responses is not related in any simple fashion to the effects 
of neonatal thymectomy. Thus, whole thoracic duct lymphocyte 
inocula, collected on the first day of drainage, transfer primary res-
ponsiveness to (1) BSA in rats (Strober, 1968) - thymus dependent 
(Jankovic, Waksman and Arnason, 1962), (2) Salmonella flagellin in 
mice (Nossal, Shortman, Miller, Mitchell and Haskill, 1967) - thymus 
independent (Martin and Miller, 1968b), (3) SRBC in mice - thymus 
dependent (vide supra), (4) SRBC in rats (Section IC) - thymus inde-
pendent, but not to (5) tetanus toxoid in rats (Strober, 1968) - thymus 
independent in mice (Hess et al., 1963; Hess and Stoner, 1966). A 
clearer picture will emerge with the development of techniques capable 
of separating or eliminating thymus-derived cells from peripheral 
lymphocyte populations. 
One must predict on the basis of the partial immunological 
effects of neonatal thymectomy, that thymus-derived lymphocytes are 
unlikely to be involved in many primary antibody responses. Their 
participation must remain doubtful until it can be demonstrated that 
prenatal thymus cell migration occurs and that the number of thymus-
derived cells is increased substantially by peripheral clonal expansion. 
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